GeneName	KCREB:C	KCREB:C	KCREB:CREC	KCREB:CREC	KCREB:CRE	KCREB:CRE	PC3M:C	PC3M:C	PC3M:CREC	PC3M:CREC	PC3M:CRE	PC3M:CRE	CREB:C	CREB:C	CREB:CREC	CREB:CREC	CREB:CRE	CREB:CRE
"OS-9precurosormRNA,completecds"	0.95	0.89	1.22	1.07	1.06	0.89	1.42	1.18	1.1	0.93	0.51	0.86	0.64	0.87	1.01	0.95	-0.13	-0.34
"TNFreceptorassociatedfactor6(TRAF6)mRNA,completecds"	-0.57	-0.54	-0.3	-0.39	-0.52	-0.46	-0.21	-0.51	-0.45	-0.68	-0.82	-0.6	-0.73	-0.45	-0.44	-0.45	-1.28	-0.97
"cyclin-selectiveubiquitincarrierproteinmRNA,completecds"	0.7	0.68	1.08	0.94	0.97	0.77	1.15	1.01	0.97	0.72	0.35	0.65	0.67	0.99	0.76	0.81	-0.1	-0.16
"inositol1,3,4-trisphosphate5/6-kinasemRNA,completecds"	0.26	0.12	0.31	0.29	0.33	0.13	0.5	0.21	0.25	0	-0.33	-0.03	0.22	0.04	0.13	-0.1	-0.64	-0.77
"interleukin-11receptoralphachainmRNA,completecds"	0.85	0.69	1.07	0.87	1.07	0.8	0.74	0.52	0.69	0.67	0.24	0.47	0.54	0.23	0.76	0.44	-0.53	-0.17
"Human low-Mr GTP-binding protein (RAB31) mRNA, complete cds"	-0.24	-0.31	-0.41	-0.32	-0.26	-0.43	-0.14	-0.5	-0.36	-0.48	-0.66	-0.42	-0.23	-0.27	-0.32	-0.5	-0.69	-0.35
TRANSCRIPTIONALREGULATORISGF3GAMMASUBUNIT	-0.27	-0.27	-0.22	-0.27	-0.24	-0.4	-0.14	-0.3	-0.28	-0.41	-0.63	-0.37	-0.48	0.26	-0.19	-0.27	-0.5	-0.41
TYROSINE-PROTEINKINASEITK/TSK	0.72	0.67	1.11	0.96	0.91	0.81	0.76	0.65	0.86	0.82	0.24	0.37	0.75	0.61	1.23	1.13	0.23	-0.01
Transcriptionfactor11(basicleucinezippertype)	-1.43	-1.31	-1.38	-1.52	-1.28	-1.53	-1.22	-1.44	-1.21	-1.25	-1.22	-1.09	-1.3	-0.72	-1	-1.33	-1	-0.6
Transmembranetyrosine-specificproteinkinaseROS1	-1.43	-1.62	-1.7	-1.47	-1.78	-1.96	-1.28	-1.54	-1.61	-1.85	-1.66	-1.5	-1.74	-1.22	-1.69	-2.05	-1.16	-0.88
V-aktmurinethymomaviraloncogenehomolog1	1.95	1.95	1.9	1.86	1.92	1.8	2.03	1.88	1.8	1.82	1.74	1.88	1.82	1.43	1.75	1.76	1.08	0.72
Vasodilator-stimulatedphosphoprotein	-0.23	-0.26	-0.25	-0.2	-0.03	-0.26	-0.3	-0.45	-0.35	-0.35	-0.46	-0.2	-0.47	-0.25	-0.12	-0.21	-0.65	-0.25
"100kDacoactivatormRNA,completecds"	-1.17	-1.12	-0.98	-1.01	-1.2	-1.18	-0.8	-0.59	-0.81	-0.96	-1.18	-1.03	-1.05	-0.59	-1.18	-1.15	-1.16	-0.93
"5'-AMP-activatedproteinkinase,gamma-1subunitmRNA,completecds"	-0.96	-1.14	-1.04	-1.24	-1.31	-1.31	-0.8	-1.1	-1.15	-1.2	-1.53	-1.08	-1.19	-0.94	-1.31	-1.42	-1.03	-1.01
"APEG-1mRNA,completecds"	0.23	0.22	0.55	0.46	0.46	0.38	0.66	0.38	0.47	0.16	-0.3	-0.06	0.25	0.57	0.22	0.21	-0.72	-0.67
"BMK1alphakinasemRNA,completecds"	-1.04	-1.05	-0.99	-0.86	-1.04	-1.03	-0.96	-1.05	-1.1	-1.18	-1.35	-1.34	-1.33	-0.91	-0.98	-1.19	-1.32	-1.38
"Bcl2,p53bindingproteinBbp/53BP2(BBP/53BP2)mRNA,completecds"	0.61	0.52	0.81	0.7	0.77	0.79	0.64	0.33	0.57	0.48	-0.09	0.27	0.35	0.27	0.62	0.57	-0.17	-0.29
"CREB-bindingprotein(CBP)mRNA,completecds"	-0.14	-0.41	-0.16	-0.23	-0.21	-0.34	-0.2	-0.49	-0.4	-0.44	-0.74	-0.46	-0.18	-0.38	-0.27	-0.44	-0.93	-0.94
"ProteinkinaseC,iota"	0.62	0.5	0.39	0.34	0.38	0.35	0.39	0.32	0.48	0.48	0.25	0.45	0.6	0.61	0.6	0.6	0.32	0.12
"Proteinkinase,cAMP-dependent,catalytic,alpha"	0.84	0.77	1.2	1.14	1.14	0.87	0.76	0.6	0.9	0.89	0.46	0.5	0.86	-0.01	1.31	0.93	0.07	-0.21
"Proteinkinase,interferon-inducibledoublestrandedRNAdependent"	-0.19	-0.39	-0.26	-0.58	-0.31	-0.45	-0.15	-0.28	-0.36	-0.34	-0.35	-0.11	-0.14	-0.12	-0.31	-0.4	-0.22	-0.65
"Proteinphosphatase2(formerly2A),regulatorysubunitB''(PR72),alphaisoformand(PR130),betaisoform"	-0.82	-0.93	-0.96	-1.03	-0.91	-0.96	-0.8	-1.03	-0.93	-0.87	-0.94	-0.73	-0.76	-0.93	-0.93	-1.18	-1.28	-0.93
"Proteintyrosinephosphatase,non-receptortype1"	0.78	0.74	0.88	0.79	0.91	0.82	0.89	0.55	0.61	0.63	0.48	0.49	0.85	0.38	0.79	0.52	-0.08	-0.46
"Proteintyrosinephosphatase,receptortype,alphapolypeptide"	-0.13	-0.42	-0.17	-0.28	-0.26	-0.24	-0.04	-0.52	-0.45	-0.58	-0.58	-0.48	-0.33	-0.55	-0.5	-0.66	-0.89	-0.77
"H.sapiens mRNA for protein containing SH3 domain, SH3GL3"	1.77	1.73	1.83	1.77	1.81	1.67	1.75	1.64	1.8	1.58	1.21	1.45	1.63	1.52	1.63	1.55	0.91	0.72
"mitogeninduciblegenemig-2,completeCDS"	2.06	2.14	2.3	2.12	2.08	2.01	2.23	1.92	1.96	1.8	1.08	1.54	1.91	0.89	2.02	1.7	-0.09	-0.7
HEMATOPOIETICLINEAGECELLSPECIFICPROTEIN	-0.32	-0.51	-0.36	-0.35	-0.33	-0.34	0.03	-0.24	-0.38	-0.55	-0.98	-0.65	-0.43	-0.02	-0.4	-0.64	-1.03	-0.67
"E2F-relatedtranscriptionfactor(DP-1)mRNA,completecds"	-0.04	-0.13	0	0.01	0.06	-0.08	0.17	0.08	-0.01	-0.1	-0.62	-0.24	0.08	-0.49	-0.16	-0.41	-1.02	-1.12
"NF-E2protein(NF-E2)mRNA,completecds"	0.9	0.89	0.91	0.96	0.87	0.99	0.55	0.73	0.89	0.89	0.2	0.57	0.92	0.07	1.12	1.12	0.53	0.48
"checkpointkinaseChk1(CHK1)mRNA,completecds"	1.63	1.65	2	1.8	1.85	1.79	1.88	1.66	1.74	1.56	1	1.17	1.29	0.56	1.91	1.78	1.41	1.16
LIMdomainkinase1	1.91	1.9	2.09	2.02	2.05	2	2.01	1.76	1.81	1.7	1.24	1.25	1.81	0.78	2.05	1.78	0.58	0.01
"Lectin,galactoside-binding,soluble,7(galectin7)"	-0.41	-0.69	-0.34	-0.67	-0.54	-0.53	-0.64	-0.88	-0.68	-0.75	-0.94	-0.78	-0.46	-0.4	-0.36	-0.56	-0.72	-0.57
MAPKINASEPHOSPHATASE-1	-0.89	-0.94	-0.91	-0.96	-1.09	-1.1	-0.86	-1.1	-0.94	-0.98	-0.95	-0.64	-1.1	-0.75	-1.09	-1.23	-1	-0.96
Macrophagestimulating1(hepatocytegrowthfactor-like)	0.01	-0.01	0.1	0.09	0.2	0.08	0.05	-0.26	-0.1	-0.27	-0.41	-0.31	-0.02	-0.13	0.09	-0.12	-0.53	-0.37
"Neurotrophictyrosinekinase,receptor,type1"	-0.06	-0.11	0.01	-0.16	0.05	-0.21	-0.14	-0.29	-0.16	-0.27	-0.37	-0.25	0.02	-0.32	-0.02	-0.28	-0.79	-0.75
PROTEINPHOSPHATASEINHIBITOR2	-0.59	-0.68	-0.32	-0.43	-0.44	-0.57	-0.69	-0.91	-0.68	-0.8	-0.83	-0.91	-0.13	-0.22	-0.6	-0.6	-1.03	-0.99
GATA-bindingprotein1(globintranscriptionfactor1)	0.08	0	0.17	-0.03	-0.04	-0.07	0.18	-0.15	-0.02	-0.22	-0.56	-0.17	-0.08	-0.24	0.01	-0.32	-0.43	-0.56
Gardner-Rasheedfelinesarcomaviral(v-fgr)oncogenehomolog	-0.15	-0.23	-0.14	-0.14	-0.22	-0.19	0.04	-0.26	-0.09	-0.25	-0.77	-0.37	-0.32	0	-0.1	-0.36	-0.75	-0.72
GeneraltranscriptionfactorIIB	-1.73	-1.63	-1.67	-1.61	-1.76	-1.68	-1.34	-1.7	-1.76	-1.76	-2.15	-1.53	-1.71	-1.09	-1.73	-1.97	-1.5	-1.38
"Guaninenucleotidebindingprotein(Gprotein),alphaactivatingactivitypolypeptide,olfactorytype"	-1.07	-1.11	-0.92	-0.65	-1	-1.02	-0.75	-1.02	-0.98	-1.08	-1.55	-1.03	-0.91	-0.61	-1.03	-1.27	-1.04	-0.94
40kDaproteinkinaserelatedtoratERK2	1.54	1.46	1.87	1.68	1.74	1.7	1.53	1.39	1.53	1.43	0.88	1.01	1.24	0.62	1.85	1.67	1.34	1.28
"KHKketohexokinase,clonepHKHK3a"	1.49	1.44	1.84	1.68	1.69	1.62	1.67	1.55	1.7	1.56	0.99	1.1	1.12	0.68	1.72	1.62	1.02	0.92
"Human orphan G protein-coupled receptor (RDC1) mRNA, partial cds"	1.76	1.78	1.91	1.83	1.9	1.86	1.9	1.56	1.74	1.63	1.13	1.27	1.15	0.99	1.74	1.79	0.72	0.54
"phosphatidylinositol-4-phosphate5-kinasetypeIIbetamRNA,completecds"	-0.99	-0.83	-0.75	-1.01	-0.84	-0.84	-0.85	-1.14	-1.02	-0.97	-1.38	-1.18	-1.02	-0.49	-1.16	-1.05	-1.16	-0.87
"proteinkinasemRNA,completecds"	-0.9	-0.91	-0.82	-1.05	-0.95	-0.86	-0.82	-1.04	-0.98	-1.03	-0.96	-1	-0.99	-0.61	-0.92	-0.94	-0.84	-0.6
"proteintyrosinekinasemRNA,completecds"	0.04	-0.05	-0.01	0.06	0.02	0.02	0.3	-0.1	0.11	-0.06	-0.18	-0.09	-0.1	0.16	-0.03	0.02	-0.25	-0.56
"proteintyrosinephosphatasemRNA,completecds"	-1.39	-1.38	-1.32	-1.42	-1.35	-1.38	-1.38	-1.43	-1.48	-1.56	-1.48	-1.25	-1.21	-0.82	-1.47	-1.38	-1	-1
"Human putative G protein-coupled receptor (AZ3B) mRNA, complete cds"	-0.45	-0.61	-0.35	-0.54	-0.53	-0.51	-0.16	-0.47	-0.49	-0.67	-0.58	-0.47	-0.44	-0.38	-0.63	-0.66	-0.7	-0.52
"KIAA0277gene,completecds"	-1.47	-1.5	-1.61	-1.65	-1.47	-1.44	-1.35	-1.38	-1.48	-1.59	-1.68	-1.55	-1.61	-0.92	-1.48	-1.51	-1.13	-1.02
alpha-fetoproteinenhancerbindingprotein	-1.67	-1.62	-1.67	-1.67	-1.62	-1.68	-1.53	-1.59	-1.65	-1.66	-1.76	-1.51	-1.54	-0.97	-1.57	-1.9	-1.52	-0.93
protein-tyrosinephosphatase	-1.78	-1.66	-1.69	-1.86	-1.83	-1.77	-1.46	-1.63	-1.72	-1.79	-2.01	-1.72	-1.68	-0.89	-1.58	-1.81	-1.39	-1.35
"mitochondrialcreatinekinase(CKMT)gene,completecds"	-0.37	-0.39	-0.2	-0.24	-0.28	-0.36	-0.06	-0.26	-0.32	-0.49	-0.98	-0.59	-0.36	0.03	-0.39	-0.66	-0.77	-0.72
"myosinlightchainkinase(MLCK)mRNA,completecds"	-0.59	-0.77	-0.18	-0.61	-0.66	-0.6	-0.8	-0.73	-0.48	-0.76	-1.06	-0.73	-0.6	-0.3	-0.72	-0.72	-0.9	-0.84
"proteinkinase(zpk)mRNA,completecds"	-0.44	-0.59	-0.37	-0.2	-0.6	-0.78	-0.49	-0.75	-0.26	-0.72	-0.65	-0.5	-0.72	-0.64	-0.63	-0.68	-0.84	-0.57
Basictranscriptionfactor3	2.69	2.84	2.51	2.41	2.65	2.59	2.54	2.49	2.55	2.63	2.35	2.29	1.85	0.88	2.21	2.19	0.79	0.27
CDC28proteinkinase1	0.41	0.25	0.57	0.46	0.5	0.58	0.41	0.46	0.51	0.27	-0.1	-0.14	0.18	0.24	0.44	0.36	-0.63	-0.43
"Celldivisioncycle42(GTP-bindingprotein,25kD)"	-1.04	-1.13	-1.08	-1.12	-1.12	-0.96	-0.93	-1.11	-1.09	-1.1	-1.11	-0.89	-1.1	-0.64	-1.36	-1.18	-0.79	-0.86
Cyclin-dependentkinase6	-0.6	-0.71	-0.84	-0.86	-0.91	-0.79	-0.4	-0.73	-0.71	-0.76	-0.55	-0.66	-0.54	-0.36	-0.83	-0.95	-0.61	-0.66
Deoxycytidinekinase	-0.81	-0.96	-0.78	-0.79	-0.86	-0.84	-0.69	-0.82	-0.9	-0.98	-0.89	-0.81	-1.09	-0.52	-0.97	-0.96	-1.11	-0.66
Deoxythymidylatekinase	0.35	0.26	0.55	0.49	0.44	0.4	0.47	0.36	0.48	0.31	0.16	0.22	0.42	0.53	0.35	0.4	-0.08	-0.13
"phosphatidylinositol4-kinase,completecds"	-1.7	-1.62	-1.65	-1.66	-1.7	-1.55	-1.64	-1.6	-1.59	-1.63	-1.83	-1.49	-1.55	-0.71	-1.44	-1.72	-1.06	-0.83
"CD40bindingprotein(CD40bp)mRNA,completecds"	-1.65	-1.7	-1.68	-1.89	-1.8	-1.67	-1.61	-1.62	-1.79	-1.95	-1.92	-1.65	-1.55	-0.85	-1.79	-1.78	-1.24	-1.32
"CSaidsbindingprotein(CSBP1)mRNA,completecds"	-1.82	-1.61	-1.75	-1.77	-1.66	-1.7	-1.68	-1.72	-1.73	-1.78	-2.11	-1.73	-1.91	-0.97	-1.67	-1.9	-1.36	-1.13
"Human GAP SH3 binding protein mRNA, complete cds"	-1.59	-1.66	-1.69	-1.71	-1.6	-1.6	-1.36	-1.68	-1.62	-1.57	-1.85	-1.66	-1.6	-0.91	-1.55	-1.73	-1.44	-1.17
"HS1bindingproteinHAX-1mRNA,nucleargeneencodingmitochondrialprotein,completecds"	0.02	-0.12	0.31	0.14	-0.1	-0.13	-0.43	-0.29	0.04	-0.03	-0.52	-0.17	0.26	-0.36	0.18	-0.03	-0.76	-0.87
"LIMproteinMLPmRNA,completecds"	-1.25	-1.25	-1.07	-1.38	-1.2	-1.08	-1.09	-1.16	-1.2	-1.33	-1.47	-1.27	-1.24	-0.64	-1.28	-1.28	-1.28	-1.27
SIGNALTRANSDUCERANDACTIVATOROFTRANSCRIPTION1-ALPHA/BETA	-0.11	-0.01	0.17	-0.01	0.17	0.08	-0.2	-0.37	0.21	-0.14	-0.6	-0.56	0.18	-0.25	-0.12	-0.31	-0.77	-0.81
Spleentyrosinekinase	-0.45	-0.51	-0.34	-0.42	-0.31	-0.34	-0.37	-0.56	-0.35	-0.54	-0.88	-0.74	-0.76	-0.31	-0.57	-0.61	-0.9	-0.92
TYROSINE-PROTEINKINASERECEPTORTIE-1	0.09	0.06	-0.03	-0.08	-0.11	-0.11	0.11	-0.05	0.1	0.07	0.17	0.2	0.11	0.25	-0.03	0.16	0.12	-0.15
"Tyrosine3-monooxygenase/tryptophan5-monooxygenaseactivationprotein,betapolypeptide"	0.39	0.32	0.46	0.41	0.43	0.38	0.39	0.29	0.21	0.37	0.06	0.17	-0.35	-0.44	0.19	0.32	-0.85	-0.91
Ubiquitin-conjugatingenzymeE2B(RAD6homolog)	0.72	0.58	0.87	0.77	0.85	0.85	0.94	0.7	0.8	0.68	0.27	0.4	0.57	0.83	0.71	0.71	0.09	-0.16
V-ablAbelsonmurineleukemiaviraloncogenehomolog1	0.03	-0.1	0.45	0.29	0.34	0.29	0.31	0.05	0.37	0.22	-0.3	0.18	0.64	0.06	0.39	0.35	-0.42	-0.22
InsP35-phosphatase	0.05	-0.03	0.21	0.05	0.19	0.06	0.13	0	0.02	-0.19	-0.41	-0.08	-0.2	0.51	0.07	0.02	-0.32	-0.19
"USF2a&USF2b,cloneP9DH"	0.69	0.76	0.91	0.76	0.85	0.79	0.82	0.73	0.71	0.49	0.37	0.55	0.45	1.3	0.83	0.8	0.42	0.3
alpha4protein	0.03	-0.06	0.13	0.21	0.13	0.06	0.14	0.09	0.18	0.02	-0.24	0.03	-0.15	0.66	0.06	0.06	-0.2	-0.05
phosphoenolpyruvatecarboxykinase	-1.43	-1.35	-1.43	-1.41	-1.52	-1.39	-1.32	-1.45	-1.41	-1.34	-1.59	-1.27	-1.13	-0.67	-1.41	-1.26	-0.95	-0.74
"proteinkinase,Dyrk2"	-0.51	-0.46	-0.24	-0.41	-0.29	-0.21	-0.43	-0.6	-0.25	-0.35	-0.85	-0.62	-0.36	0.23	0.06	-0.04	-0.69	-0.73
proteinphosphatase6	0.08	0.04	0.68	0.66	0.62	0.64	0.19	0.03	0.6	0.43	-0.38	-0.18	0.37	0.29	1.46	1.25	-0.31	-0.51
"Proteinkinaseinhibitor[,neuroblastomacelllineSH-SY-5Y,mRNA,2147nt]"	-0.43	-0.48	-0.05	-0.04	-0.21	-0.22	-0.37	-0.57	-0.04	-0.28	-0.62	-0.29	-0.23	-0.09	0.22	0.11	-0.67	-0.49
"Proteinphosphatase1,catalyticsubunit,alphaisoform"	1.5	1.47	1.6	1.57	1.58	1.57	1.55	1.35	1.41	1.35	1.28	1.25	1.33	1.19	1.54	1.47	0.34	-0.17
"Proteinphosphatase2(formerly2A),regulatorysubunitB(PR52),alphaisoform"	-0.05	-0.14	0.07	0.09	0.1	0.01	0.19	-0.04	0.03	-0.09	-0.22	-0.17	-0.26	0.53	0.05	0.03	-0.26	-0.48
Proteinserine/threoninekinasestk2	-0.65	-0.67	-0.53	-0.64	-0.65	-0.54	-0.46	-0.64	-0.61	-0.66	-0.93	-0.72	-0.82	-0.36	-0.62	-0.5	-0.7	-0.65
"Proteintyrosinephosphatase,receptortype,betapolypeptide"	0.63	0.51	0.54	0.5	0.48	0.59	0.95	0.78	0.55	0.52	0.65	0.69	0.37	1	0.62	0.71	0.97	1
"Proteintyrosinephosphatase,receptor-type,zetapolypeptide1"	3.3	3.41	2.77	2.92	2.79	3.04	3.43	3.42	3.28	3.29	3.67	3.52	3.31	3.44	2.93	3.31	4.02	4.37
Chimerin(chimaerin)1	-0.66	-0.71	-0.62	-0.76	-0.56	-0.65	-0.75	-0.74	-0.61	-0.89	-1.09	-0.77	-0.67	-0.06	-0.81	-0.71	-0.83	-0.32
Complementcomponent7	-0.82	-0.87	-0.87	-0.8	-0.82	-0.79	-0.49	-1.08	-0.74	-0.83	-1.19	-0.77	-0.67	-0.34	-0.88	-0.93	-0.74	0.04
CyclinH	-0.28	-0.49	-0.38	-0.41	-0.27	-0.32	0.01	-0.49	-0.16	-0.23	-0.28	-0.1	-0.24	0.34	-0.4	-0.48	0.06	-0.1
DUTPpyrophosphatase	-0.74	-0.85	-0.83	-0.98	-0.89	-0.77	-0.81	-1.03	-0.8	-0.9	-1.07	-0.71	-0.93	-0.2	-0.83	-0.86	-0.54	-0.55
"Diacylglycerolkinase,alpha(80kD)"	0.8	0.86	1.17	0.96	1.06	1.05	1.13	0.89	1.12	1.06	0.6	0.75	0.88	1.26	1.39	1.34	0.85	0.69
Eph-relatedreceptortyrosinekinaseligand5	1.06	0.99	0.89	0.86	0.85	0.82	1.71	1.29	1.39	1.27	1.29	1.43	1.36	1.35	1.06	1.09	1.37	1.33
"sulfotransferasemRNA,completecds"	0.58	0.48	0.82	0.7	0.77	0.78	0.85	0.72	0.82	0.62	0.32	0.42	0.53	0.9	0.82	0.64	0.04	-0.22
"thymidinekinase2(TK2)mRNA,completecds"	1.15	1.16	1.27	1.19	1.33	1.16	1.42	1.27	1.26	1.16	0.87	0.92	1.17	1.05	1.24	1.08	0.06	-0.31
Inositolpolyphosphatephosphatase-likeprotein1(51Cprotein)	-1.11	-1.26	-1.05	-1.25	-1.21	-1.06	-0.94	-1.25	-1.05	-1.09	-1.22	-1.19	-1.08	-0.53	-1.12	-1.21	-0.82	-0.61
Insulin-likegrowthfactorbindingprotein6	0.62	0.47	0.61	0.61	0.68	0.69	0.94	0.61	0.66	0.55	0.44	0.48	0.41	1.27	0.53	0.56	0.5	0.35
Leptinreceptor	-0.49	-0.59	-0.73	-0.61	-0.58	-0.39	-0.41	-0.66	-0.52	-0.51	-0.59	-0.37	-0.7	-0.11	-0.72	-0.65	-0.13	-0.39
"Majorhistocompatibilitycomplex,classII,DPbeta1"	0.38	0.14	0.14	0.12	0.24	0.46	0.33	0.22	0.31	0.2	0.18	0.26	0.19	0.54	0.32	0.28	0.54	1.08
"Human squamous cell carcinama of esophagus mRNA for GRB-7 SH2 domain protein, complete cds"	-1.11	-1.26	-1.25	-1.24	-1.23	-1.13	-1.29	-1.28	-1.18	-1.16	-1.22	-1.17	-1.25	-0.59	-1.11	-1.51	-0.63	-0.36
ragBprotein	-0.09	0.02	0.09	0.08	0.2	0.04	0.19	-0.06	0.16	-0.11	-0.43	-0.1	-0.15	0.64	0.05	0.01	-0.04	0.06
Mevalonatekinase	1.78	1.85	1.71	1.76	1.7	1.72	1.89	1.86	1.73	1.75	1.88	1.98	1.76	2.27	1.69	1.9	2.59	2.59
"MutT(E.coli)homolog(8-oxo-7,8-dihydroguanosinetriphosphatase)"	2.02	2.08	1.71	1.39	1.72	1.76	2.12	2.19	2.13	2.11	2.26	2.38	2.28	2.36	1.73	1.84	2.49	2.53
"NucleartranscriptionfactorY,alpha"	-0.25	-0.46	-0.18	-0.2	-0.18	0.01	-0.43	-0.44	-0.26	-0.26	-0.61	-0.32	-0.13	0	0.22	0.03	-0.4	-0.13
PHOSPHATIDYLINOSITOL4-KINASEALPHA	0.25	0.2	0.6	0.43	0.39	0.42	0.55	0.11	0.5	0.39	-0.04	0.06	0.23	0.81	0.47	0.41	0.3	0.04
AMP-activatedproteinkinasebeta-1	-0.44	-0.52	-0.37	-0.62	-0.62	-0.51	-0.24	-0.39	-0.5	-0.58	-0.75	-0.68	-0.61	-0.36	-0.6	-0.63	-0.81	-0.7
"camkinaseImRNA,completecds"	1.37	1.33	1.43	1.3	1.4	1.35	1.46	1.27	1.42	1.24	1.05	0.99	1.51	0.97	1.36	1.19	0.37	-0.32
"homozygousdeletiontargetinpancreaticcarcinoma(DPC4)mRNA,completecds"	-0.77	-0.87	-0.83	-0.83	-0.95	-0.58	-0.62	-0.73	-0.69	-0.72	-0.99	-0.79	-0.86	-0.35	-0.94	-0.82	-0.85	-0.48
Immunoglobulin-associatedalpha	-0.91	-0.94	-1.08	-0.98	-0.92	-0.9	-0.72	-0.98	-0.87	-0.99	-1.26	-0.93	-0.92	-0.51	-1.09	-1.07	-0.66	-0.38
"Proteinphosphatase2(formerly2A),catalyticsubunit,alphaisoform"	0	-0.38	-0.54	-0.36	-0.42	-0.21	0.22	0.01	-0.15	-0.18	-0.13	-0.01	-0.19	0.44	-0.37	-0.27	0.48	0.17
Signaltransducerandactivatoroftranscription5A	-0.76	-1.02	-1.06	-1.14	-1.08	-0.82	-0.9	-0.99	-1.06	-1.18	-1.2	-0.78	-0.99	-0.53	-1.06	-0.99	-0.43	-0.45
"kinasesuppressorofras-1(KSR1)mRNA,partialcds"	-1.74	-1.6	-1.8	-2.01	-1.76	-1.63	-1.71	-1.73	-1.66	-1.62	-1.94	-1.44	-1.66	-1.18	-1.78	-1.61	-0.94	-0.85
"Human low-Mr GTP-binding protein (RAB32) mRNA, partial cds"	0.89	0.86	1.16	1.12	1.1	1.02	0.94	0.89	1.02	0.88	0.49	0.71	0.9	0.98	1.06	1	0.63	0.61
"KIAA0348gene,completecds"	0.71	0.65	0.83	0.86	0.74	0.8	0.98	0.92	0.75	0.67	0.75	0.81	0.7	1.16	0.72	0.93	1.32	1.18
"Human mRNA for SH3 binding protein, clone RES4-23A, complete cds"	0.61	0.55	0.56	0.64	0.44	0.6	0.75	0.72	0.57	0.44	0.5	0.66	0.48	1.07	0.47	0.56	1.39	1.33
"ninjurin1mRNA,completecds"	-0.28	-0.38	-0.15	-0.16	-0.28	-0.2	-0.05	-0.12	-0.21	-0.31	-0.63	-0.36	-0.33	0.2	0.03	-0.17	0.18	-0.11
"proteinkinaseC-bindingproteinRACK17mRNA,partialcds"	0.06	0.08	0.52	0.38	0.43	0.43	0.53	-0.1	0.35	0.15	-0.36	-0.17	0.38	0.66	0.41	0.39	0.01	-0.27
"ESTs,HighlysimilartoPROTEIN-TYROSINEPHOSPHATASEMEG1[]"	-1.24	-1.18	-1.01	-1.27	-1.15	-0.96	-1.11	-1.13	-1.04	-1.17	-1.55	-1.27	-1.14	-0.62	-1.1	-1.27	-0.72	-0.79
"ESTs,HighlysimilartoRETICULOCALBIN[Musmusculus]"	0.47	0.44	0.71	0.61	0.55	0.66	0.72	0.43	0.68	0.55	0.08	0.39	0.44	0.83	0.68	0.59	0.39	0.14
"ESTs,HighlysimilartoSERINE/THREONINE-PROTEINKINASESGK[Rattusnorvegicus]"	0.04	-0.11	-0.1	-0.22	-0.13	-0.1	0.04	-0.1	-0.17	-0.15	-0.46	-0.39	-0.18	0.19	-0.13	-0.13	-0.73	-0.58
"ESTs,HighlysimilartoPROTEIN-TYROSINEPHOSPHATASEEPSILON[]"	-0.31	-0.47	-0.64	-0.45	-0.58	-0.41	0.02	-0.24	-0.51	-0.46	-0.64	-0.51	-0.56	0.08	-0.67	-0.36	-0.39	-0.55
"ESTs,Highlysimilartophosphoinositide3-kinase[]"	1.01	0.78	0.49	0.4	0.53	0.63	1.18	0.84	0.99	1.02	1.18	1.27	1.3	1.2	0.47	0.71	1.14	1.01
"ESTs,ModeratelysimilartoPROTEINKINASEYAK1[Saccharomycescerevisiae]"	0.88	0.83	0.79	0.78	0.77	0.93	1	0.93	0.83	0.77	0.85	0.99	0.7	1.33	0.78	0.9	1.32	1.34
Brutonagammaglobulinemia(BTK)gene	-0.65	-0.64	-0.55	-0.56	-0.58	-0.48	-0.69	-0.54	-0.62	-0.65	-0.94	-0.6	-0.51	-0.22	-0.56	-0.85	-0.55	-0.66
Insulin-likegrowthfactor2(somatomedinA)	1.75	1.76	1.76	1.7	1.68	1.51	1.69	1.66	1.77	1.82	1.63	1.79	2.16	1.65	1.79	1.57	1.62	1.48
"GTPbindingprotein(ARL3)mRNA,completecds"	0.88	0.92	0.63	1.03	0.93	0.98	0.95	0.94	0.79	0.77	0.65	0.85	0.83	1.32	0.91	0.94	1.24	1.21
"MAPkinasekinase6(MKK6)mRNA,completecds"	-0.82	-0.79	-0.77	-0.61	-0.78	-0.62	-0.69	-0.71	-0.77	-0.95	-1.04	-0.72	-0.73	-0.21	-0.79	-0.76	-0.22	-0.26
"MAPKAPkinase(3pK)mRNA,completecds"	-0.26	-0.25	-0.19	-0.11	-0.18	-0.21	0.02	-0.1	-0.17	-0.26	-0.32	-0.21	-0.19	0.29	-0.23	-0.24	0.09	-0.15
"SEF2-1Aprotein(SEF2-1A)mRNA,5'end"	-0.22	-0.38	-0.11	-0.31	-0.2	-0.11	-0.14	-0.57	-0.13	-0.32	-0.65	-0.32	-0.53	-0.19	-0.28	-0.37	-0.48	-0.65
"ESTs,WeaklysimilartoCLATHRINCOATASSEMBLYPROTEINAP17[Rattusnorvegicus]"	0.65	0.47	0.73	0.66	0.67	0.66	0.85	0.85	0.88	0.73	0.57	0.7	0.74	0.9	0.52	0.57	0.55	0.57
"ESTs, Weakly similar to GTPase-activating protein rhoGAP [H.sapiens]"	0.01	-0.14	0.15	0.05	0.02	0.15	0.17	-0.02	0.09	0	-0.33	-0.2	-0.01	0.3	-0.07	0.09	-0.2	-0.44
"ESTs,WeaklysimilartoSIP2PROTEIN[Saccharomycescerevisiae]"	-0.23	-0.36	-0.32	-0.23	-0.28	-0.22	-0.46	-0.37	-0.26	-0.25	-0.59	-0.44	0.04	-0.16	-0.38	-0.31	-0.38	-0.45
"ESTs,Weaklysimilartodualspecificityphosphatase[]"	0.73	0.47	0.72	0.83	0.77	0.87	0.9	0.59	0.77	0.65	0.36	0.45	0.76	0.88	0.61	0.6	0.37	0.38
"ESTs,Weaklysimilartoepidermalgrowthfactorreceptorkinasesubstrate[]"	3.57	3.77	3.37	3.12	3.29	3.49	3.78	3.84	3.59	3.53	3.77	3.68	3.44	3.59	3.48	3.79	4.18	4.49
"Platelet-derivedgrowthfactorreceptor,alphapolypeptide"	0.66	0.31	0.22	0.33	0.27	0.45	0.27	0.26	0.23	0	-0.01	0.21	0.11	0.62	0.23	0.44	0.71	0.33
"Cdc7-relatedkinase,completecds"	-0.11	0.01	0.02	0.13	0.08	-0.01	-0.13	-0.2	-0.17	-0.41	-0.64	-0.39	-0.17	-0.13	-0.23	-0.3	-0.67	-0.94
"VRK1,completecds"	0.55	0.55	0.67	0.57	0.66	0.64	0.5	0.43	0.4	0.31	0.12	0.38	0.53	0.41	0.47	0.52	0.27	0.04
myosinphosphatasetargetsubunit1(MYPT1)	0.21	0.22	0.42	0.4	0.32	0.36	0.16	0.1	0.08	0.06	-0.3	0.07	0.13	0.47	0.17	0.26	0.16	0.18
"myo-inositolmonophosphatase2mRNA,completecds"	0.23	0.31	0.31	0.33	0.27	0.27	0.42	0.32	0.24	0.2	-0.03	0.24	0.27	0.73	0.09	0.23	0.58	0.56
"phosphodiesteraseI/nucleotidepyrophosphatasebeta(PDNP3)mRNA,completecds"	0.97	0.95	1.04	1.1	1.14	1.12	1.19	1.04	1.15	1.05	0.6	0.79	0.91	0.97	0.98	0.99	0.72	0.6
"integrin-linkedkinase(ILK)mRNA,completecds"	-1.08	-1.23	-1.1	-1.33	-1.2	-1.1	-1.14	-1.36	-1.34	-1.45	-1.53	-1.25	-1.02	-0.83	-1.29	-1.26	-1.05	-0.88
"Proteintyrosinephosphatase,non-receptortype2"	-1.4	-1.51	-1.61	-1.5	-1.6	-1.44	-1.48	-1.31	-1.46	-1.56	-1.66	-1.3	-1.48	-0.82	-1.67	-1.46	-1.05	-0.64
"Proteintyrosinephosphatase,receptortype,mupolypeptide"	-1.29	-1.34	-1.22	-1.28	-1.35	-1.1	-1.18	-1.19	-1.1	-1.23	-1.38	-1.15	-1.2	-0.81	-1.52	-1.26	-0.86	-0.68
Recoverin	0.44	0.19	0.31	0.38	0.25	0.53	0.53	0.51	0.48	0.43	0.3	0.47	0.37	0.85	0.36	0.44	0.58	0.39
ESTs	0.03	-0.49	-0.04	-0.03	-0.12	0.31	0.23	0.03	0.11	0.02	-0.27	-0.14	0.18	0.5	-0.1	0.15	0.23	0.18
ESTs	3.22	3.32	2.86	2.96	2.89	3.11	3.41	3.31	3.15	3.2	3.46	3.42	3.19	3.36	3.09	3.31	3.81	3.88
"ESTs,HighlysimilartoCALCIUM/CALMODULIN-DEPENDENTPROTEINKINASEGR[Rattusnorvegicus]"	1.65	1.62	1.56	1.6	1.49	1.59	1.81	1.66	1.67	1.6	1.5	1.68	1.44	1.92	1.61	1.76	2.16	2.01
"Gprotein-coupledreceptorSTRL33.1(STRL33)mRNA,completecds"	0.22	0.19	0.39	0.28	0.29	0.14	0.68	0.5	0.41	0.33	0.18	0.11	-0.01	0.78	0.25	0.35	-0.33	-0.33
"Etstranscriptionfactor(NERF-2)mRNA,completecds"	0.5	0.37	0.83	0.64	0.59	0.51	1.08	0.84	0.8	0.76	0.59	0.65	0.54	1.04	0.62	0.64	-0.19	-0.28
"Gprotein-coupledreceptorGPR-NGAgene,completecds"	0.1	0.03	0.31	0.21	0.27	0.08	0.23	0.24	0.21	0.18	0.09	0.07	0.16	0.36	0.02	0.11	-0.89	-0.65
"Human Gem GTPase (gem) mRNA, complete cds"	0.8	0.77	0.8	0.75	0.88	0.66	0.79	0.66	0.7	0.74	0.88	0.87	0.85	0.13	0.56	0.73	-1.08	-0.79
"HuRRNAbindingprotein(HuR)mRNA,completecds"	-1	-0.85	-0.9	-0.99	-0.95	-1.12	-0.73	-0.85	-0.79	-0.85	-0.47	-0.95	-0.74	-0.24	-1.01	-1.14	-0.94	-0.51
"LGNproteinmRNA,completecds"	-0.61	-0.68	-0.38	-0.87	-0.59	-0.74	-0.59	-0.63	-0.74	-0.65	-0.28	-0.71	-0.54	-0.2	-0.59	-0.65	-1.14	-0.34
"Proteintyrosinephosphatase,receptortype,gammapolypeptide"	0.5	0.5	1.01	0.83	0.73	0.7	0.44	0.36	0.62	0.65	0.54	0.28	0.54	0.55	0.99	1.08	-0.25	-0.13
Protein-tyrosinekinasetyk2(non-receptor)	-1.55	-1.31	-1.21	-1.01	-1.25	-1.26	-1.51	-1.68	-1.46	-1.36	-0.85	-1.17	-1.24	-0.61	-1.25	-1.3	-1.3	-0.91
"Pyruvatekinase,liver"	-0.97	-0.95	-0.86	-1.1	-0.91	-1.28	-1.01	-1.08	-0.91	-1.06	-0.4	-0.79	-0.73	-0.47	-0.89	-0.95	-1.25	-0.89
RAS-RELATEDPROTEINRAB-5A	1.35	1.38	1.57	1.44	1.52	1.34	1.33	1.24	1.34	1.4	1.6	1.41	1.47	0.86	1.27	1.26	0.31	0.11
Riegersyndrome(solurshin)	0.96	0.94	1.12	1.02	1.09	0.96	0.94	0.88	0.69	0.84	1.03	0.84	0.93	0.55	0.91	1.02	0.09	0
Sp3transcriptionfactor	0.06	0.19	0.28	0.13	0.29	0.17	0.26	0.01	-0.04	-0.03	0.23	-0.02	0.07	0.18	0.1	0.09	-0.58	-0.7
"inositolpolyphosphate4-phosphatasetypeII-alphamRNA,completecds"	-1.69	-1.64	-1.93	-1.79	-1.95	-1.79	-1.39	-1.61	-1.43	-1.62	-1.51	-1.37	-1.51	-0.88	-1.69	-1.8	-1.09	-0.81
"HNSPC,completecds"	-0.69	-0.77	-0.57	-0.65	-0.73	-0.77	-0.36	-0.66	-0.55	-0.65	-0.63	-0.74	-0.67	-0.08	-0.62	-0.64	-1.06	-0.78
SKAP55protein	-1.48	-1.44	-1.33	-1.43	-1.54	-1.35	-1.26	-1.17	-1.43	-1.14	-1.2	-1.23	-1.35	-0.7	-1.22	-1.61	-1.34	-0.67
"pescadillomRNA,completecds"	-1.07	-1.09	-1.03	-1.14	-1.27	-1.22	-0.91	-1.06	-1.13	-0.95	-0.83	-1.11	-1.04	-0.71	-1.04	-1.22	-0.95	-0.49
"phosphomevalonatekinasemRNA,completecds"	-0.94	-0.95	-0.72	-0.92	-0.9	-0.87	-0.85	-0.93	-0.95	-0.99	-0.82	-0.91	-0.83	-0.53	-0.83	-0.9	-0.67	-0.6
"(cloneN5-4)proteinp84mRNA,completecds"	-1.06	-0.85	-0.83	-0.91	-0.83	-0.76	-0.89	-1.03	-0.81	-0.93	-0.6	-0.91	-0.95	-0.26	-0.73	-0.79	-0.78	-0.69
PROTEIN-TYROSINEPHOSPHATASE2C	0.31	0.14	0.76	0.61	0.48	0.34	0.19	-0.1	0.6	0.5	0.21	0.07	0.45	-0.03	0.97	0.91	-0.59	-0.1
"Phosphatidylinositol3-kinase,catalytic,gammapolypeptide"	0.91	0.94	1.21	1.09	1.18	1.06	0.47	0.47	0.89	0.92	0.74	0.7	1.16	0.02	1.18	1.04	-0.25	-0.24
"PhospholipaseC,beta4"	0.46	0.37	0.13	0.1	0.18	0.19	0.54	0.57	0.64	0.55	0.91	0.9	0.91	0.97	0.24	0.3	0.47	0.42
Pim-1oncogene	-0.37	-0.23	-0.39	-0.42	-0.38	-0.48	-0.28	-0.46	-0.23	-0.3	-0.14	-0.27	0	-0.16	-0.5	-0.43	-0.76	-0.86
"Platelet-derivedgrowthfactorreceptor,betapolypeptide"	0.23	0.32	0.3	0.19	0.37	0.23	0.41	0.34	0.3	0.14	0.38	0.42	0.21	-0.2	0.27	0.27	-0.48	-0.68
"ProteinkinaseC,beta1"	-0.28	-0.34	-0.14	-0.23	-0.18	-0.33	-0.18	-0.19	-0.32	-0.41	-0.06	-0.32	-0.41	-0.59	-0.32	-0.44	-0.82	-1.05
YPT3mRNA	1.1	1.01	0.68	0.65	0.47	0.62	1.4	1.38	1.32	1.24	1.47	1.47	1.47	1.74	0.75	0.92	1.42	1.45
AP-2betatranscriptionfactor	0.02	0.01	0.24	0.08	0.13	-0.08	0.43	0.34	0.26	0.22	0.02	0.02	0.04	0.75	0.12	0.15	-0.19	-0.2
Iclnprotein	-0.01	-0.09	0.13	-0.05	0.06	-0.15	0.36	0.13	0.09	-0.12	-0.21	-0.05	0.12	0.36	-0.05	-0.08	-1.2	-0.7
Rab11gene	0	0.07	0.2	0.13	0.2	0.02	0.28	0.28	0.15	0.02	-0.06	-0.1	0.21	0.11	-0.03	-0.07	-0.96	-0.66
TGIFprotein	0.09	-0.11	0.27	0.24	0.23	0.16	0.12	0.02	0.1	0.04	-0.11	-0.17	-0.02	-0.08	0.34	0.18	-0.31	0.02
chemokineHCC-1	0.11	0.09	0.52	0.52	0.34	0.39	0.24	0.22	0.35	0.33	0.01	-0.13	0.09	0.06	0.56	0.55	-0.32	0.15
"rasinhibitormRNA,3'end"	1.05	1.16	1.51	1.4	1.36	1.27	1.09	1.1	1.22	1.19	0.9	0.82	0.83	0.72	1.44	1.51	0.68	0.69
"signal-transducingguaninenucleotide-bindingregulatory(G)proteinbetasubunitmRNA,completecds"	-1.28	-0.79	-1.1	-0.94	-0.84	-1.09	-1.23	-1.25	-1.26	-0.99	-1.07	-1.01	-1.07	-0.73	-1.1	-1.16	-1.05	-0.78
"stressresponsiveserine/threonineproteinkinaseKrs-2mRNA,completecds"	-0.56	-0.5	-0.5	-0.76	-0.47	-0.5	-0.64	-0.57	-0.54	-0.6	-0.37	-0.53	-0.47	-0.56	-0.45	-0.72	-0.87	-0.61
"transcriptionfactorERF-1mRNA,completecds"	0.24	0.19	0.55	0.35	0.45	0.35	0.11	0.2	0.27	0.21	0.1	-0.11	0.38	-0.33	0.34	0.13	-0.71	-0.47
"Inositol1,4,5-trisphosphate3-kinaseB"	0.08	0.14	0.31	0.2	0.26	0.18	0.39	0.12	0.18	0.04	0.12	0.06	0.08	0.02	0.11	0.15	-0.43	-0.69
Insulin-likegrowthfactor1receptor	0.06	-0.05	0.11	0.14	0.12	0.09	-0.35	-0.31	-0.05	-0.16	-0.3	-0.42	0.76	-0.21	-0.05	-0.08	-0.81	-0.92
EXTRACELLULARSIGNAL-REGULATEDKINASE1	-0.44	-0.5	-0.37	-0.54	-0.53	-0.45	-0.25	-0.39	-0.34	-0.4	-0.6	-0.52	-0.36	0.27	-0.48	-0.29	-0.64	-0.44
EndothelinreceptortypeB	-1.4	-1.36	-1.22	-1.37	-1.43	-1.31	-1.14	-1.32	-1.37	-1.36	-1.31	-1.32	-1.25	-0.69	-1.51	-1.52	-0.84	-1.02
"Fibroblastgrowthfactorreceptor2(bacteria-expressedkinase,keratinocytegrowthfactorreceptor,craniofacialdysostosis1,Crouzonsyndrome,Pfeiffersyndrome,Jackson-Weisssyndrome)"	-0.06	-0.14	-0.05	-0.1	-0.06	-0.11	0.05	-0.12	-0.1	-0.2	-0.44	-0.33	-0.07	-0.28	-0.38	-0.27	-1.17	-1.12
Fms-relatedtyrosinekinase1(vascularendothelialgrowthfactor/vascularpermeabilityfactorreceptor)	-1.13	-1.14	-1.06	-1.04	-1.22	-1.06	-0.98	-1.08	-0.96	-1.15	-1.05	-1.19	-0.94	-0.68	-1.15	-1.28	-1.2	-0.98
Friedreichataxia	0.31	0.22	0.72	0.64	0.58	0.59	0.48	0.44	0.5	0.5	0.1	0.13	0.39	0.14	0.73	0.8	-0.02	0.23
"GA-bindingproteintranscriptionfactor,alphasubunit(60kD)"	-0.53	-0.58	-0.2	-0.34	-0.49	-0.5	-0.44	-0.57	-0.44	-0.51	-0.65	-0.64	-0.75	-0.55	-0.54	-0.24	-0.73	-0.33
"KIAA0311gene,partialcds"	1.42	1.43	1.77	1.54	1.62	1.63	1.51	1.49	1.5	1.49	1.18	1.13	1.03	0.89	1.56	1.65	0.54	0.49
"KIAA0387gene,partialcds"	0.11	0.14	0.18	-0.06	0.19	0.26	-0.33	-0.36	0.05	-0.08	-0.22	-0.18	-0.04	-0.63	0.01	-0.07	-0.82	-1.06
"histamineN-methyltransferase,completecds"	-0.55	-0.45	-0.48	-0.62	-0.43	-0.37	-0.39	-0.69	-0.53	-0.64	-0.56	-0.57	-0.69	-0.19	-0.63	-0.52	-1.09	-0.94
"tobfamily,completecds"	-1	-0.99	-0.95	-1.15	-1.07	-1.01	-0.99	-1.18	-1.16	-1.26	-0.84	-0.97	-0.99	-1.05	-1.24	-1.18	-1	-0.78
"mitogen-responsivephosphoprotein(DOC-2)mRNA,completecds"	-0.87	-0.96	-0.8	-0.91	-0.85	-0.78	-0.93	-1.33	-1.02	-1.11	-0.82	-1.1	-0.53	-0.62	-0.8	-0.97	-0.93	-1.11
"myleoiddifferentiationprimaryresponseproteinMyD88mRNA,completecds"	-0.63	-0.74	-0.78	-0.83	-0.82	-0.69	-0.74	-1.13	-0.73	-0.77	-0.67	-0.8	-0.61	-0.27	-0.83	-0.82	-0.79	-0.51
"RSU-1/RSP-1mRNA,completecds"	-1.08	-1.32	-1.43	-1.7	-1.58	-1.45	-1.42	-1.48	-1.56	-1.57	-1.62	-1.54	-1.55	-0.78	-1.71	-1.57	-0.9	-0.96
"Human SH3 domain-containing protein SH3P17 mRNA, complete cds"	-0.86	-0.98	-0.96	-1.1	-1.04	-1.02	-0.76	-0.85	-0.83	-0.91	-1.15	-0.95	-0.84	-0.18	-1.05	-0.97	-0.95	-0.59
"alpha-CP1mRNA,completecds"	-0.75	-0.72	-0.73	-0.85	-0.81	-0.78	-0.38	-0.89	-0.66	-0.79	-0.86	-0.87	-0.61	-0.27	-0.84	-0.77	-1.18	-0.73
"clone23840mRNA,partialcds"	-1.32	-1.31	-1.37	-1.35	-1.32	-1.39	-1.34	-1.61	-1.42	-1.46	-1.39	-1.29	-1.14	-0.99	-1.54	-1.55	-1	-1.01
"diacylglycerolkinasezetamRNA,completecds"	-0.65	-0.95	-0.96	-0.9	-1.04	-0.55	-0.84	-1.2	-0.9	-1.03	-0.64	-0.68	-0.85	-0.77	-0.98	-1.26	-1.06	-0.92
"guanylatekinase(GUK1)mRNA,completecds"	3.2	3.38	2.97	3.01	3.17	3.13	3.02	3.05	3.15	3.06	3.05	2.89	2.44	0.99	2.87	2.89	1.03	0.69
V-rafmurinesarcomaviraloncogenehomologB1	0.97	0.89	1.07	0.99	1	1.03	0.95	0.92	1.03	0.91	0.7	0.73	0.46	0.22	0.87	0.86	-0.31	-0.3
"Acidphosphatase5,tartrateresistant"	-0.65	-0.54	-0.74	-0.97	-0.91	-0.89	-0.76	-0.94	-0.79	-0.78	-0.61	-0.79	-0.61	-0.36	-0.87	-0.86	-0.75	-0.71
Activatingtranscriptionfactor3	-1.16	-1.13	-1.35	-1.25	-1.32	-1.3	-1.09	-1.29	-1.17	-1.11	-0.94	-1.01	-1.18	-0.76	-1.46	-1.29	-0.85	-0.91
Adenosinekinase	-0.76	-0.83	-0.65	-0.79	-0.81	-0.77	-0.51	-0.91	-0.77	-0.76	-0.59	-0.7	-0.62	-0.36	-0.65	-0.77	-1.04	-0.85
Alternativeguaninenucleotide-bindingregulatoryprotein(G)alpha-inhibitory-subunit	-1.1	-1.18	-1.11	-1.23	-1.2	-1.25	-0.97	-1.24	-1.1	-0.95	-0.86	-0.95	-1	-0.67	-1.21	-1.18	-0.88	-0.81
Arachidonate5-lipoxygenase	0.69	0.64	0.23	0.19	0.24	0.27	0.86	0.78	0.83	0.85	1.11	1.08	1.19	1.42	0.35	0.4	0.86	0.57
ragAprotein	-1.18	-1.31	-1.32	-1.63	-1.66	-1.23	-1.27	-1.5	-1.25	-1.35	-1.44	-1.19	-1.29	-0.63	-1.52	-1.52	-0.97	-0.78
nek3proteinkinase	-1.24	-1.21	-1.26	-1.23	-1.26	-1.07	-0.96	-1.18	-0.99	-1.26	-1.46	-1.21	-1.23	-0.43	-1.39	-1.22	-0.77	-1.21
Hemopoieticcellkinase	-1.74	-1.64	-1.81	-1.74	-1.82	-1.5	-1.54	-1.59	-1.54	-1.7	-1.66	-1.44	-1.48	-0.78	-1.7	-1.52	-1.28	-1.1
Hexokinase1	-1.58	-1.52	-1.54	-1.8	-1.72	-1.47	-1.34	-1.71	-1.49	-1.64	-1.54	-1.51	-1.47	-0.92	-1.75	-1.71	-1.22	-0.83
"clk1mRNA,completecds"	-1.48	-1.66	-1.53	-1.72	-1.62	-1.43	-1.7	-1.76	-1.59	-1.62	-1.6	-1.48	-1.52	-1.04	-1.69	-1.76	-1.25	-0.76
"cysteineandglycine-richprotein2(CSRP2)mRNA,completecds"	1.08	1.07	1.22	1.12	1.26	1.25	1.15	1.16	1.2	1.16	0.83	0.91	0.85	0.48	0.94	1.02	-0.37	-0.48
"RAP1A,memberofRASoncogenefamily"	1.19	0.91	1.18	1.12	1.3	1.17	1	0.93	1.03	0.99	0.71	0.75	0.55	-0.39	0.83	0.7	-1.05	-0.63
RIBOSOMALPROTEINS6KINASE	0.46	0.36	0.53	0.33	0.27	0.52	0.11	0.19	0.22	0.28	-0.04	-0.02	0.07	-0.33	0.23	0.2	-0.91	-0.66
Ras-relatedC3botulinumtoxinsubstrate2	-0.31	-0.27	-0.32	-0.48	-0.51	-0.41	-0.01	-0.28	-0.3	-0.26	-0.08	-0.14	-0.14	0.03	-0.52	-0.23	-0.5	-0.21
"Retproto-oncogene(multipleendocrineneoplasiaMEN2A,MEN2Bandmedullarythyroidcarcinoma1,Hirschsprungdisease)"	0.35	0.22	0.44	0.33	0.32	0.33	0.45	0.09	0.37	0.24	0.14	0.17	0.14	0.22	0.24	0.28	-0.78	-0.5
"RibosomalproteinS6kinase,90kD,polypeptide2"	-0.06	-0.17	0.3	0.05	0.09	0.08	0.22	0.19	0.21	0.2	-0.13	-0.04	0.58	-0.03	0.3	0.19	-0.6	-0.44
SERINE/THREONINE-PROTEINKINASEPCTAIRE-1	0.69	0.55	1.08	0.94	0.95	0.84	1.03	0.95	0.97	0.97	0.65	0.73	1.31	0.6	1.01	0.76	-0.04	-0.25
"FYNoncogenerelatedtoSRC,FGR,YES"	-0.18	-0.24	-0.13	-0.25	-0.1	-0.09	-0.33	-0.26	-0.23	-0.27	-0.45	-0.17	-0.4	-0.38	-0.22	-0.27	-0.55	-0.64
GTP cyclohydrolase 1 (dopa-responsive dystonia) {alternative products}	-0.36	-0.41	-0.26	-0.48	-0.31	-0.24	-0.3	-0.43	-0.36	-0.45	-0.41	-0.26	-0.56	0.23	-0.39	-0.37	-0.15	-0.47
"GeneraltranscriptionfactorIIF,polypeptide1(74kDsubunit)"	0.85	0.78	1.07	0.92	0.94	0.89	0.85	0.75	0.9	0.82	0.75	0.82	0.77	1.57	0.84	0.88	0.42	0.23
Growthfactorreceptor-boundprotein2	-0.44	-0.57	-0.44	-0.7	-0.65	-0.48	-0.28	-0.44	-0.31	-0.36	-0.31	-0.41	-0.47	0.2	-0.75	-0.6	-0.23	-0.2
"Guaninenucleotidebindingprotein(Gprotein),betapolypeptide1"	-0.92	-0.98	-0.73	-0.88	-0.8	-0.73	-0.9	-0.86	-0.91	-0.89	-1.03	-0.98	-0.27	-0.19	-0.64	-0.58	-0.78	-0.6
MLN62mRNA	0.53	0.38	1.18	0.92	0.9	0.83	0.11	0.26	0.89	0.94	0.29	0.36	1.02	0.61	1.23	1.23	0.18	-0.01
Myristoylatedalanine-richC-kinasesubstrate	-0.18	-0.29	0.04	0.02	0	0.04	-0.13	-0.16	-0.02	-0.08	-0.27	-0.17	-0.16	0.31	0.11	0.1	-0.53	-0.56
Non-catalyticregionoftyrosinekinase	0.66	0.59	0.59	0.74	0.9	0.74	0.55	0.54	0.68	0.54	0.54	0.5	0.67	0.77	0.67	0.8	-0.59	-0.63
PLECKSTRIN	-0.58	-0.55	-0.72	-0.71	-0.65	-0.47	-0.37	-0.59	-0.44	-0.5	-0.5	-0.49	-0.58	0.11	-0.57	-0.44	-0.3	-0.43
PROBABLE G PROTEIN-COUPLED RECEPTOR LCR1 HOMOLOG	0.54	0.43	0.33	0.26	0.31	0.36	0.61	0.69	0.44	0.39	0.65	0.69	0.56	1.15	0.34	0.44	0.94	0.76
"Phosphofructokinase,platelet"	0.06	-0.25	-0.07	-0.12	-0.12	-0.07	0.15	0.01	0.01	-0.02	0.28	0.21	0.07	0.56	-0.24	-0.06	0.42	0.51
Platelet-derivedgrowthfactorbetapolypeptide(simiansarcomaviral(v-sis)oncogenehomolog)	2	2.05	1.75	1.82	1.64	1.82	2.13	2.15	1.98	2	2.36	2.29	2.03	2.59	1.79	2.12	2.79	2.9
V-rafmurinesarcoma3611viraloncogenehomolog1	-0.48	-0.5	-0.61	-0.77	-0.71	-0.36	-0.62	-0.94	-0.58	-0.63	-0.43	-0.48	-0.51	-0.11	-0.7	-0.59	-0.64	-0.32
V-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)	0.41	0.36	-0.04	-0.07	0.03	0.11	0.37	0.19	0.51	0.55	0.79	0.73	0.73	0.68	0.1	0.13	0.73	0.55
CD68antigen	0.35	0.34	0.55	0.35	0.32	0.41	0.49	0.45	0.54	0.46	0.47	0.49	0.46	1.09	0.28	0.45	0.32	0.11
CDC28proteinkinase2	0.85	0.73	0.91	0.88	0.76	0.86	0.87	0.93	1.01	0.96	0.97	1.01	0.94	1.39	0.76	0.83	0.95	0.82
CLEAVAGESIGNAL-1PROTEIN	0.43	0.32	0.67	0.64	0.54	0.58	0.75	0.69	0.76	0.61	0.48	0.57	0.48	0.98	0.71	0.78	0.35	0.17
"Cappingprotein(actinfilament),gelsolin-like"	0.09	0.09	0.34	0.26	0.21	0.22	0.36	0.3	0.4	0.39	0.07	0.12	0.15	0.8	0.26	0.34	-0.1	0.03
"proteinphosphatase-1inhibitormRNA,completecds"	1.31	1.38	1.5	1.42	1.44	1.44	1.55	1.48	1.51	1.41	1.01	1	1.1	1.2	1.45	1.52	0.19	0.02
"protein-tyrosinephosphatase(HU-PP-1)mRNA,partialsequence"	-0.41	-0.52	-0.34	-0.38	-0.27	-0.44	-0.4	-0.41	-0.5	-0.51	-0.54	-0.38	-0.3	-0.08	-0.49	-0.45	-0.85	-0.82
"putativeproteinkinaseCinhibitor(PKCI-1)mRNA,completecds"	-1.39	-1.25	-1.52	-1.66	-1.48	-1.23	-1.13	-1.48	-1.37	-1.32	-1.12	-1.1	-1.26	-0.82	-1.6	-1.5	-0.93	-0.92
"putativesrc-likeadapterprotein(SLAP)mRNA,completecds"	-1.47	-1.27	-1.51	-1.25	-1.49	-1.2	-1.24	-1.36	-1.39	-1.3	-1.09	-1.11	-1.15	-0.73	-1.52	-1.4	-1.16	-0.52
"regulatorofG-proteinsignalingsimilarity(RGS7)mRNA,partialcds"	-0.93	-0.86	-0.96	-0.85	-0.96	-0.82	-1.21	-1.22	-0.93	-1.01	-0.98	-0.93	-1.03	-0.82	-1.06	-1.04	-0.71	-0.39
"signalinginositolpolyphosphate5phosphataseSIP-110mRNA,completecds"	0.13	0	0.15	0.08	0.11	0.19	0.42	0.19	0.2	0.07	0.26	0.26	0.09	0.63	-0.04	0.19	0.32	0.51
"protein-tyrosinephosphatasemRNA,completecds"	-0.25	-0.5	-0.56	-0.65	-0.41	-0.29	-0.27	-0.31	-0.27	-0.3	-0.36	-0.2	-0.25	0.18	-0.53	-0.43	-0.21	-0.33
"pyridoxalkinasemRNA,completecds"	0.51	0.48	0.51	0.53	0.43	0.63	0.72	0.72	0.7	0.63	0.7	0.74	0.46	1.38	0.53	0.68	0.97	0.86
"receptorproteintyrosinephosphatasehPTP-J,mRNA,completecds"	-1.1	-1.27	-1.14	-1.21	-1.24	-1.01	-1.19	-1.13	-1.09	-1.09	-0.97	-0.73	-1.07	-0.56	-1.28	-1.05	-0.52	-0.48
"ser-thrproteinkinasePK428mRNA,completecds"	0.13	0.05	0.14	-0.02	0.01	0.06	-0.15	0.02	0.07	0.1	-0.14	-0.04	0.05	0.12	-0.04	0.16	-0.16	-0.23
"serinekinasemRNA,completecds"	-0.54	-0.55	-0.44	-0.53	-0.54	-0.45	-0.19	-0.36	-0.25	-0.49	-0.71	-0.45	-0.49	0.1	-0.45	-0.34	-0.34	-0.67
"serine-threoninephosphatase(PP5)mRNA,partialcds"	-1.27	-1.23	-1.37	-1.45	-1.47	-1.07	-1.24	-1.32	-1.3	-1.32	-1.31	-1.18	-1.38	-0.71	-1.37	-1.08	-0.94	-1.05
"ESTs,ModeratelysimilartoPUTATIVESERINE/THREONINE-PROTEINKINASEPKWA[Thermomonosporacurvata]"	-1.09	-1.15	-1.35	-1.43	-1.24	-1.02	-0.95	-1.17	-1.09	-0.92	-1.04	-0.89	-1.17	-0.62	-1.11	-1.07	-0.65	-0.65
"ESTs,ModeratelysimilartoMIXEDLINEAGEKINASE2[]"	-0.09	-0.33	0.03	-0.22	-0.06	0.01	-0.04	-0.12	-0.04	-0.13	-0.32	-0.21	-0.01	0.19	-0.21	-0.13	-0.22	-0.49
"ESTs,ModeratelysimilartotranscriptionfactorE2F-4[]"	-0.82	-1.03	-1.09	-1.05	-1.19	-0.78	-0.91	-1.08	-0.97	-1.12	-0.96	-0.83	-1.11	-0.79	-1.19	-1.05	-0.85	-0.76
"ESTs,Weaklysimilartoprotein-tyrosinekinase-relatedreceptorPTK7[]"	-1.01	-1.1	-1.3	-1.26	-1.33	-1.19	-1.05	-1.05	-1.01	-1.08	-0.82	-0.77	-1.05	-0.4	-1.37	-1.14	-0.41	-0.33
"ESTs,Weaklysimilartoprotein-tyrosinephosphatase[]"	-1.26	-1.3	-1.42	-1.3	-1.47	-1.2	-1.02	-1.3	-1.32	-1.27	-1.09	-1.09	-1.27	-0.62	-1.41	-1.38	-0.86	-0.94
"ESTs,Weaklysimilartosimilartoyeastadenylatecyclase[]"	-0.66	-0.63	-0.61	-0.62	-0.69	-0.47	-0.59	-0.68	-0.57	-0.73	-0.52	-0.51	-0.78	0.09	-0.73	-0.56	-0.28	0.06
"SREBP-1mRNA,completecds"	-1.49	-1.61	-1.54	-1.82	-1.56	-1.36	-1.46	-1.49	-1.44	-1.66	-1.67	-1.3	-1.46	-1.01	-1.78	-1.64	-0.98	-0.82
"activatedp21cdc42Hskinase(ack)mRNA,completecds"	-0.92	-1.21	-1.01	-1.13	-1.15	-0.95	-0.89	-0.89	-0.92	-1	-1.09	-0.72	-0.93	-0.31	-1.07	-0.95	-0.46	-0.46
"cartilage-specifichomeodomainproteinCart-1mRNA,completecds"	0.39	0.13	0.45	0.42	0.22	0.43	0.56	0.6	0.49	0.54	0.42	0.57	0.57	1	0.43	0.5	0.83	0.84
"chloridechannelprotein(CLCN7)mRNA,partialcds"	2.47	2.57	1.99	2.19	2.01	2.3	2.17	2.49	2.37	2.37	2.69	2.68	2.48	2.8	2.17	2.55	3.19	3.45
"densityenhancedphosphatase-1mRNA,completecds"	0.81	0.72	0.83	0.78	0.75	0.9	1.22	1.17	0.97	0.86	0.81	0.89	0.89	1.29	0.91	0.88	1.04	1.07
"focaladhesionkinase(FAK)mRNA,completecds"	-1	-1.11	-0.95	-1.07	-1.14	-0.86	-0.93	-1	-0.74	-0.89	-1.1	-0.93	-0.98	-0.43	-1.05	-0.91	-0.81	-0.74
ESTs	-1.02	-1.09	-1.26	-1.38	-1.19	-0.99	-0.8	-1.04	-0.92	-1.06	-1.06	-0.88	-0.95	-0.59	-1.19	-0.98	-0.49	-0.38
ESTs	2.32	2.41	1.94	1.97	1.83	2.08	2.31	2.52	2.45	2.45	2.63	2.7	2.57	2.66	2.03	2.29	2.8	2.92
"ESTs,HighlysimilartoADENYLYLSULFATEKINASE[Saccharomycescerevisiae]"	-0.17	-0.17	-0.33	-0.31	-0.09	-0.06	-0.09	-0.02	-0.28	-0.17	-0.35	0.35	0.01	0.09	-0.35	-0.31	-0.09	0.19
"ESTs,HighlysimilartoDEVELOPMENTALLYREGULATEDGTP-BINDINGPROTEINDRG[Musmusculus]"	0.8	0.48	0.65	0.65	0.56	0.74	1.17	1.15	0.99	0.98	0.95	1.18	0.94	1.63	0.74	0.83	1.32	1.15
"ESTs,HighlysimilartoGAMMA-AMINOBUTYRIC-ACIDRECEPTORDELTASUBUNIT[Rattusnorvegicus]"	0.23	0.18	-0.14	-0.11	-0.09	0.03	0.37	0.29	0.28	0.25	0.35	0.52	0.48	0.91	-0.01	0.08	0.53	0.17
"ESTs,HighlysimilartoGUANINENUCLEOTIDE-BINDINGPROTEING(I)/G(S)/G(O)GAMMA-5SUBUNIT[Bostaurus;Rattusnorvegicus]"	0.88	0.69	0.53	0.56	0.56	0.67	1.11	1.05	1.05	0.99	1.06	1.29	1.08	1.61	0.67	0.82	1.36	1.26
"proteinphosphatase2AB56-beta(PP2A)mRNA,completecds"	-1.28	-1.39	-1.53	-1.55	-1.46	-1.16	-1.42	-1.39	-1.24	-1.46	-1.37	-1.28	-1.21	-0.81	-1.45	-1.4	-0.86	-0.49
"proteinphosphatasewithEF-hands-1(PPEF-1)mRNA,completecds"	0.89	0.77	0.81	0.74	0.7	0.81	0.9	0.7	0.77	0.61	0.7	0.88	0.72	1.19	0.61	0.79	1.26	1.18
"pyruvatedehydrogenasekinaseisoenzyme3(PDK3)mRNA,completecds"	1.82	1.72	1.54	1.62	1.48	1.72	1.81	1.83	1.75	1.72	1.96	1.95	1.67	2.39	1.62	1.84	2.6	2.73
"stress-activatedproteinkinase4mRNA,completecds"	-0.11	-0.41	-0.37	-0.33	-0.51	-0.23	-0.12	-0.02	-0.13	-0.11	-0.07	0.33	-0.04	0.4	-0.4	-0.16	0.61	0.71
"14-3-3epsilonmRNA,completecds"	-0.87	-0.86	-0.91	-1.01	-0.98	-0.75	-0.77	-0.77	-0.76	-0.8	-0.95	-0.73	-0.9	-0.37	-0.97	-0.81	-0.56	-0.46
"ARF-activatedphosphatidylcholine-specificphospholipaseD1a(hPLD1)mRNA,completecds"	-0.33	-0.51	-0.08	-0.28	-0.34	-0.25	-0.35	-0.38	-0.22	-0.38	-0.58	-0.45	-0.1	-0.12	-0.32	-0.48	-0.65	-0.35
"ESTs, Highly  similar to HYPOTHETICAL GTP-BINDING PROTEIN IN PMI40-PAC2 INTERGENIC REGION [Saccharomyces cerevisiae]"	-1.27	-1.44	-1.42	-1.37	-1.49	-1.19	-1.42	-1.36	-1.37	-1.35	-1.48	-1.21	-1.2	-0.79	-1.55	-1.42	-1.14	-0.69
"ESTs,HighlysimilartoPROTEINPHOSPHATASEPP2A,55KDREGULATORYSUBUNIT,ALPHAISOFORM[;Oryctolaguscuniculus]"	0.12	-0.06	0.33	0.29	0.13	0.39	0.14	0.13	0.22	0.37	-0.21	-0.14	0.34	0.55	0.23	0.47	0.05	0.2
"ESTs,HighlysimilartoRIBOSOMALPROTEINS6KINASE[]"	0.76	0.51	1.09	0.84	0.88	0.99	0.77	0.65	0.86	0.64	0.52	0.64	0.9	1.41	0.89	0.94	0.44	0.07
"ESTs,ModeratelysimilartoCYCLIC-AMP-DEPENDENTTRANSCRIPTIONFACTORATF-6[]"	0.04	-0.25	0.12	-0.26	-0.04	0.04	0.14	0.02	0.1	-0.01	-0.18	-0.03	0.01	0.66	0.01	0.19	0.24	0.17
"ESTs,ModeratelysimilartoSERINE/THREONINE-PROTEINKINASEPAK[Rattusnorvegicus]"	1.62	1.61	1.66	1.63	1.53	1.6	1.78	1.78	1.69	1.65	1.66	1.82	1.65	2.13	1.72	1.88	2.19	2.09
"ESTs,WeaklysimilartoCALMODULIN[S.cerevisiae]"	0.89	0.93	0.83	0.92	0.71	0.94	1.39	1.32	1.22	1.17	1.24	1.4	1.22	1.79	0.92	1.03	1.5	1.51
tyrosinekinaseactivatorprotein1(TKA-1)	0.79	0.68	0.9	0.82	0.77	0.76	0.62	0.51	0.61	0.58	0.38	0.61	0.73	0.77	0.69	0.72	0.31	0.39
	1.14	1.03	1.16	1.1	1.08	1.02	0.89	0.85	0.98	0.86	0.59	0.76	1.09	0.13	0.81	0.75	-0.18	0
"JNKkinase2(JNKK2)mRNA,completecds"	1.79	1.71	1.52	1.73	1.51	1.77	1.84	1.85	1.69	1.62	1.74	1.84	1.68	2.29	1.6	1.83	2.43	2.47
"angiopoietin-2mRNA,completecds"	0.92	0.9	0.98	0.86	0.83	0.97	0.97	0.93	0.89	0.84	0.9	0.96	0.91	1.39	0.81	0.93	1.34	1.06
"clk2kinase(CLK2),propin1,cote1,glucocerebrosidase(GBA),andmetaxingenes,completecds;metaxinpseudogeneandglucocerebrosidasepseudogene;andthrombospondin3(THBS3)gene,partialcds"	0.85	0.69	1.03	1.03	0.93	1	1.12	1.06	1.14	1.02	0.81	0.87	0.91	1.16	0.88	0.97	0.57	0.52
"clone23863mRNA,partialcds"	-0.17	-0.2	0.11	0.02	-0.19	0.1	-0.13	-0.09	0.07	0.02	-0.55	-0.43	-0.07	0.23	-0.06	-0.12	-0.56	-0.46
POTASSIUMCHANNELPROTEINKV1.1	-0.67	-0.81	-1	-0.69	-0.79	-0.55	-0.8	-0.62	-0.62	-0.57	-0.87	-0.73	-0.87	-0.14	-0.76	-0.64	-0.36	-0.35
"PROTEINKINASEC,THETATYPE"	-0.55	-0.72	-0.29	-0.44	-0.46	-0.29	-0.64	-0.74	-0.45	-0.56	-0.92	-0.73	-0.59	-0.27	-0.52	-0.38	-0.76	-0.72
"Phosphofructokinase,muscle"	0.5	0.2	0.76	0.52	0.59	0.64	0.33	0.42	0.6	0.52	0.02	0.25	0.98	0.86	0.89	0.78	0.19	-0.08
"Phosphorylasekinase,gamma2(testis)"	1.55	1.71	1.67	1.61	1.55	1.67	1.71	1.73	1.74	1.75	1.67	1.84	1.66	2.04	1.8	1.95	2.05	2.09
Prolactinreceptor	2.43	2.45	2.3	2.28	2.26	2.31	2.4	2.44	2.38	2.37	2.43	2.52	2.38	2.85	2.43	2.64	2.96	2.96
"Proteinkinase,cAMP-dependent,catalytic,beta"	-0.59	-0.37	-0.37	-0.15	-0.61	-0.22	-0.44	-0.05	-0.3	-0.47	-0.26	-0.13	-0.33	0.08	-0.45	-0.64	0.52	-0.1
Down syndrome candidate region 1	-0.4	-0.34	-0.54	-0.67	-0.51	-0.55	-0.37	-0.67	-0.42	-0.5	-0.08	-0.39	-0.24	-0.18	-0.55	-0.46	-0.59	-0.5
ESTs	-1.45	-1.3	-1.64	-1.59	-1.41	-1.51	-1.26	-1.54	-1.34	-1.37	-0.86	-1.41	-1.32	-0.76	-1.32	-1.33	-1.2	-0.77
"ESTs,HighlysimilartoCHLORINECHANNELPROTEINP64[Bostaurus]"	-0.06	0.12	0.12	0.07	0.18	0.14	-0.08	-0.22	-0.12	-0.06	0.09	-0.09	-0.15	-0.06	0.05	0.02	-0.84	-0.58
"ESTs,HighlysimilartoGAMMA-AMINOBUTYRIC-ACIDRECEPTORALPHA-2SUBUNIT[Bostaurus]"	-0.51	-0.51	-0.25	-0.43	-0.33	-0.34	-0.39	-0.51	-0.46	-0.47	-0.28	-0.72	-0.84	0.12	-0.32	-0.36	-0.66	-0.43
"ESTs, Highly  similar to HYPOTHETICAL 64.3 KD GTP-BINDING PROTEIN C02F5.3 IN CHROMOSOME III [Caenorhabditis elegans]"	-1.12	-0.84	-0.85	-1.05	-1.28	-1.17	-0.97	-1.03	-1.3	-1.13	-0.49	-1.02	-1.08	-0.91	-1.04	-1.15	-1.17	-0.53
"ESTs,HighlysimilartoMAPKINASEPHOSPHATASE-1[]"	0.45	0.35	0.63	0.55	0.46	0.51	0.38	0.37	0.09	0.2	0.11	-0.15	0.41	-0.43	0.42	0.03	-0.79	-0.47
Glycerolkinase2(testisspecific)	0.72	0.81	0.84	0.87	0.96	0.95	0.68	0.67	0.6	0.64	0.49	0.23	0.34	0.27	0.78	0.53	-0.49	-0.15
"Guaninenucleotidebindingprotein(Gprotein),alphainhibitingactivitypolypeptide2"	-0.6	-0.33	-0.66	-0.8	-0.44	-0.58	-0.42	-0.72	-0.66	-0.81	-0.26	-0.75	-0.9	-0.45	-0.56	-0.78	-0.62	-0.39
DAP-kinasemRNA	-0.18	-0.05	-0.35	-0.22	-0.28	-0.25	-0.2	-0.33	-0.3	-0.26	0	-0.35	0.09	-0.03	-0.03	-0.25	-0.1	-0.14
"basictranscriptionfactor2,34kDsubunit"	-0.1	0.2	-0.1	-0.16	-0.23	-0.16	0.28	-0.07	0.02	0.08	0.4	0.2	0.23	0.32	0.04	0.01	0.17	0.25
"H.sapiens mRNA for protein containing SH3 domain, SH3GL2"	0.74	0.75	0.72	0.82	0.74	0.78	0.95	0.97	0.89	0.82	0.93	0.82	0.84	1.17	0.68	0.74	1.15	0.79
protein-tyrosine-phosphatase(tissuetype:foreskin)	-0.53	-0.32	-0.56	-0.43	-0.5	-0.5	-0.42	-0.49	-0.55	-0.64	-0.18	-0.6	-0.24	-0.08	-0.32	-0.6	-0.29	-0.61
"ESTs,ModeratelysimilartoPROTEIN-TYROSINEPHOSPHATASE[Autographacalifornicanuclearpolyhedrosisvirus]"	-1.03	-0.82	-0.94	-1.07	-0.91	-0.93	-1.08	-1.02	-1.04	-0.95	-0.51	-1.06	-0.91	-0.53	-0.89	-0.86	-1.25	-0.84
"ESTs, Weakly similar to GTPASE-ACTIVATING PROTEIN SPA-1 [M.musculus]"	-1.5	-1.26	-1.45	-1.26	-1.16	-1.35	-1.37	-1.61	-1.46	-1.34	-0.9	-1.55	-1.23	-0.98	-1.29	-1.45	-1.11	-0.78
"ESTs,WeaklysimilartoeukaryoticinitiationfactoreIF-2alphakinase[D.melanogaster]"	0.81	0.76	1.27	1.09	1.21	1.16	0.92	0.81	0.94	0.83	0.83	0.81	1.1	0.02	0.8	0.57	-0.29	-0.2
"ESTs,Weaklysimilartop56KKIAMREproteinkinase[]"	-0.85	-0.78	-0.44	-0.28	-0.35	-0.44	-0.71	-0.81	-0.61	-0.54	-0.54	-1.09	-0.48	-0.12	-0.12	-0.43	-1.11	-0.75
"Sprouty2(SPRY2)mRNA,completecds"	0.6	0.52	0.82	0.81	0.9	0.75	0.57	0.55	0.65	0.56	0.47	0.32	0.49	0.78	0.73	0.67	-0.02	-0.1
putativeGTP-bindingprotein	-0.87	-0.74	-1.06	-0.79	-0.7	-0.84	-0.81	-0.75	-0.95	-0.97	-0.62	-0.9	-0.89	-0.69	-0.77	-0.96	-0.74	-0.74
CALMODULIN-RELATEDPROTEINNB-1	-0.83	-0.62	-0.99	-1.04	-0.92	-1.02	-0.78	-0.84	-0.55	-0.89	-0.49	-0.78	-0.84	-0.55	-0.95	-0.88	-0.71	-0.69
CELLULARNUCLEICACIDBINDINGPROTEIN	1.7	1.52	1.2	1.36	1.39	1.48	1.72	1.74	1.82	1.86	1.88	2	1.93	2.07	1.5	1.62	1.71	1.71
"Caseinkinase1,alpha1"	1	0.85	1.04	0.93	1.11	1.29	0.66	0.72	0.79	0.9	0.53	0.58	1.51	0.42	1.11	0.4	0.38	0.25
"Catenin(cadherin-associatedprotein),alpha1(102kD)"	-1.39	-1	-1.36	-1.24	-1.29	-1.36	-1.12	-1.43	-1.28	-1.24	-0.77	-1.08	-0.92	-0.83	-1.12	-1.15	-0.81	-0.38
Celldivisioncycle25C	-1.42	-0.87	-1.46	-1.28	-1.47	-1.52	-1.04	-1.3	-1.33	-1.27	-0.71	-1.03	-1.08	-0.73	-1.5	-1.18	-0.77	-0.75
Cholinekinase	-1.46	-0.83	-1.83	-1.48	-1.62	-1.71	-1.3	-1.32	-1.35	-1.45	-0.76	-1.13	-1.37	-0.93	-1.13	-1.32	-0.64	-0.25
"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"	-1.19	-1.07	-1.02	-1.09	-1.09	-1.03	-1.17	-1.3	-1.19	-1.14	-0.98	-1.38	-0.77	-0.72	-1.37	-1.25	-1.44	-0.63
v-myc avian myelocytomatosis viral oncogene homolog	-0.65	-0.9	-0.99	-0.92	-0.92	-0.98	-0.76	-0.94	-0.81	-0.68	-0.52	-0.72	-0.47	-0.23	-0.99	-0.72	-0.42	-0.45
v-raf-1 murine leukemia viral oncogene homolog 1	0.44	0.38	0.67	0.61	0.72	0.67	0.4	0.33	0.48	0.46	0.49	0.34	0.52	0.21	0.29	0.28	-0.64	-0.82
v-jun avian sarcoma virus 17 oncogene homolog	0.22	-0.04	0.42	0.29	0.33	0.3	-0.05	-0.1	-0.06	-0.01	0.03	-0.06	0.26	-0.66	0.1	-0.17	-1.07	-0.7
Fibronectin 1	0.34	0.32	0.19	0.36	0.35	0.35	0.62	0.51	0.46	0.39	0.48	0.45	0.3	1	0.41	0.38	0.64	0.53
"""""""Caspase 9, apoptosis-related cysteine protease"""""""	-0.97	-0.85	-1.15	-1.19	-1.17	-1.38	-0.86	-1.25	-0.9	-1.17	-0.72	-0.9	-1.1	-0.51	-0.98	-1.26	-0.76	-0.45
ESTs	1.1	1.16	1.08	1.08	1.06	1.17	1.06	1.09	1.18	1.09	1.21	1.29	1.03	0.93	1.02	0.8	0.87	0.73
ESTs	-0.09	-0.09	0.19	0.04	0.12	0.02	-0.1	-0.09	-0.1	0.08	-0.1	-0.05	-0.02	-0.06	-0.11	-0.3	-0.46	-0.47
"ESTs,HighlysimilartoACYLPHOSPHATASE,ORGAN-COMMONTYPEISOZYME[]"	0.32	0.36	0.46	0.44	0.37	0.4	0.34	0.42	0.29	0.22	0.12	0.2	0.38	0.27	0.23	0.07	0.13	0.2
"ESTs,ModeratelysimilartoRarprotein[]"	0.18	0.31	0.31	0.32	0.4	0.38	0.49	0.19	0.14	0.25	0.21	0.05	0.21	0.34	0.18	0.1	0.04	-0.09
"ESTs,ModeratelysimilartoSERINE/THREONINE-PROTEINKINASENEK1[M.musculus]"	-0.1	0	-0.3	-0.35	-0.23	-0.29	-0.03	-0.16	-0.17	-0.05	0	-0.17	-0.19	0.04	-0.13	-0.3	-0.11	-0.1
"ESTs,ModeratelysimilartoglutamatereceptorchainB[M.musculus]"	1.11	1.1	0.45	0.62	0.7	0.82	1.26	1.33	1.19	1.26	1.39	1.51	1.19	1.41	0.97	1.08	1.55	1.43
retinoblastoma-like 1 (p107)	-0.87	-0.94	-0.85	-0.93	-0.93	-0.97	-0.98	-1.08	-0.9	-0.84	-0.98	-1.06	-0.47	-0.65	-1.06	-0.97	-0.98	-1.06
selectin E (endothelial adhesion molecule 1); ELAM; CD62E	-0.6	-0.67	-0.4	-0.43	-0.41	-0.41	-0.59	-0.74	-0.62	-0.6	-0.48	-0.77	-0.69	-0.06	-0.56	-0.5	-0.63	-0.77
v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65))	0.12	-0.07	0.29	0.23	0.27	0.19	0.03	-0.1	0.01	0.07	-0.01	-0.16	0.06	0.1	0.01	-0.08	-0.78	-0.28
"""transforming growth factor, beta 2"""	-1.13	-1.08	-1.16	-1.02	-0.92	-1.17	-1.22	-1.17	-1.31	-0.95	-0.93	-1.29	-1.08	-0.73	-1.2	-1.19	-0.93	-0.99
vascular endothelial growth factor	-0.09	0	-0.18	-0.01	-0.17	-0.08	0.08	0.12	-0.07	0.08	0.19	0.17	-0.03	0.62	-0.06	-0.12	0.24	0.45
Down syndrome critical region gene 2	-0.43	-0.43	-0.39	-0.4	-0.38	-0.39	-0.29	-0.34	-0.46	-0.48	-0.41	-0.37	-0.69	-0.18	-0.59	-0.72	-0.39	-0.18
"ESTs,WeaklysimilartoPROSTATICACIDPHOSPHATASE[Rattusnorvegicus]"	0.27	0.23	0.51	0.49	0.57	0.47	0.15	0.12	0.23	0.04	-0.06	0.23	-0.05	0.46	0.27	0.06	-0.66	-0.65
"ESTs,WeaklysimilartoTestis-specificA-kinase-anchoring-protein[R.norvegicus]"	-0.55	-0.64	-0.46	-0.31	-0.42	-0.49	-0.71	-0.62	-0.51	-0.62	-0.6	-0.78	-0.77	0.03	-0.62	-0.64	-0.82	-0.45
"ESTs,Weaklysimilartoproteinkinase[]"	-0.96	-0.86	-1.06	-1.15	-1.05	-1.26	-0.96	-0.83	-0.85	-1.15	-0.93	-1.04	-0.97	-0.65	-1.18	-1.33	-0.63	-0.41
"ESTs,Weaklysimilartosimilartoyeastadenylatecyclase[]"	0.88	0.84	1.04	1	0.93	0.93	1.22	1.18	1.04	0.91	0.87	0.92	0.99	1.03	0.94	0.79	0.81	0.7
"serine/threonineproteinkinase,NIK"	0.29	0.3	0.55	0.49	0.23	0.57	0.09	0.14	0.26	0.32	0.01	-0.09	0.58	-0.16	0.52	-0.27	-0.25	-0.19
"calmegin,completecds"	0.35	0.28	-0.11	-0.04	-0.05	0.12	0.9	0.76	0.55	0.51	0.62	0.77	0.36	0.62	0.34	0.34	0.83	0.57
cannabinoid receptor 1 (brain)	-0.67	-0.68	-0.43	-0.67	-0.58	-0.54	-0.84	-0.78	-0.63	-0.68	-0.82	-0.87	-0.4	-0.48	-0.74	-0.89	-0.78	-1.06
"""colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog"""	-0.14	-0.16	0	-0.02	0.01	-0.05	-0.21	-0.21	-0.21	-0.24	-0.33	-0.55	-0.37	0.14	-0.29	-0.21	-0.73	-0.68
"""GRO1 oncogene (melanoma growth stimulating activity, alpha)"""	0.23	0.07	-0.02	-0.03	-0.06	-0.11	0.38	0.32	0.36	0.46	0.52	0.61	0.55	0.8	-0.05	-0.01	0.29	0.3
"""glutamate receptor, ionotropic, N-methyl D-aspartate 1"""	-0.65	-0.57	-0.22	-0.29	-0.37	-0.28	-0.45	-0.77	-0.54	-0.23	-0.52	-0.71	-0.87	-0.59	-0.18	-0.44	-0.79	-0.7
transcription factor binding to IGHM enhancer 3	-0.91	-0.86	-0.76	-0.77	-0.9	-0.76	-0.93	-1.08	-0.96	-0.61	-0.66	-1.01	-1.02	-0.38	-0.79	-0.77	-0.57	-0.44
interferon stimulated gene (20kD)	0.12	0.06	0.03	0.21	0.24	0.11	-0.05	-0.1	0.07	0.3	0.07	0.02	0.12	0.09	0.4	0.13	0.12	-0.17
"""tumor necrosis factor receptor superfamily, member 12"""	-0.32	-0.23	-0.45	-0.41	-0.47	-0.42	-0.33	-0.53	-0.39	-0.54	-0.18	-0.29	-0.39	0.07	-0.36	-0.35	-0.45	-0.53
platelet-derived growth factor receptor-like	-1.02	-0.61	-0.92	-0.8	-0.9	-1.03	-0.93	-0.92	-0.93	-1	-0.79	-1.02	-1.13	-0.55	-0.98	-1.08	-0.85	-0.82
suppression of tumorigenicity 13 (colon carcinoma)	-0.36	-0.51	-0.41	-0.38	-0.49	-0.49	-0.83	-0.69	-0.84	-0.68	-0.73	-0.92	-0.45	-0.79	-0.7	-1.13	-0.71	-0.45
interferon gamma receptor 1	0.29	0.39	0.57	0.48	0.49	0.45	0.6	0.48	0.43	0.23	0.34	0.2	0.22	0.68	0.39	0.39	0.23	0.25
interleukin enhancer binding factor 1	-0.48	-0.34	-0.48	-0.37	-0.47	-0.58	-0.33	-0.42	-0.37	-0.5	-0.29	-0.52	-0.55	-0.37	-0.47	-0.51	-0.36	-0.24
insulin-like growth factor binding protein 2 (36kD)	1.84	1.75	1.21	1.36	1.41	1.53	2.13	2.22	1.98	2.08	2.25	2.3	1.96	1.99	1.72	1.79	2.34	2.28
B-cell-homing chemokine (ligand for Burkitt's lymphoma receptor-1)	-0.79	-0.72	-0.74	-0.67	-0.72	-0.76	-0.67	-0.86	-0.92	-0.86	-0.78	-0.81	-0.73	-0.61	-0.74	-0.97	-1	-0.49
zinc finger protein 6 (CMPX1)	-0.43	-0.4	-0.28	-0.2	-0.14	-0.33	-0.5	-0.55	-0.59	-0.4	-0.58	-0.63	-0.46	-0.25	-0.46	-0.51	-0.7	-0.68
ESTs	-0.91	-1.02	-0.76	-0.87	-0.93	-0.85	-0.79	-1.13	-0.96	-0.68	-0.9	-0.99	-0.88	-0.49	-0.99	-1.11	-0.92	-0.53
acyloxyacyl hydrolase (neutrophil)	-1.14	-1.31	-1.1	-1.15	-1.13	-1.25	-1.23	-1.33	-1.28	-0.91	-1.18	-1.33	-1.08	-0.96	-1.28	-1.47	-1.18	-1.07
"""enolase 2, (gamma, neuronal)"""	-0.79	-0.56	-0.42	-0.48	-0.47	-0.56	-0.76	-0.64	-0.64	-0.48	-0.69	-0.91	-0.24	-0.45	-0.49	-0.63	-0.76	-1.07
"""ras homolog gene family, member D"""	-0.93	-0.77	-0.79	-0.83	-0.8	-0.99	-0.8	-0.96	-0.85	-0.68	-0.69	-0.91	-0.95	-0.49	-0.77	-0.99	-0.89	-0.9
CD34 antigen	-0.05	-0.23	0.14	0.07	0.08	-0.02	-0.1	-0.24	-0.28	-0.29	-0.3	-0.32	-0.37	0.34	-0.11	-0.05	-0.29	-0.7
"""CD47 antigen (Rh-related antigen, integrin-associated signal transducer)"""	1.09	0.96	0.85	1.52	1.5	1.5	1.26	1.32	1.15	1.21	1.19	1.15	0.48	-0.38	1.05	0.14	-0.49	-0.92
"""CD8 antigen, alpha polypeptide (p32)"""	0.14	0.19	0.29	0.36	0.37	0.37	0.12	0.12	0.2	0.15	-0.06	-0.2	0.35	0.09	0.26	-0.26	-0.58	-0.3
"""calcineurin A gamma; protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform"""	0.07	0.06	0.21	0.28	0.19	0.2	0.3	0.18	0	-0.03	-0.01	-0.06	-0.08	0.47	0.13	0.07	-0.09	-0.14
chemokine (C-X3-C) receptor 1	0.87	0.84	1.63	1.36	1.2	1.26	0.59	0.65	1.03	1.06	0.53	0.48	1.14	-0.05	1.13	0.14	-0.05	0.13
colony stimulating factor 3 receptor (granulocyte)	-0.48	-0.22	-0.5	-0.49	-0.58	-0.48	-0.24	-0.44	-0.16	-0.19	0.06	-0.12	-0.44	-0.48	-0.14	-0.4	-0.01	0
complement component 5 receptor 1 (C5a ligand)	0.34	0.27	0.18	0.4	0.3	0.5	0.45	0.34	0.29	0.32	0.33	0.39	0.41	0.8	0.18	0.27	0.29	0.11
class I cytokine receptor	1.12	0.89	0.92	0.9	0.93	0.93	1.25	1.13	1.05	1.1	1.18	1.2	1.28	1.65	0.89	1.15	1.42	1.21
"""CD4 receptor {exons 1 and 2} [human, T-lymphocyte, mRNA, 3429 nt]"""	-0.4	-0.54	-0.36	-0.42	-0.41	-0.39	-0.15	-0.34	-0.42	-0.44	-0.37	-0.35	-0.55	0.27	-0.41	-0.4	0.12	-0.08
androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)	0.06	0.05	0.22	0.22	0.29	0.19	0.44	0.28	0.19	0.15	0.1	0.08	-0.03	0.74	0.09	0.17	-0.12	-0.07
PTK2 protein tyrosine kinase 2; FAK	0.06	0.1	0.36	0.38	0.34	0.35	0.27	0.09	0.18	0.28	-0.27	-0.26	0.4	0.23	0.5	0.24	-0.64	-0.56
chemokine (C-C motif) receptor 5	-0.99	-0.94	-0.93	-0.92	-0.95	-0.99	-0.73	-0.97	-0.91	-0.87	-0.97	-1.18	-0.91	-0.71	-1	-1.16	-0.84	-0.69
"""requiem, apoptosis response zinc finger gene"""	-0.12	-0.12	0.15	0.08	0.03	0	0.2	0.06	-0.05	-0.21	-0.11	-0.32	0.1	-0.23	-0.12	-0.48	-0.78	-0.51
interferon gamma receptor 2 (interferon gamma transducer1)	0.56	0.56	0.66	0.6	0.66	0.52	1.02	0.85	0.77	0.65	0.59	0.64	0.69	1	0.57	0.43	0.43	0.3
insulin-like growth factor binding protein 3	-0.26	-0.34	-0.27	-0.22	-0.33	-0.21	-0.54	-0.47	-0.36	-0.43	-0.51	-0.34	-0.29	-0.27	-0.38	-0.52	-0.56	-0.62
somatostatin	-0.62	-0.55	-0.64	-0.89	-0.48	-0.48	-0.56	-0.61	-0.58	-0.72	-0.61	-0.54	-0.64	-0.22	-0.57	-0.72	-0.38	-0.39
insulin-like growth factor 2 receptor	0.87	0.86	0.62	0.7	0.73	0.75	0.96	1.11	1.05	1.03	1.01	1.09	1	1.06	0.72	0.51	1.04	0.93
small inducible cytokine A7 (monocyte chemotactic protein 3; Mcp-3)	-0.22	-0.06	0.13	0.02	0.03	0.05	-0.15	-0.23	0.03	-0.22	-0.62	-0.65	-0.35	-0.63	0.16	-0.36	-0.67	-0.65
"""adrenergic, beta-3-, receptor"""	0.45	0.46	0.49	0.52	0.44	0.47	0.81	0.59	0.49	0.42	0.5	0.43	0.49	1.1	0.34	0.51	1.04	0.88
histamine receptor H1	1.37	1.4	1.69	1.49	1.39	1.38	1.98	1.69	1.68	1.55	1.5	1.46	1.68	2.11	1.35	1.37	1.64	1.46
flotillin 1	0	-0.2	0.06	0.12	0.08	-0.01	0.16	-0.12	-0.09	-0.07	-0.11	-0.15	-0.04	0.15	-0.17	-0.07	-0.22	-0.31
ems1 sequence (mammary tumor and squamous cell carcinoma-associated (p80/85 src substrate)	-0.83	-0.87	-0.68	-0.76	-0.76	-0.88	-0.69	-0.8	-0.71	-0.76	-0.71	-0.86	-0.69	-0.37	-0.88	-0.73	-0.76	-0.49
"""interleukin 12 receptor, beta 2"""	1.03	1.04	0.93	1.03	1.09	1.03	1.31	1.19	1.28	1.24	1.1	1.14	1.24	1.24	1.02	0.99	0.81	0.61
guanine nucleotide regulatory protein (oncogene)	0.27	0.24	0.14	0.19	0.34	0.27	0.81	0.47	0.43	0.4	0.39	0.36	0.35	0.53	0.1	0.12	0.34	-0.02
"""major histocompatibility complex, class II, DR beta 1"""	0.51	0.52	0.59	0.61	0.61	0.53	0.89	0.64	0.69	0.59	0.4	0.36	0.51	0.57	0.55	0.41	0.14	-0.01
v-fos FBJ murine osteosarcoma viral oncogene homolog	-1.06	-0.93	-1.12	-1.17	-1.03	-1.2	-0.87	-1	-0.87	-0.9	-0.89	-0.8	-0.83	-0.67	-1.17	-1.03	-0.74	-0.46
DNA (cytosine-5-) methyltransferase 3 beta	-0.29	-0.13	-0.29	-0.34	-0.2	-0.2	-0.06	-0.21	-0.33	-0.3	-0.34	-0.29	-0.32	0.12	-0.37	-0.47	-0.23	-0.21
"""thymosin, beta, identified in neuroblastoma cells; thymosin beta-4"""	-0.18	0	-0.25	-0.11	-0.01	-0.08	0.11	-0.04	-0.09	-0.18	-0.21	-0.12	-0.18	-0.02	-0.21	-0.25	-0.45	-0.36
"""glutamate receptor, ionotropic, kainate 1"""	0.15	0.18	0.18	0.14	0.2	0.17	0.54	0.31	0.31	0.2	0.21	0.34	0.28	0.46	0.09	-0.11	-0.09	0.1
CD39-like 2	-0.76	-0.59	-0.87	-0.84	-0.9	-0.87	-0.71	-0.93	-0.84	-0.95	-0.82	-0.73	-0.93	-1.05	-0.76	-1.12	-0.65	-0.48
Pro-galanin	-0.29	-0.33	-0.1	-0.03	-0.21	-0.17	-0.03	-0.17	-0.21	-0.24	-0.41	-0.23	-0.33	0.3	-0.3	-0.04	0.1	0.11
Glucose Dependent Insulinotropic Polypeptide	-0.36	-0.38	-0.33	-0.25	-0.19	-0.16	-0.05	-0.18	-0.2	-0.22	-0.42	-0.31	-0.17	0.1	-0.33	-0.21	-0.37	-0.11
"Calmodulin (calmodulin 3 (phosphorylase kinase, delta)(CALM3)"	-0.27	-0.29	-0.23	-0.22	-0.18	-0.21	0.08	-0.23	-0.14	-0.13	-0.32	-0.17	-0.19	0.09	-0.22	-0.24	-0.12	-0.18
ribosomal protein S6 kinase II alpha 1 (S6KII-alpha 1); ribosomal S6 kinase 1 (RSK1)	0.81	0.74	0.55	0.47	0.62	0.56	1.3	1.16	1.12	1.15	1.23	1.38	1.21	1.45	0.7	0.73	1.15	0.97
zinc finger protein 37 (ZFP37); KRAB domain zinc finger protein	-0.19	-0.01	-0.06	0.02	0.12	-0.02	-0.03	-0.19	-0.08	-0.1	-0.31	-0.25	-0.1	0.14	-0.23	-0.15	-0.58	-0.51
"Transcription Regulatory Protein SWI3 (NR2F2:  nuclear receptor subfamily 2, group F, member 2)"	-1.13	-1.08	-1.14	-1.19	-1.12	-1.02	-0.86	-1.09	-0.94	-0.98	-1.13	-1.03	-1.03	-0.66	-1.26	-1	-0.66	-0.57
progesterone receptor	-0.02	0.23	-0.11	-0.03	-0.02	0	0.57	0.38	0.39	0.48	0.52	0.61	0.66	0.73	-0.03	0.05	0.37	0.06
mitogen-activated protein kinase 8; JNK; SAPK1	-0.39	-0.27	-0.88	-0.73	-0.73	-0.65	-0.12	-0.33	-0.32	-0.23	-0.6	-0.28	-0.51	-0.31	-0.6	-0.51	-0.27	-0.27
interferon consensus sequence binding protein 1	2.64	2.65	2.15	2.31	2.37	2.45	2.91	2.94	2.89	2.84	2.87	3.01	2.72	2.69	2.49	2.51	3.02	3.01
tachykinin receptor 1	2.33	2.49	2.42	2.4	2.51	2.48	2.42	2.28	2.27	2.22	2.34	2.32	2.38	0.77	2.16	1.12	0.8	0.42
mitogen-activated protein kinase kinase kinase 1	1.23	1.35	1.45	1.46	1.51	1.51	1.57	1.22	1.43	1.32	1.24	1.26	1.41	0.69	1.36	0.77	0.17	-0.18
glucagon receptor	-0.06	-0.06	-0.06	-0.05	-0.05	0.02	0.18	-0.02	-0.06	-0.08	-0.16	-0.12	-0.24	-0.11	-0.04	-0.05	0.03	0.12
"Protease Do Precursor (PRSS11:  protease, serine, 11 (IGF binding))"	1.06	1.07	1.2	1.3	1.22	1.2	1.33	1.16	1.31	1.15	1.16	1.3	0.97	0.22	1.07	0.99	-0.65	-0.6
alcohol dehydrogenase 6 + aldehyde dehydrogenase 1 (ALDH1) (ADH6:  alcohol dehydrogenase 6 (class V))	0.54	0.55	0.83	0.88	1.06	0.85	1.02	0.71	0.77	0.69	0.44	0.5	0.36	0.81	0.86	0.94	0.03	0.17
NADH-ubiquinone dehydrogenase 1 beta subcomplex 7 18-kDa subunit (NDUFB7); complex I-B18 (CI-B18); cell adhesion protein SQM1	-1.39	-1.47	-1.61	-1.38	-1.4	-1.39	-1.19	-1.44	-1.41	-1.39	-1.38	-1.21	-1.26	-0.78	-1.35	-1.47	-0.96	-0.67
mitochondrial cytochrome P450 XIA1 precursor; P450(SCC); cholesterol side-chain cleavage enzyme; cholesterol desmolase CYP11A1	-0.13	-0.12	-0.15	-0.1	-0.09	-0.11	0.36	0.02	0.04	0.05	0.02	0.15	0.27	0.5	-0.09	-0.03	0.02	-0.1
AKT2; rac protein kinase beta	0.17	0.15	0.3	0.13	0.23	0.13	0.2	0.09	0.12	0.01	-0.18	-0.12	0.03	0.2	-0.02	0.05	-0.43	-0.43
cyclin K (CPR4)	0.62	0.75	0.86	0.83	0.83	0.77	0.86	0.45	0.64	0.44	0.03	0.12	0.46	0.2	0.65	0.56	-0.41	-0.71
"""tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; TRAIL-R3"""	0.6	0.7	0.62	0.61	0.74	0.66	0.77	0.63	0.59	0.42	0.46	0.6	0.5	-0.32	0.53	0	-0.3	-0.87
Down syndrome critical region gene 2	0.38	0.38	0.05	-0.03	-0.02	0.12	0.39	0.42	0.5	0.42	0.51	0.56	0.62	0.53	0.21	0.08	0.57	0.47
glutathione peroxidase 1	0.04	-0.05	-0.11	-0.06	0.03	0	0.3	0.33	0.07	0.2	0.06	0.59	0.19	0.48	-0.01	0.17	0.42	0.17
insulin receptor substrate 2	-0.44	-0.42	-0.33	-0.59	-0.32	-0.05	-0.08	-0.25	-0.39	-0.01	-0.35	0.12	0.06	-0.41	-0.33	-0.4	-0.17	-0.14
"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"	0.05	0.12	0.21	0.27	0.13	0.21	0.4	-0.07	0.28	0.11	0.08	0.1	-0.03	0.08	0.2	0.04	0.33	0.19
adaptor protein with pleckstrin homology and src homology 2 domains	-1.41	-0.91	-1.47	-1.44	-1.4	-1.48	-0.99	-1.11	-1.15	-1.29	-0.92	-1.16	-1.17	-1.09	-1.1	-1.18	-0.57	-0.52
NEDD5 protein homolog; DIFF6; KIAA0158	-0.1	-0.08	-0.25	-0.36	-0.44	-0.16	-0.28	-0.43	-0.32	-0.24	-0.21	0.04	-0.15	0.08	-0.41	-0.29	-0.19	0
cell division protein kinase 9 (CDK9); serine/threonine protein kinase PITALRE	-0.61	-0.75	-0.49	-0.3	-0.68	-0.16	-0.23	-0.32	-0.37	-0.57	-0.81	-0.69	-0.92	-0.27	-0.45	-0.25	-0.57	-0.62
6-O-methylguanine-DNA methyltransferase (MGMT); methylated-DNA-protein-cysteine methyltransferase	-1.01	-1.02	-0.99	-0.91	-0.71	-0.61	-0.57	-0.77	-1.02	-0.98	-0.99	-0.94	-1.07	-0.72	-0.8	-0.58	-0.65	-0.65
DNA repair protein RAD54 homolog	-0.7	-0.6	-0.64	-0.41	-0.41	-0.32	-0.21	-0.49	-0.44	-0.57	-0.73	-0.69	-0.62	-0.32	-0.39	-0.3	-0.53	-0.33
thioredoxin peroxidase 2 (TDPX2); thioredoxin-dependent peroxide reductase 2; proliferation-associated gene (PAG); natural killer cell enhancing factor A (NKEFA)	0.55	0.26	0.56	0.57	0.65	0.57	0.95	0.69	0.6	0.72	0.44	0.69	0.9	0.95	0.68	0.55	0.38	0.18
inhibitor of apoptosis protein 3 (API3; IAP3); X-linked inhibitor of apotosis protein (X-linked IAP; XIAP); IAP-like protein (HILP)	-1.31	-1.23	-1.16	-1.44	-1.31	-1.19	-1.28	-0.95	-1.24	-1.22	-1.2	-0.94	-1.08	-0.89	-1.33	-1.17	-0.66	-0.98
adenosine A3 receptor	-1.51	-1.39	-1.5	-1.75	-1.28	-1.42	-1.3	-1.26	-1.39	-1.54	-1.21	-1	-1.21	-1.01	-1.41	-1.54	-0.97	-0.64
interferon regulatory factor 4; MUM1; LSIRF	-0.56	-0.52	-0.47	-0.64	-0.63	-0.49	-0.62	-0.67	-0.73	-0.7	-0.87	-0.83	-0.45	-0.72	-0.46	-0.74	-0.65	-0.54
"""neurotrophic tyrosine kinase, receptor, type 3; TrkC"""	1.41	1.6	1.34	1.59	1.7	1.67	1.33	1.43	1.49	1.47	1.05	1.3	0.86	0.63	1.49	1.07	0.37	0.34
sterile 20 (oxidant stress response kinase 1; yeast Sps1/Ste20-related kinase 1)	-1.08	-0.68	-1.23	-1.03	-1.07	-0.8	-0.79	-0.86	-0.99	-0.99	-0.85	-0.86	-1.16	-0.84	-0.93	-1.08	-0.32	-0.37
Janus kinase 1 (a protein tyrosine kinase)	0.18	0.34	0.32	0.43	0.51	0.47	0.37	0.26	0.31	0.22	-0.07	0.02	0.08	0.18	0.55	0.21	-0.01	-0.09
v-rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)	0.33	0.41	0.37	0.63	0.44	0.39	0.34	0.32	0.41	0.01	0.09	0.07	-0.36	-0.78	0.51	-0.33	-0.35	-0.43
"POLL: polymerase (DNA-directed), lambda"	0.12	0.11	0.14	0.14	0.06	0.26	0.28	0.22	0.13	-0.02	-0.04	0.17	-0.09	0.6	0.09	0.2	0.85	0.67
Alpha Globin (TFCP2:  transcription factor CP2)	-0.12	-0.12	-0.13	-0.08	-0.15	-0.06	-0.03	-0.11	-0.13	-0.18	-0.31	-0.18	-0.27	-0.3	-0.01	-0.07	0.09	0.06
oncostatin M (OSM)	2.12	2.2	2.06	2.11	1.97	2.12	2.42	2.2	2.03	2.02	2.06	2.26	1.89	2.62	2.08	2.29	2.9	3.04
Protein phosphatase 1 gamma	0.83	0.75	0.69	0.91	0.91	0.91	1.14	0.95	0.94	0.93	0.86	1.09	0.83	1.35	0.88	1.03	1.15	1.04
cyclin-dependent kinase 4 inhibitor B (CDKN2B); p14-INK4B; multiple tumor suppressor 2 (MTS2)	-0.95	-0.94	-1.12	-1.05	-1.14	-0.87	-0.75	-0.96	-0.93	-1.06	-1.07	-0.77	-0.91	-0.45	-1.01	-1.08	-0.67	-0.63
Abl interactor 2 (Abi-2) + Abl binding protein 3 (AblBP3) [ArgBPIB]	-0.95	-0.95	-0.9	-0.93	-0.95	-0.85	-0.9	-0.99	-0.97	-1.07	-1.09	-1.01	-1.2	-0.4	-1.06	-1.03	-0.83	-0.45
OXTR: oxytocin receptor	-1.34	-1.19	-1.48	-1.46	-1.36	-1.29	-1.32	-1.3	-1.27	-1.25	-1.21	-1.33	-1.27	-0.84	-1.25	-1.35	-0.84	-0.62
"casper, a FADD- and caspase-related inducer of apoptosis (CASH-alpha + CASH-beta); FLAME-1; FLICE-like inhibitory protein"	-1.1	-1.01	-0.78	-1.09	-1.12	-0.89	-1.24	-1.03	-0.93	-0.96	-1.09	-1.25	-0.76	-0.73	-0.81	-1.11	-0.89	-0.64
Zinc Finger Protein 32	-0.16	-0.07	-0.4	-0.35	-0.31	-0.28	-0.31	-0.11	-0.07	-0.03	-0.06	-0.05	-0.05	0.03	-0.38	-0.42	-0.02	-0.32
NOS1: nitric oxide synthase 1 (neuronal)	1.19	1.17	1.22	1.36	1.29	1.29	1.7	1.49	1.46	1.29	1.23	1.21	1.13	1.9	1.33	1.38	1.65	1.62
cyclin-dependent protein kinase 2 (CDK2); p33 protein kinase	-1.08	-0.93	-0.84	-1.01	-1.02	-1.17	-1	-0.96	-1.13	-1.07	-0.99	-0.81	-1.16	-0.94	-1.09	-0.84	-0.39	-0.54
Cyclophilin isoform (cis/trans isomerase)	-0.74	-0.53	-0.76	-0.77	-0.78	-0.71	-0.69	-0.65	-0.68	-0.64	-0.66	-0.62	-0.78	-0.6	-0.54	-0.81	-0.3	-0.21
"phospholipaseD2(PLD2)mRNA,completecds"	0.64	0.74	0.36	0.67	0.67	0.7	0.5	0.48	0.49	0.56	0.73	0.75	0.95	-0.74	0.58	-0.27	-0.86	-0.38
"TFIIBrelatedfactorhBRF(HBRF)mRNA,completecds"	-0.31	0.12	-0.22	-0.12	-0.14	-0.15	-0.16	-0.19	-0.17	-0.24	0.16	-0.24	-0.26	0.17	-0.02	-0.12	-0.33	-0.11
"proteinkinaseC-bindingproteinRACK17mRNA,partialcds"	-1.39	-0.5	-1.3	-1.09	-1.25	-1.21	-0.86	-1.08	-0.91	-1.26	-0.34	-0.88	-1.27	-0.77	-0.66	-0.77	-0.59	-0.4
"EST,Highlysimilarto5-HYDROXYTRYPTAMINE2BRECEPTOR[]"	1.47	1.47	1.62	1.71	1.75	1.64	2.21	2.2	1.89	2.16	2.25	2.19	1.89	0.77	2.3	1.49	1.54	1.1
"EST,WeaklysimilartoC16C10.5[C.elegans]"	0.7	0.71	0.67	0.91	0.83	0.87	0.52	0.37	0.32	0.57	0.6	0.46	0.23	-0.22	0.54	0.27	-0.13	-0.07
ESTs	0.36	0.47	0.5	0.53	0.55	0.63	0.35	0.26	0.22	0.39	0.51	0.22	0.15	-0.24	0.35	0.25	-0.3	0.06
"Cyclin-dependentkinase5,regulatorysubunit"	0.39	0.47	0.49	0.68	0.74	0.69	0.46	0.55	0.46	0.63	0.93	0.74	-0.18	-0.72	0.07	-0.14	-0.37	0.3
DUALSPECIFICITYMITOGEN-ACTIVATEDPROTEINKINASEKINASE2	-1.08	-0.51	-1.3	-0.87	-0.94	-0.85	-0.68	-0.94	-0.9	-0.89	0.11	-0.62	-1.02	-0.96	-0.98	-0.53	-0.4	0.23
Dual-specificitytyrosine-(Y)-phosphorylationregulatedkinase	-0.32	0.05	-0.42	-0.2	-0.43	-0.32	0.2	-0.07	-0.19	-0.09	0.77	0.17	-0.03	-0.15	-0.33	0.05	0.43	0.57
Estrogenreceptor	0.18	-0.1	-0.63	-0.07	-0.45	-0.46	0.17	-0.47	0.33	-0.3	0.72	-0.02	-0.4	-0.43	-0.27	-0.11	0.27	0.78
Fructose-bisphosphatase1	0.61	0.69	0.51	0.66	0.69	0.57	0.69	0.41	0.47	0.66	1.18	0.76	1	-0.22	0.61	0.64	0.63	1
Gprotein-coupledreceptorkinase6	0.25	0.51	-0.1	0.19	0.26	0.23	0.55	0.19	0.18	0.44	1.28	0.51	0.46	-0.13	0.27	0.44	0.65	1.18
Interferon regulatory factor 1	-1.2	-0.54	-1.18	-1.05	-1.07	-0.97	-1.05	-1.07	-1.09	-1.01	-0.59	-1.1	-0.79	-0.79	-0.51	-0.85	-0.6	-0.14
Serum response factor (c-fos serum response element-binding transcription factor)	-0.79	-0.49	-0.76	-0.71	-0.71	-0.87	-0.53	-0.68	-0.72	-0.72	-0.42	-0.8	-0.82	-0.34	-0.51	-0.61	-0.5	-0.38
Tumor protein p53 (Li-Fraumeni syndrome)	-1.1	-0.49	-0.64	-0.53	-0.67	-0.7	-0.68	-0.78	-0.48	-0.56	-0.36	-1.11	-0.57	-0.21	-0.18	-0.3	-0.36	-0.21
Fibronectin 1	-1.16	-0.54	-1.02	-0.61	-0.67	-0.64	-0.77	-0.66	-0.41	-0.35	-0.23	-0.6	-0.46	-0.54	-0.8	-0.68	-0.4	-0.34
"""""""Matrix metalloproteinase 7 (matrilysin, uterine)"""""""	-0.18	-0.14	-0.13	-0.07	-0.05	-0.1	-0.31	-0.53	-0.57	-0.3	0.09	-0.14	-0.02	-0.63	-0.3	-0.47	-0.49	-0.09
v-myc avian myelocytomatosis viral oncogene homolog	-0.26	-0.07	-0.26	-0.25	-0.22	-0.15	-0.32	-0.57	-0.58	-0.38	0.06	-0.4	-0.52	-0.45	-0.23	-0.22	-0.36	0.24
"ESTs,Weaklysimilartoproteinphosphatase1MchainM110isoform[R.norvegicus]"	0.95	0.79	0.99	1.06	1.07	1.11	0.76	0.81	0.69	1.02	0.99	0.82	1.06	0.78	0.8	0.75	0.6	0.38
PSSALREforserine/threonineproteinkinase	0.63	0.7	0.83	0.9	0.76	0.87	0.7	0.7	0.7	0.83	0.88	0.67	0.72	-0.02	0.7	0.73	0.3	0.35
AXLreceptortyrosinekinase	0.02	0.14	-0.52	-0.29	-0.43	-0.24	0.04	-0.23	0.21	-0.24	0.7	0.4	-0.08	-0.46	-0.24	0.13	0.47	0.57
"Acidphosphatase2,lysosomal"	3.31	3.21	2.39	2.68	2.6	2.72	3.31	3.32	3.11	3.35	3.63	3.63	3.39	2.84	3.05	3.48	4.01	4.3
"Alkalinephosphatase,placental(Reganisozyme)"	0.17	0.77	-0.46	-0.29	-0.09	-0.28	0.61	0.65	0.36	0.71	1.14	0.7	0.33	0.22	0.3	0.84	0.83	1.48
Arachidonate12-lipoxygenase	-0.46	0.01	-0.53	-0.17	-0.17	-0.39	0.01	-0.14	-0.34	-0.1	0.93	0	-0.28	-0.8	-0.15	-0.01	0.09	1.04
Ribosomal protein S6	-1.02	-0.55	-1.01	-0.8	-0.89	-0.84	-0.88	-0.92	-0.99	-0.9	-0.66	-0.94	-0.78	-0.29	-0.43	-0.59	-0.61	-0.24
B-cell CLL/lymphoma 2	-1.29	-0.87	-1.14	-1.15	-1.33	-1.4	-1.2	-1.25	-1.18	-1.24	-0.7	-1.01	-1.25	-0.84	-0.89	-1.19	-0.67	-0.25
TRAF family member-associated NFKB activator	0.58	0.48	0.58	0.68	0.59	0.72	0.23	0.24	0.25	0.43	0.38	0.31	0.56	-0.54	0.45	-0.08	-0.6	-0.31
"""""""Interleukin 1, beta"""""""	0.49	0.17	0.49	0.39	0.54	0.48	0.11	0.12	0.22	0.13	0.28	0.15	0.32	-0.31	0.24	-0.15	-0.1	0.1
Interleukin 8	-0.42	-0.27	-0.38	-0.28	-0.46	-0.33	-0.19	-0.4	-0.15	-0.36	0.02	-0.28	-0.24	-0.02	-0.29	-0.26	-0.15	-0.08
"""""""Mouse double minute 2, human homolog of; p53-binding protein"""""""	0.81	0.86	0.82	0.95	0.84	0.89	1.04	0.9	0.86	0.94	1.13	1.12	0.77	1.04	0.74	0.79	0.84	0.95
"hTRIP(hTRIP)mRNA,completecds"	0.5	0.48	0.63	0.62	0.71	0.56	0.33	0.4	0.5	0.61	0.6	0.46	0.43	0.03	0.48	0.51	0.1	0.07
"Interleukin1,beta"	0.61	0.57	0.74	0.73	0.76	0.78	0.46	0.54	0.76	0.52	0.74	0.48	0.53	-0.04	0.66	0.75	0.15	0.26
Phosphatidylinositol3-kinasep110betaisoform	1.78	1.74	1.39	1.45	1.43	1.56	1.93	1.98	1.82	2.04	2.17	2.16	1.96	1.75	1.65	1.8	2.22	2.11
"Pyruvatedehydrogenasekinase,isoenzyme4"	0.21	0.37	-0.02	0.16	0	0.33	0.55	0.39	0.52	0.95	1.38	1.08	0.72	0.18	0.37	0.72	1.19	1.08
ESTs	0.63	0.7	0.46	0.63	0.67	0.62	0.88	0.74	0.68	0.85	1.17	0.94	0.49	0.41	0.7	0.69	0.79	1.16
ESTs	1.03	0.91	0.7	0.84	0.87	0.84	1.11	1.09	1.08	1.17	1.45	1.29	0.87	0.8	0.96	0.99	1.23	1.48
"""integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)"""	-0.78	-0.27	-0.79	-0.59	-0.59	-0.67	-0.67	-0.59	-0.69	-0.77	-0.56	-0.69	-0.61	-0.19	-0.31	-0.71	-0.7	-0.37
"""integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit)"""	-0.14	-0.08	-0.16	0.07	0.03	0.01	-0.16	-0.17	-0.02	-0.22	-0.09	-0.21	-0.11	0.4	0.06	-0.06	-0.4	-0.06
interferon regulatory factor 2	0.03	0.05	-0.3	-0.11	-0.25	-0.21	-0.31	-0.11	0.1	-0.13	0.04	0.11	-0.22	-0.09	-0.13	-0.28	0.04	0.29
"""major histocompatibility complex, class II, DO beta"""	3.16	3.15	2.5	2.78	2.67	2.82	2.88	3.14	2.9	3.04	3.22	3.29	3.03	3.22	2.85	3.3	3.87	4.06
met proto-oncogene (hepatocyte growth factor receptor)	1.29	1.3	1.27	1.35	1.38	1.27	1.38	1.53	1.41	1.5	1.54	1.55	1.37	1.86	1.36	1.4	1.46	1.42
"""properdin P factor, complement"""	1.53	1.4	0.87	0.94	0.91	1.02	1.59	1.8	1.66	1.75	2	2.08	1.9	2.26	1.29	1.56	2.1	2.1
"ESTs,HighlysimilartoPOSSIBLEGLOBALTRANSCRIPTIONACTIVATORSNF2L1[]"	-0.44	-0.13	-0.35	-0.32	-0.43	-0.4	-0.44	-0.38	-0.11	-0.27	0.09	-0.15	-0.3	-0.27	-0.42	-0.27	-0.17	0.04
"ESTs, Highly  similar to PUTATIVE GTP-BINDING PROTEIN MOV10 [Mus musculus]"	2.92	3.1	3.33	3.35	3.37	3.35	2.53	2.86	2.76	3.03	1.85	1.77	2.12	-0.05	3.06	2	-0.09	0.27
"ESTs,HighlysimilartoRIBOSOMALPROTEINS6KINASEIIALPHA2[Musmusculus]"	1.35	1.29	1.17	1.28	1.26	1.28	1.73	1.64	1.6	1.6	1.76	1.64	1.44	1.2	1.22	1.3	1.66	1.72
"ESTs,HighlysimilartoL-3-phosphoserine-phosphatasehomologue[]"	0.46	0.55	0.39	0.58	0.48	0.49	0.69	0.61	0.6	0.7	1.02	0.72	0.56	0.53	0.4	0.64	0.81	1.06
"ESTs,Highlysimilartoguanylatekinase[]"	0.28	0.34	-0.1	0.22	0.12	0.13	0.67	0.57	0.54	0.53	1.15	0.68	0.38	0.22	0.25	0.55	0.92	1.01
"ESTs,WeaklysimilartoGcn2p:Proteinkinase,phosphorylatesthealphasubunitofeIF-2[S.cerevisiae]"	3.34	3.41	2.69	2.85	2.81	2.96	3.34	3.46	3.14	3.41	3.56	3.51	3.24	2.4	3.06	3.61	4.1	4.4
zinc finger protein 220	-1.22	-0.69	-1.35	-1.2	-1.14	-1.24	-1.03	-0.97	-1.22	-1.28	-0.86	-1.02	-1.12	-0.83	-0.65	-1.15	-0.7	-0.55
"""surfactant, pulmonary-associated protein C"""	-0.27	0.07	0.02	0.06	0.01	0.01	-0.11	-0.08	-0.11	-0.11	-0.11	-0.18	-0.09	0.28	0.18	-0.18	-0.1	-0.13
phosphodiesterase I/nucleotide pyrophosphatase 2 (autotaxin)	-0.92	-0.55	-1.02	-0.85	-1.06	-0.97	-0.94	-0.86	-0.85	-0.87	-0.54	-0.81	-0.93	-0.5	-0.72	-0.75	-0.42	-0.17
signaling lymphocytic activation molecule	-0.77	-0.31	-0.85	-0.63	-1.2	-0.74	-0.7	-0.64	-0.08	0.12	-0.23	0.62	0.03	-0.19	-0.53	-0.37	0.13	0.39
serine/threonine protein-kinase	-0.83	-0.33	-0.85	-0.73	-1.28	-0.81	-0.72	-0.69	-0.75	-0.58	-0.43	-0.26	-0.58	-0.27	-0.66	-0.44	-0.11	-0.15
"""activin A receptor, type II"""	-0.81	-0.45	-0.89	-0.13	-0.9	-0.79	-0.63	-0.67	-0.86	-0.28	-0.15	-0.47	-0.33	0.03	-0.35	-0.12	-0.22	0.2
glutathione peroxidase 1	-1.47	-0.86	-1.36	-1.18	-1.27	-1.39	-1.09	-1.16	-1.13	-1.15	-0.36	-0.81	-1.18	-1.14	-1.3	-0.99	-0.59	-0.09
"""fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)"""	1.29	1.39	1.45	1.44	1.45	1.39	1.22	1.35	1.5	1.58	1.48	1.44	1.49	0.59	1.33	0.9	0.75	0.84
group-specific component (vitamin D binding protein)	0.52	0.71	0.75	0.78	0.79	0.71	0.72	0.67	0.66	0.67	1.01	0.73	0.56	0.71	0.73	0.79	0.52	0.78
FK506-binding protein 1B (12.6 kD)	-0.31	0.14	-0.3	-0.22	-0.18	-0.11	-0.01	0.02	-0.17	0.09	0.71	-0.01	-0.08	-0.27	-0.17	0.12	-0.15	0.77
"""SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3"""	-0.37	-0.02	-0.47	-0.32	-0.49	-0.35	0.08	-0.02	-0.31	-0.03	0.87	0.12	-0.3	-0.43	-0.19	-0.06	-0.15	0.62
"""TATA box binding protein (TBP)-associated factor, RNA polymerase II, J, 20kD"""	-0.12	0.43	-0.42	-0.05	-0.52	0.05	0.23	0.18	0.38	1.26	1.29	1.33	0.75	-0.37	0.21	0.19	0.65	0.95
"""transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)"""	-0.94	-0.67	-0.74	-0.72	-0.7	-0.52	-0.72	-0.82	-0.67	-0.81	-0.64	-0.86	-1.13	-0.77	-0.6	-0.72	-0.55	-0.61
"""tumor necrosis factor receptor superfamily, member 11a, activator of NFKB"""	0.42	0.4	0.61	0.63	0.59	0.67	0.14	0.32	0.33	0.42	0.06	0.22	0.48	-0.41	0.59	-0.06	-0.56	0.04
mitogen-activated protein kinase 11	-1.23	-0.8	-1.38	-1.31	-1.07	-1.22	-1.14	-1.14	-1.21	-1.2	-0.95	-1.1	-1.22	-1.09	-1.01	-1.16	-0.74	-0.34
runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)	-1.33	-0.99	-1.41	-1.15	-1.42	-1.41	-1.35	-1.15	-1.37	-1.26	-1.02	-1.21	-1.1	-1.13	-1.28	-1.29	-0.65	-0.32
muscarinic acetylcholine receptor M1 (human)	-0.44	-0.09	-0.49	-0.3	-0.39	-0.45	-0.4	-0.39	-0.56	-0.47	-0.29	-0.48	-0.54	-0.14	-0.27	-0.31	-0.25	-0.16
EST	-0.82	-0.58	-0.9	-0.7	-0.82	-0.87	-0.89	-0.72	-0.87	-0.71	-0.36	-0.68	-0.76	-0.53	-0.8	-0.79	-0.68	-0.37
murine leukemia viral (bmi-1) oncogene homolog	-0.91	-0.61	-0.79	-0.68	-0.66	-0.68	-0.52	-0.6	-0.68	-0.65	-0.16	-0.55	-0.72	-0.82	-0.67	-0.69	-0.54	-0.35
prolactin	-0.8	-0.46	-0.73	-0.63	-0.73	-0.7	-0.48	-0.36	-0.42	-0.5	0.03	-0.35	-0.76	-0.86	-0.75	-0.55	-0.37	-0.01
"""RAB2, member RAS oncogene family"""	0.38	0.58	0.54	0.55	0.56	0.49	0.64	0.6	0.39	0.58	0.86	0.59	0.37	0.28	0.46	0.57	0.15	0.4
ESTs	-0.46	-0.13	-0.32	-0.28	-0.23	-0.25	-0.22	0.05	-0.29	-0.14	0.55	0.03	-0.25	-0.9	-0.42	-0.43	-0.52	0.26
brain-derived neurotrophic factor	-1.02	-0.43	-1.06	-0.77	-0.54	-0.82	-0.47	-0.5	-0.88	-0.62	0.53	-0.4	-0.86	-1.21	-0.69	-0.52	-0.48	0.61
chemokine (C-C motif) receptor 2	0.02	0.34	0.24	0.3	0.28	0.24	0.25	0.27	0.03	0.31	1.04	0.35	0.15	-0.48	0.17	0.07	-0.11	0.8
v-maf musculoaponeurotic fibrosarcoma (avian) oncogene homolog; c-maf mRNA	-0.65	-0.3	-0.57	-0.46	-0.47	-0.47	-0.32	-0.31	-0.28	-0.44	-0.34	-0.39	-0.56	-0.3	-0.25	-0.37	-0.35	-0.14
fms-related tyrosine kinase 4	0.05	0.01	0.11	-0.01	0.07	-0.01	-0.03	-0.13	-0.21	-0.19	0.06	0.01	0.22	-0.77	0.01	-0.44	-0.38	0.02
cannabinoid receptor 2 (macrophage)	-0.83	-0.64	-0.87	-0.92	-0.93	-1.1	-0.85	-0.82	-0.75	-0.88	-0.72	-0.68	-0.72	-0.92	-0.62	-0.77	-0.38	-0.46
mitogen-activated protein kinase 10	0.63	0.58	0.8	0.81	0.73	0.74	0.18	0.43	0.35	0.41	0.25	0.24	0.88	-0.36	0.67	-0.08	-0.12	-0.26
"""Burkitt lymphoma receptor 1, GTP-binding protein"""	-0.42	-0.2	-0.43	-0.29	-0.44	-0.29	-0.22	-0.3	-0.28	-0.33	-0.29	-0.48	0.08	-0.29	-0.01	-0.38	-0.44	-0.17
"""tumor necrosis factor receptor superfamily, member 6; FAS; APO-1; CD95; APT1"""	-1.3	-0.92	-1.47	-1.26	-1.19	-1.52	-0.92	-0.98	-1.01	-1.12	-0.52	-0.95	-1.17	-1.21	-1.22	-1.09	-0.68	-0.23
protein S (alpha)	-0.46	-0.19	-0.5	-0.32	-0.34	-0.47	0.19	0	-0.26	-0.22	0.22	-0.24	-0.38	-0.4	-0.52	-0.24	-0.09	-0.01
insulin-like growth factor 1 receptor	-1.65	-0.72	-1.71	-1.43	-1.49	-1.37	-0.95	-0.98	-1.35	-1.3	-0.29	-0.85	-1.29	-1.55	-1.35	-0.88	-0.83	-0.08
"""tumor necrosis factor receptor superfamily, member 10b; DR5; TRAIL-R2; TRICK2A"""	-0.83	-0.5	-0.67	-0.59	-0.57	-0.55	-0.53	-0.67	-0.64	-0.53	-0.13	-0.41	-0.63	-1.06	-0.68	-0.53	-0.59	0.25
opioid-binding protein/cell adhesion molecule-like	-1.15	-0.72	-1.14	-1.03	-0.98	-1.02	-0.7	-0.8	-0.95	-0.89	0.03	-0.61	-0.85	-1.21	-1.02	-0.87	-0.61	0.12
"""cholinergic receptor, nicotinic, epsilon polypeptide"""	-1.21	-0.73	-1.26	-1.04	-0.89	-0.91	-0.71	-0.75	-1.14	-0.84	0.19	-0.63	-1.07	-1.04	-1.01	-0.75	-0.44	0.16
formyl peptide receptor 1	-0.66	-0.18	-0.57	-0.39	-0.21	-0.22	-0.11	-0.03	-0.57	-0.03	0.63	-0.14	-0.41	-0.85	-0.42	-0.33	-0.32	0.32
ubiquitin-binding protein p62; phosphotyrosine independent ligand for the Lck SH2 domain p62	1.3	1.28	1.45	1.46	1.19	1.26	1.68	1.62	1.44	1.41	1.36	1.48	1.29	2.04	1.34	1.51	2.02	1.83
megakaryocyte-associated tyrosine kinase	-0.73	-0.43	-0.63	-0.74	-0.68	-0.66	-0.39	-0.47	-0.49	-0.63	-0.22	-0.35	-0.55	0.02	-0.49	-0.52	0.02	0.07
prostaglandin D2 receptor (DP)	1.27	1.24	0.83	0.86	0.85	1.03	1.43	1.57	1.49	1.49	1.6	1.74	1.43	2.05	1.23	1.42	1.94	1.75
feline sarcoma (Snyder-Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog	-0.83	-0.38	-0.83	-0.73	-0.93	-0.59	-0.41	-0.52	-0.56	-0.49	-0.14	-0.58	-0.27	-0.4	-0.67	-0.51	-0.34	-0.37
v-Ha-ras Harvey rat sarcoma viral oncogene homolog	0.8	0.71	0.26	0.21	0.36	0.39	0.91	0.77	1.02	1.1	1.13	1.21	1.18	1.01	0.46	0.56	1.01	0.73
"""tumor necrosis factor receptor superfamily, member 1A"""	0.47	0.44	0.5	0.54	0.48	0.56	0.6	0.51	0.62	0.61	0.6	0.45	0.73	0.59	0.55	0.31	0.15	0.14
"""purinergic receptor P2Y, G-protein coupled, 2"""	0.47	0.59	0.46	0.48	0.6	0.59	0.68	0.38	0.62	0.72	0.76	0.69	0.67	0.57	0.46	0.48	0.32	0.42
adenosine A2a receptor	0.37	0.29	-0.14	-0.09	-0.19	-0.08	0.48	0.32	0.02	-0.32	0.09	0.24	-0.27	-0.02	-0.19	0.43	0.34	0.9
insulin-like growth factor binding protein 5 (IGFBP5) mRNA	0.02	0.04	-0.31	-0.1	-0.12	-0.21	0.05	-0.01	-0.04	-0.15	0.44	0.12	-0.08	-0.63	-0.43	-0.14	-0.11	0.28
"""interleukin 10 receptor, alpha"""	0.27	0.41	0.35	0.5	0.46	0.34	0.43	0.48	0.33	0.46	0.78	0.48	0.33	-0.35	0.31	0.25	0.11	0.53
"""major histocompatibility complex, class I, A"""	-0.93	-0.48	-0.85	-0.68	-0.62	-0.76	-0.37	-0.42	-0.93	-0.46	0.42	-0.39	-0.76	-1.3	-0.7	-0.45	-0.5	0.54
"""major histocompatibility complex, class II, DN alpha"""	-0.91	-0.46	-0.88	-0.72	-0.72	-0.9	-0.46	-0.48	-0.95	-0.53	0.51	-0.27	-0.91	-1.61	-0.85	-0.74	-0.59	0.22
RCL growth-related c-myc-responsive gene	-1.02	-0.55	-1.14	-0.88	-1.11	-1.07	-0.86	-0.74	-0.82	-0.85	-0.65	-0.44	-0.79	-0.49	-0.72	-0.85	-0.55	-0.06
78-kDa glucose regulated protein precursor (GRP 78); immunoglobulin heavy chain binding protein (BIP)(HSPA5:  heat shock 70kD protein 5)	-0.59	-0.16	-0.53	-0.57	-0.57	-0.56	-0.49	-0.48	-0.41	-0.29	-0.25	-0.43	-0.45	-0.28	-0.37	-0.41	-0.1	-0.21
Nuclear localization receptor hSRP1-alpha	-0.82	-0.52	-0.89	-0.97	-0.95	-0.83	-0.52	-0.38	-0.44	-0.39	-0.23	-0.45	-0.44	0.02	-0.59	-0.66	-0.15	-0.23
L-lactate dehydrogenase H subunit (LDHB)	-1	-0.75	-1.23	-1.24	-1.33	-1.29	-0.89	-0.92	-0.96	-1.05	-0.62	-0.86	-1.02	-0.72	-1.02	-0.87	-0.46	-0.2
C-jun N-terminal kinase 3 alpha2 (JNK3A2); PRKM10 + MAP kinase p493F12	-0.39	-0.11	-0.23	-0.17	-0.14	-0.28	-0.18	-0.13	-0.07	-0.22	0.07	-0.28	-0.15	0.07	-0.21	-0.19	-0.42	-0.04
Phox2 Homeodomain Protein (HIPK3:  homeodomain-interacting protein kinase 3)	-0.7	-0.39	-0.57	-0.6	-0.71	-0.76	-0.42	-0.6	-0.54	-0.46	-0.09	-0.53	-0.45	-0.44	-0.59	-0.57	-0.53	-0.06
"""MAD (mothers against decapentaplegic, Drosophila) homolog 6; Smad6"""	0.37	0.74	0.15	0.19	0.17	0.14	0.17	0.3	0.32	0.22	0.69	0.35	-0.07	0.34	0.22	0.01	0.58	0.67
glutathione peroxidase 2 (gastrointestinal)	4.09	4.43	3.56	3.79	3.63	3.86	4.2	4.18	3.84	4	4.24	4.22	3.93	3.95	3.82	4.41	5	5.27
G protein-coupled receptor 9; CXCR3	2.03	2.11	2.03	2.04	2	2.03	2.29	2.24	2.11	2.19	2.35	2.21	2.05	1.38	1.95	1.87	1.98	2.72
chemokine (C-X3-C) receptor 1	1.86	2.08	1.9	1.92	2.14	1.77	1.9	1.96	1.78	1.98	2.24	2.12	1.98	0.2	1.66	1.03	0.79	0.89
"""SHIP; inositol polyphosphate-5-phosphatase, 145kD"""	0.15	0.29	0.24	0.47	0.39	0.3	0.24	0.32	0.2	0.33	0.73	0.33	0.41	-0.95	0.38	-0.14	-0.46	0.66
chemokine (C-C motif) receptor 7	-0.38	0.05	-0.18	-0.01	-0.06	-0.02	0.05	0.07	-0.25	0.13	0.87	0.14	-0.33	-1.32	-0.09	-0.02	-0.48	0.66
Wnt-4	-0.39	-0.12	-0.28	-0.23	-0.32	-0.36	-0.12	-0.4	-0.13	-0.18	-0.09	0.05	-0.41	-0.35	-0.23	-0.32	-0.55	-0.37
dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5; MAPKK 5)	-0.73	-0.42	-0.63	-0.93	-0.75	-0.83	-0.56	-0.51	-0.51	-0.56	-0.31	-0.5	-0.56	-0.42	-0.57	-0.44	-0.15	-0.21
ubiquitin (UBC:  ubiquitin C)	-1.23	-0.87	-1.46	-1.36	-1.27	-1.56	-1.03	-1.02	-1.06	-1.26	-0.73	-0.89	-1.12	-0.83	-1.14	-0.98	-0.47	-0.45
"excision repair protein ERCC6; Cockayne syndrome protein CSB (Cockayne syndrome-2, type B)"	0.79	0.72	0.27	0.39	0.28	0.3	0.89	0.94	1.05	0.97	1.26	1.25	1.24	1.51	0.54	0.66	1.17	0.96
heat shock protein beta 2 (HSPB2); DMPK-binding protein; MKBP	-0.42	-0.36	-0.73	-0.79	-0.82	-0.74	-0.44	-0.33	-0.46	-0.44	0.11	-0.28	-0.19	-0.07	-0.68	-0.6	-0.15	-0.01
OX40 ligand (OX40L); GP34; tax-transcriptionally activated glycoprotein 1 (TXGP1)	0.02	0.06	0.01	0.14	0.11	0.01	0.27	-0.07	0.04	0.08	0.5	-0.02	0.3	0.02	0.11	-0.12	-0.22	0.1
"""pyrimidinergic receptor P2Y, G-protein coupled, 6"""	-0.65	-0.41	-0.51	-0.44	-0.6	-0.51	-0.45	-0.43	-0.45	-0.53	0.13	-0.31	-0.61	-0.2	-0.58	-0.28	-0.08	0.1
"""retinol-binding protein 1, cellular"""	0.71	0.22	0.16	0.28	0.07	0.13	0.23	0.89	0.22	1.49	1.12	1.5	1.2	0.27	0.08	0.13	1.35	1.21
"""secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)"""	0.06	0.21	0.08	0.24	0.14	0.12	0.49	0.21	0.42	0.4	0.76	0.56	0.15	-0.34	0.17	0.45	0.6	0.92
5-hydroxytryptamine (serotonin) receptor 2C	0	0.14	0.07	0.23	0.18	0.14	0.42	0.27	0.19	0.35	0.69	0.34	-0.04	-1.02	0.14	0.1	0.14	0.77
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3	-0.29	0.04	-0.24	-0.04	-0.11	-0.17	0.24	0.2	-0.06	0.05	0.7	0.21	-0.19	-1.24	-0.02	-0.03	0.02	0.7
"""phospholipase C, delta 1"""	-0.55	-0.09	-0.37	-0.04	-0.11	-0.2	0.06	0.06	-0.29	0.14	0.67	0.06	-0.56	-1.57	-0.12	-0.25	-0.4	0.47
CDC25B; CDC25HU2; M-phase inducer phosphatase 2	0.34	0.24	0.3	0.32	0.2	-0.15	0.42	0.29	0.42	0.28	0.57	0.38	-0.06	-0.06	0.29	0.38	0.72	0.51
cyclin G-associated kinase (GAK)	1.13	0.85	1.2	1.79	1.81	1.53	1.47	1.62	1.64	1.63	0.88	1.01	0.53	-0.59	1.91	0.7	0.04	-0.15
B-lymphocyte kinase; tyrosine-protein kinase BLK; p55-BLK	-0.7	-0.48	-0.91	-0.69	-0.47	-0.76	-0.1	-0.25	-0.65	-0.51	-0.27	-0.63	-0.91	-0.58	-0.51	-0.52	-0.12	-0.14
NADPH-cytochrome p450 reductase	-0.2	-0.14	-0.34	-0.13	-0.02	-0.14	-0.04	0.03	0.1	0.03	0.14	-0.01	0.01	0.16	0.13	0	-0.06	0.03
SUI1ISO1 (SUI1: putative translation initiation factor)	-0.88	-0.59	-0.79	-0.72	-0.84	-0.94	-0.77	-0.73	-0.88	-0.81	-0.34	-0.88	-0.85	-0.61	-0.62	-0.89	-0.59	-0.37
cadherin 12 (CDH12); brain cadherin precursor (Br-cadherin); neural cadherin 2 (N-cadherin 2)	-1.45	-1	-1.44	-1.41	-1.55	-1.52	-1.24	-1.15	-1.42	-1.28	-0.23	-0.97	-1	-0.93	-1.07	-1.1	-0.62	-0.21
delta-like protein precursor (DLK)	-0.15	-0.1	0	0.1	-0.08	-0.09	0.02	-0.06	-0.13	-0.04	0.36	-0.03	-0.37	0.1	-0.04	-0.15	-0.25	-0.03
mitogen-activated protein kinase P38 beta (MAP kinase P38 beta); stress-activated protein kinase 2 (SAPK2)	-0.71	-0.44	-0.74	-0.51	-0.48	-0.7	-0.23	-0.27	-0.48	-0.42	0.2	-0.37	-0.69	-0.43	-0.58	-0.33	-0.33	0.17
tyrosine aminotransferase (TAT); I-tyrosine:2-oxoglutarateaminotransferase	-0.47	-0.21	-0.64	-0.53	-0.61	-0.59	-0.13	-0.43	-0.44	-0.29	0.45	-0.05	-0.36	-1.38	-0.37	-0.3	-0.21	0.61
"calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (CAM-PDE1B); HCAM2 "	0.33	0.41	0.49	0.57	0.58	0.56	0.42	0.38	0.36	0.53	0.53	0.19	0.38	-0.84	0.78	0.44	-0.12	0.49
GTP-binding protein Ran/TC4	-0.14	0.07	-0.33	-0.01	-0.22	-0.29	0.21	0.2	-0.08	0.19	0.73	0.19	-0.12	-1.9	0.1	-0.4	-0.44	0.29
"""phospholipase A2, group IB (pancreas)"""	0.7	0.84	0.2	0.43	0.31	0.37	1.08	1.13	0.87	1.14	1.45	1.31	0.95	-0.7	0.74	0.84	1.2	1.37
enolase 1 alpha (ENO1); non-neural enolase (NNE); phosphopyruvate hydratase (PPH)	4.45	4.77	4	4.2	3.99	4.2	4.33	4.52	4.3	4.37	4.7	4.63	4.34	4.02	4.34	4.51	5.39	5.72
MRP14 (S100A9:  S100 calcium-binding protein A9 (calgranulin B))	1.35	1.32	0.87	0.98	0.78	0.99	-0.13	1.18	1.52	0.81	1.3	1.08	0.77	0.88	1.33	1.17	1.64	1.57
H-ras proto-oncogene; transforming G protein	-0.84	-0.49	-1.02	-0.94	-0.95	-1	-1.01	-0.72	-0.91	-0.87	-0.39	-0.64	-0.86	-0.57	-0.8	-0.75	-0.23	0.01
EF-1-Gamma (eukaryotic translation elongation factor 1 gamma)	0.03	0.11	-0.14	0.2	0.09	0	0.49	0.41	0.21	0.19	0.68	0.2	0.03	0.53	0.2	0.13	0.19	0.21
BCL-2 binding athanogene-1 (BAG-1); glucocorticoid receptor-associated protein RAP46	-0.6	-0.33	-0.45	-0.4	-0.4	-0.5	-0.3	-0.24	-0.43	-0.36	0.09	-0.19	-0.63	-0.23	-0.34	-0.23	-0.16	-0.08
FAS soluble protein; Apo1	-1.36	-0.79	-1.24	-1.09	-1.24	-1.25	-1.14	-0.89	-1.27	-1.1	-0.1	-0.86	-1.13	-0.98	-0.92	-0.94	-0.57	-0.14
cytochrome P450 VIIA1  (CYP7A1)	-1.25	-0.66	-1.14	-0.85	-0.82	-0.92	-0.68	-0.79	-1.12	-0.83	0.01	-0.7	-0.91	-1.53	-0.83	-0.51	-0.46	0
RBQ-3 (RBBP5:  retinoblastoma-binding protein 5)	0.19	0.5	0.1	0.51	0.44	0.1	0.81	0.58	0.49	0.41	0.8	0.47	0.36	-1.74	0.77	0.09	-0.44	0.28
"Myosin Heavy Chain, Perinatal (MYHSA1   MYHa   MyHC-2X/D   MYH1)"	-0.59	-0.35	-0.51	-0.33	-0.44	-0.57	-0.38	-0.29	-0.45	-0.38	0.38	-0.23	-0.52	-1.92	-0.71	-0.62	-0.44	0.35
75-kDa glucose-regulated protein (GRP 75); mitochondrial stress-70 protein precursor; peptide-binding protein 74 (PBP74); mortalin' MOT (HSPA9B:  heat shock 70kD protein 9B (mortalin-2))	0.25	0.61	0.54	0.59	0.59	0.45	0.4	0.55	0.6	0.65	0.83	0.32	0.98	-1.55	0.74	0.38	-0.19	0.61
heat shock protein 40 homolog (HSP40 homolog); DNAJW	1.63	1.76	0.92	1.24	1.19	1.23	1.94	2.03	1.83	1.88	2.12	2.14	1.93	-0.1	1.51	1.74	2.43	2.52
Poly(ADP-ribose) synthetase	-0.3	0.1	-0.37	-0.1	-0.1	-0.29	0.19	0.27	-0.14	0.16	0.72	0.22	-0.01	-2.21	0.03	-0.32	0.19	0.47
"Ste20-likekinase(MST2)mRNA,completecds"	-0.5	-0.69	-0.45	-0.57	-0.63	-0.39	-0.61	-0.81	-0.58	-0.74	-1.05	-0.7	-0.82	0.06	-0.64	-0.64	-0.73	-1.03
"cAMPphosphodiesterasemRNA,3'end"	-0.8	-1.03	-0.71	-0.96	-0.78	-0.81	-0.89	-0.93	-0.86	-1	-1.29	-0.84	-1.12	-0.16	-0.9	-0.74	-0.9	-0.56
"guaninenucleotideexchangefactormss4mRNA,completecds"	0.61	0.45	0.95	0.96	0.95	0.8	0.57	0.46	0.79	0.73	0.14	0.62	0.84	0.4	0.72	0.58	-0.82	-0.77
"insulin-stimulatedproteinkinase1(ISPK-1)mRNA,completecds"	-1.25	-1.75	-1.13	-1.52	-1.66	-1.45	-1.75	-1.74	-1.38	-1.57	-1.89	-1.26	-1.43	-1.02	-1.87	-1.6	-1.23	-1.29
"lipid-activated,proteinkinasePRK2mRNA,completecds"	0.75	0.52	0.92	0.85	0.85	0.87	0.4	0.28	0.61	0.61	-0.06	0.26	0.47	-0.09	0.7	0.22	-0.93	-0.55
"KIAA0137gene,completecds"	-0.56	-0.84	-0.41	-0.52	-0.58	-0.47	-1.13	-0.86	-0.84	-0.97	-1.4	-0.89	-0.86	-0.73	-0.8	-0.74	-0.94	-0.94
TYROSINE-PROTEINKINASECSK	1.01	0.92	1.44	1.34	1.31	1.21	0.88	0.8	1	0.96	0.49	0.62	0.8	1.1	1.51	1.27	0.49	0.2
TYROSINE-PROTEINKINASERECEPTORECK	-1.09	-1.42	-0.88	-1.21	-0.98	-1.06	-1.49	-1.42	-1.31	-1.26	-1.59	-1.19	-1.53	-0.59	-1.24	-1.11	-0.92	-0.75
TranscriptionfactorAP-4(activatingenhancer-bindingprotein4)	0.06	-0.08	-0.08	0.01	0.01	0.03	-0.12	-0.14	-0.03	0.01	-0.05	0.14	0.04	0.28	-0.1	-0.12	-0.06	-0.12
"Tyrosine3-monooxygenase/tryptophan5-monooxygenaseactivationprotein,etapolypeptide"	-0.23	-0.38	-0.14	-0.2	-0.23	-0.21	-0.44	-0.41	-0.33	-0.55	-0.54	-0.3	-0.22	-0.12	-0.25	-0.45	-0.73	-0.41
V-aktmurinethymomaviraloncogenehomolog2	1.06	0.95	1.07	1.06	1.16	1.1	0.76	0.82	0.94	0.82	0.72	0.85	1.08	0.67	1.02	0.86	0.34	-0.26
"Wingless-typeMMTVintegrationsite2,homolog"	-0.23	-0.56	-0.18	-0.38	-0.32	-0.36	-0.65	-0.58	-0.42	-0.6	-0.86	-0.74	-0.75	-0.54	-0.44	-0.64	-0.74	-0.7
"3',5'cyclicnucleotidephosphodiesterase(HSPDE1A3A)mRNA,completecds"	-0.19	-0.49	-0.43	-0.54	-0.47	-0.56	-0.37	-0.24	-0.2	-0.33	-0.26	-0.1	0.04	0.1	-0.53	-0.41	0.02	0.01
"53KisoformofTypeIIphosphatidylinositol-4-phosphate5-kinase(PIPK)mRNA,completecds"	-1.24	-1.36	-1.24	-1.38	-1.23	-1.3	-1.26	-1.3	-1.36	-1.49	-1.5	-1.19	-1.28	-0.67	-1.4	-1.27	-0.93	-0.74
"Blymphocyteserine/threonineproteinkinasemRNA,completecds"	0.71	0.68	1.05	0.98	1.06	1.02	0.78	0.7	0.79	0.84	-0.22	0.12	1.16	0.98	0.75	0.77	-0.68	-0.55
"BTG2(BTG2)mRNA,completecds"	-1.28	-1.57	-1.21	-1.31	-1.34	-1.15	-1.49	-1.37	-1.32	-1.24	-1.71	-1.41	-0.82	-0.62	-1.46	-1.21	-1.11	-0.85
"Bruton'styrosinekinase-associatedprotein-135mRNA,completecds"	-0.57	-0.89	-0.71	-0.79	-0.72	-0.58	-0.93	-0.86	-0.85	-0.92	-0.99	-0.55	-0.87	-0.19	-0.74	-0.65	-0.17	-0.1
"Ca2+-dependentphospholipaseA2mRNA,completecds"	0.04	-0.17	0.22	0.12	0.17	0.13	-0.37	-0.35	0.01	-0.2	-0.78	-0.34	0.04	-0.36	0.06	-0.09	-0.55	-0.41
"ProteinkinaseC,zeta"	1.18	1.1	1.4	1.33	1.38	1.2	0.82	0.9	1.1	1.03	0.46	0.47	0.92	0.64	1.42	1.23	-0.07	-0.36
"Proteinkinase,cAMP-dependent,regulatory,typeI,beta"	0.28	0.19	0.67	0.61	0.52	0.38	0.07	0.12	0.39	0.21	-0.16	-0.08	0.2	0.54	0.64	0.54	-0.19	-0.52
"Proteinphosphatase1,catalyticsubunit,betaisoform"	-0.62	-0.93	-0.67	-0.85	-0.72	-0.71	-0.85	-0.87	-0.85	-0.92	-0.95	-0.75	-0.69	-0.65	-0.89	-0.91	-0.63	-0.83
"Proteinphosphatase2A,regulatorysubunitB'alpha-1"	-0.64	-1.02	-0.74	-0.77	-0.69	-0.65	-0.94	-0.87	-0.88	-0.98	-1.14	-0.74	-0.82	-1.04	-0.8	-0.84	-0.66	-0.92
"Proteintyrosinephosphatase,non-receptortype9"	0.5	0.4	0.49	0.47	0.63	0.45	0.26	0.28	0.29	0.25	0.13	0.28	0.3	0.03	0.47	0.35	-0.05	-0.47
"Proteintyrosinephosphatase,receptortype,cpolypeptide"	0.36	0.24	0.31	0.29	0.38	0.25	0.24	0.13	0.13	0.01	-0.11	0.12	-0.07	-0.23	0.28	0.16	-0.26	-0.47
receptorproteintyrosinekinase	1.94	1.86	1.71	1.77	1.77	1.84	1.5	1.51	1.55	1.58	1.47	1.6	1.75	1.62	1.7	1.66	1.99	1.94
HEATSHOCK70KDPROTEIN1	0.66	0.66	0.86	0.76	0.93	0.68	0.67	0.58	0.7	0.42	0.11	0.44	0.57	0.96	0.73	0.58	-0.3	-0.39
"CaMkinaseIIisoformmRNA,completecds"	0.17	0.06	0.28	0.14	0.29	0.21	-0.21	-0.09	0.18	0.15	-0.65	-0.24	-0.08	-0.23	0	-0.08	-1.02	-0.72
"Rac3(RAC3)mRNA,completecds"	0.24	0.03	0.3	0.27	0.33	0.29	0.09	0.18	0.2	0.06	-0.38	-0.06	0.3	-0.29	-0.05	-0.43	-0.94	-1.05
"calcium/calmodulin-dependentproteinkinaseIImRNA,partialcds"	1.11	1.03	1.38	1.28	1.32	1.35	0.89	0.84	0.99	0.9	0.47	0.61	0.67	0.53	1.39	1.1	1.17	1.12
"delta-cateninmRNA,partialcds"	0.63	0.41	0.88	0.71	0.81	0.75	0.44	0.45	0.43	0.4	-0.08	0.21	0.27	0.28	0.69	0.54	0.31	0.05
Lecithin-cholesterolacyltransferase	1.06	1.27	1.52	1.45	1.48	1.3	1.13	1.09	1.18	1.14	0.72	0.78	0.78	0.92	1.41	1.26	0.72	0.4
Lumican	-0.58	-0.66	-0.4	-0.54	-0.55	-0.66	-0.86	-0.8	-0.67	-0.73	-1.15	-0.69	-0.81	-0.47	-0.47	-0.57	-0.55	-0.6
MYO-INOSITOL-1(OR4)-MONOPHOSPHATASE	-0.41	-0.51	-0.49	-0.56	-0.44	-0.44	-0.69	-0.56	-0.51	-0.51	-0.73	-0.54	-0.78	-0.74	-0.5	-0.68	-0.76	-1.03
NKG2-DTYPEIIINTEGRALMEMBRANEPROTEIN	-0.06	-0.45	-0.07	-0.04	-0.12	-0.07	-0.51	-0.36	-0.36	-0.46	-0.56	-0.47	-0.33	-0.37	-0.13	-0.46	-0.56	-0.99
"PHOSPHATIDYLINOSITOL3-KINASECATALYTICSUBUNIT,ALPHAISOFORM"	-0.45	-0.79	-0.44	-0.46	-0.46	-0.39	-0.63	-0.58	-0.7	-0.78	-0.79	-0.72	-0.42	-0.52	-0.44	-0.71	-0.8	-0.83
"PROTEINPHOSPHATASEPP2A,65KDREGULATORYSUBUNIT,ALPHAISOFORM"	-0.93	-1.11	-0.81	-1	-1.02	-0.83	-1.01	-0.86	-1.06	-1.25	-1.18	-1.07	-0.98	-0.81	-1	-1	-1.02	-0.76
GUANINENUCLEOTIDE-BINDINGPROTEINBETASUBUNIT-LIKEPROTEIN12.3	-0.65	-0.79	-0.95	-0.65	-0.59	-0.7	-0.9	-0.79	-0.66	-0.77	-1.18	-1	-0.77	-0.51	-0.72	-0.93	-0.62	-0.49
Glucose-6-phosphatase	-0.29	-0.48	-0.72	-0.75	-0.4	-0.7	-0.49	-0.41	-0.49	-0.4	-0.34	-0.15	-0.14	-0.03	-0.63	-0.7	-0.23	-0.35
GlutathioneS-transferaseM3(brain)	0.22	0.08	0.17	0.25	0.38	0.14	-0.04	-0.13	0	-0.14	-0.48	-0.36	0.18	0.07	-0.03	-0.3	-1.01	-0.88
"Guaninenucleotidebindingprotein(Gprotein),alphainhibitingactivitypolypeptide1"	-1.53	-1.84	-1.46	-1.66	-1.85	-1.69	-1.74	-1.57	-1.91	-1.81	-2.1	-1.62	-1.48	-1.35	-2.01	-2.11	-1.39	-1.28
ERK3mRNA	-0.38	-0.58	-0.31	-0.3	-0.33	-0.51	-0.57	-0.58	-0.54	-0.58	-0.92	-0.67	-0.71	-0.39	-0.56	-0.54	-0.67	-0.49
TTFsmallGprotein	1	1.09	1.12	1.03	1.22	1.13	0.9	0.78	1.01	0.85	0.42	0.73	0.42	0.55	0.82	0.73	-0.1	-0.6
"phosphatidylinositol(4,5)bisphosphate5-phosphatasehomologmRNA,partialcds"	0.83	0.85	0.97	0.94	1.16	1.07	0.75	0.6	0.77	0.66	0.39	0.53	0.23	0.29	0.84	0.69	0.02	-0.09
"proteinkinaseC-L(PRKCL)mRNA,completecds"	-0.15	-0.33	-0.13	-0.25	-0.02	-0.17	-0.29	-0.42	-0.38	-0.42	-0.58	-0.39	-0.34	-0.58	-0.47	-0.67	-0.74	-1.09
"proteinphosphatase2AbetasubunitmRNA,completecds"	-0.67	-1.01	-0.9	-1.03	-0.95	-1.13	-0.85	-0.67	-0.89	-0.9	-0.7	-0.66	-0.67	-0.41	-1.01	-0.99	-0.55	-0.78
"proteintyrosinephosphatasePTPCAAX1(hPTPCAAX1)mRNA,completecds"	-0.52	-0.53	-0.39	-0.56	-0.5	-0.54	-0.45	-0.67	-0.58	-0.72	-0.64	-0.53	-0.56	-0.19	-0.57	-0.51	-0.44	-0.68
"proteintyrosinephosphatasemRNA,completecds"	-1.18	-1.11	-1.1	-1.14	-1.08	-1.06	-1.07	-0.99	-1.3	-1.18	-1.23	-1.02	-1.19	-0.74	-1.24	-0.92	-0.79	-1.2
rap2ras-relatedprotein	-0.54	-0.63	-0.35	-0.47	-0.44	-0.44	-0.45	-0.5	-0.66	-0.67	-0.78	-0.49	-0.71	-0.25	-0.45	-0.41	-0.8	-0.69
"VRK2,completecds"	-1.85	-1.77	-2.31	-2.02	-1.99	-2.01	-1.96	-2.05	-2	-2.17	-2.25	-1.73	-1.84	-1.28	-1.9	-2.06	-1.23	-0.92
"clathrincoatassemblyprotein-like,completecds"	-0.93	-1.17	-0.63	-0.75	-0.68	-0.72	-1	-1.12	-0.95	-1.06	-1.19	-1.09	-1.08	0.04	-0.98	-0.89	-0.74	-0.98
retinalS-antigen(48KDaprotein)	-1.05	-1.23	-0.91	-0.86	-0.91	-0.92	-1.15	-1.18	-1.01	-1.19	-1.48	-1.33	-1.23	-0.5	-1.1	-0.94	-1.07	-0.84
"mitogen-activatedkinasekinasekinase5(MAPKKK5)mRNA,completecds"	-1.6	-1.61	-1.68	-1.69	-1.53	-1.77	-1.78	-1.78	-1.81	-1.7	-2	-1.58	-1.32	-0.88	-1.69	-1.68	-1.04	-1.1
"phosphatidylinositol(4,5)bisphosphate5-phosphatasehomologmRNA,partialcds"	-0.38	-0.73	-0.37	-0.52	-0.45	-0.47	-0.78	-0.69	-0.68	-0.82	-1	-0.85	-0.73	-0.12	-0.63	-0.54	-0.9	-0.71
"proteinkinaseC-bindingproteinRACK7mRNA,partialcds"	-0.53	-0.52	-0.47	-0.57	-0.5	-0.63	-0.63	-0.97	-0.7	-0.74	-0.76	-0.58	-0.44	-0.56	-0.7	-1.12	-0.53	-0.87
"CD36antigen(collagentypeIreceptor,thrombospondinreceptor)"	0.93	0.73	1.04	0.94	1.12	0.9	0.55	0.55	0.68	0.64	0.03	0.43	0.77	0.07	0.77	0.14	-0.63	-0.67
"Caseinkinase2,alpha1polypeptide"	1.03	0.76	0.9	0.93	1.07	0.94	0.51	0.51	0.61	0.57	0.32	0.48	0.21	-0.61	0.58	-0.33	-1.01	-0.94
Chloridechannel4	0	-0.24	-0.18	-0.44	-0.33	-0.4	-0.21	-0.25	-0.12	-0.2	0.01	-0.07	0.07	0.03	-0.48	-0.46	-0.25	-0.26
DUALSPECIFICITYMITOGEN-ACTIVATEDPROTEINKINASEKINASE1	0.02	-0.3	0.04	-0.05	-0.07	-0.21	-0.28	-0.28	-0.28	-0.31	-0.56	-0.41	-0.78	-0.8	-0.2	-0.35	-0.99	-0.86
Deoxyguanosinekinase	-0.92	-1.38	-1.09	-0.92	-0.99	-1.07	-1.28	-1.12	-1.05	-1.1	-1.29	-1.13	-1.13	-0.85	-0.93	-1.04	-0.97	-1.09
"Diacylglycerolkinase,gamma(90kD)"	0.36	0.1	0.68	0.58	0.56	0.44	0.28	0.38	0.56	0.52	0.04	0.15	0.95	-0.48	0.56	0.07	-0.86	-1.04
"proteintyrosinephosphatase(CIP2)mRNA,completecds"	-1.21	-1	-0.94	-0.9	-0.93	-0.98	-1.2	-1.12	-1.05	-1.06	-1.45	-0.95	-1.19	-0.27	-0.99	-0.98	-0.88	-0.89
"COP9homolog(HCOP9)mRNA,completecds"	-0.63	-0.81	-0.8	-0.93	-0.85	-1.02	-0.95	-0.87	-0.96	-1.05	-1.07	-0.78	-0.62	-0.32	-1	-0.96	-0.36	-0.33
"Gproteingamma-10subunitmRNA,completecds"	-0.78	-0.95	-0.71	-0.74	-0.61	-0.72	-0.83	-1.07	-0.85	-0.91	-1.25	-1.11	-0.91	-0.16	-0.82	-0.82	-1.18	-1.05
"GDP-dissociationinhibitorprotein(Ly-GDI)mRNA,completecds"	-1.13	-1.31	-1.11	-0.99	-1.1	-1.12	-1.23	-1.35	-1.37	-1.22	-1.54	-1.22	-1.18	-0.65	-1.2	-1.15	-0.87	-0.8
"HoumRNA,completecds"	0.97	0.81	0.56	0.51	0.61	0.65	0.75	0.82	0.94	0.92	0.96	1.25	1.24	1.05	0.48	0.57	1	0.85
P13-kinaseassociatedp85mRNAsequence	0.04	-0.11	-0.01	-0.14	-0.03	-0.05	-0.33	-0.28	-0.22	-0.24	-0.57	-0.32	-0.11	-0.5	-0.18	-0.7	-0.72	-1.01
"Signalsequencereceptor,alpha"	0.51	0.3	0.53	0.52	0.63	0.61	0.06	0.1	0.31	0.21	-0.33	-0.02	0.22	0.16	0.39	-0.06	-0.63	-0.74
TXKtyrosinekinase	0.7	0.58	0.67	0.68	0.71	0.65	0.28	0.32	0.38	0.32	0.07	0.19	-0.14	0.18	0.45	0	-0.7	-0.86
"Transcriptionfactor12(HTF4,helix-loop-helixtranscriptionfactors4)"	-0.84	-1	-0.74	-0.9	-0.8	-0.82	-0.97	-0.84	-0.65	-0.62	-0.93	-0.64	-1.14	-0.78	-0.5	-0.71	-0.82	-1.08
Ubiquitin-conjugatingenzymeE2A(RAD6homolog)	-0.58	-0.7	-0.43	-0.5	-0.48	-0.52	-0.68	-0.7	-0.68	-0.8	-0.88	-0.57	-0.89	-0.41	-0.61	-0.51	-0.88	-0.76
Urokinase-typeplasminogenactivator	-1.37	-1.71	-1.51	-1.53	-1.41	-1.84	-1.36	-1.42	-1.4	-1.55	-1.55	-1.26	-1.51	-1.06	-1.5	-1.33	-1.02	-1.04
V-erb-b2avianerythroblasticleukemiaviraloncogenehomolog2(neuro/glioblastomaderivedoncogenehomolog)	0.03	0.02	0.87	0.7	0.76	0.5	0.41	0.44	0.57	0.51	-0.09	0.1	0.84	0.03	0.72	0.32	-0.9	-0.88
Ndrproteinkinase	-0.28	-0.45	-0.2	-0.28	-0.31	-0.3	-0.47	-0.4	-0.4	-0.59	-0.66	-0.29	-0.55	0.19	-0.33	-0.25	-0.72	-0.32
Zyxin	0.2	0.01	0.31	0.24	0.3	0.18	0.14	0.15	0.16	0.01	-0.23	0.06	-0.08	0.73	0.15	0.14	0	-0.33
kinaseAanchorprotein	0.38	0.24	0.25	0.28	0.41	0.2	0.3	0.2	0.29	0.26	0.14	0.35	0.29	0.94	0.1	0.29	0.37	-0.07
"phosphorylase-kinase,betasubunit"	-1.02	-1.24	-1.18	-1.21	-1.23	-1.26	-1.4	-1.4	-1.02	-1.33	-1.43	-1.08	-1.21	-0.68	-1.42	-1.27	-0.86	-1
"proteinkinase,Dyrk4,partial"	1.39	1.43	1.74	1.59	1.74	1.74	1.11	1.28	1.53	1.68	0.95	1.16	1.63	0.89	1.87	1.19	0.03	-0.22
putativeserine/threonineproteinkinase	-0.88	-0.95	-0.73	-0.77	-0.93	-1.01	-1.19	-0.76	-0.83	-1.04	-1.04	-0.79	-0.84	-0.5	-0.98	-1.14	-0.91	-1.09
"Proteinkinase,cAMP-dependent,regulatory,typeII,beta"	0.13	-0.06	0.33	0.22	0.31	0.19	0.09	0.05	0.11	0.05	-0.05	0.04	0.08	0.38	0.42	0.06	-0.34	-0.62
"Proteinphosphatase2(formerly2A),catalyticsubunit,alphaisoform"	0.81	0.73	0.99	0.93	1.07	0.89	0.76	0.64	0.74	0.67	0.33	0.52	0.59	0.94	0.84	0.66	-0.06	-0.42
"Proteinphosphatase4(formerlyX),catalyticsubunit"	-1.2	-1.32	-1.24	-1.14	-1.24	-1.21	-1.43	-1.19	-1.44	-1.25	-1.3	-1.21	-1.31	-0.67	-1.38	-1.05	-0.91	-0.93
"Proteintyrosinephosphatase,non-receptortype12"	-1.1	-1.36	-1.19	-1.03	-1.19	-1.28	-1.34	-1.17	-1.38	-1.33	-1.29	-1.19	-1.18	-0.7	-1.3	-1.1	-0.9	-0.91
"Proteintyrosinephosphatase,receptortype,fpolypeptide"	-0.14	-0.31	-0.23	-0.16	-0.3	-0.17	-0.32	-0.22	-0.3	-0.43	-0.33	-0.2	-0.44	0.26	-0.17	-0.05	0.25	0.21
Protein-tyrosinekinaseRON	-1.23	-1.46	-1.13	-1.37	-1.26	-1.28	-1.36	-1.18	-1.23	-1.44	-1.33	-1.16	-0.99	-0.62	-1.37	-1.12	-0.83	-0.6
"Complementcomponent4-bindingprotein,alpha"	-0.91	-1	-0.95	-1.1	-1.02	-1.12	-1.13	-0.87	-0.87	-1.06	-1.23	-0.87	-0.89	-0.42	-0.99	-0.96	-0.86	-0.95
"Creatinekinase,mitochondrial2(sarcomeric)"	0.71	0.68	0.9	0.79	0.97	0.88	0.56	0.71	0.71	0.71	0.22	0.45	0.28	0.29	0.97	0.81	-0.03	-0.09
DUALSPECIFICITYMITOGEN-ACTIVATEDPROTEINKINASEKINASE3	0.01	-0.24	-0.26	-0.15	-0.12	-0.16	-0.22	-0.22	-0.2	-0.24	-0.24	0.05	-0.18	0.41	-0.19	-0.11	0.21	0.03
Diacylglycerolkinasedelta	-0.55	-0.72	-0.36	-0.71	-0.69	-0.77	-0.81	-0.5	-0.66	-0.62	-0.52	-0.12	-0.61	-0.24	-0.86	-0.6	0.13	-0.3
"E2Ftranscriptionfactor4,p107/p130-binding"	-0.42	-0.57	-0.3	-0.39	-0.47	-0.33	-0.69	-0.59	-0.42	-0.57	-0.92	-0.68	-0.47	-0.06	-0.17	-0.17	-0.51	-0.63
FK506-bindingprotein3(25kD)	1.23	1.11	1.32	1.24	1.29	1.27	1.18	1.06	1.12	1.06	0.69	0.86	0.96	1.52	1.35	1.34	0.62	0.59
"synaptobrevin-3mRNA,completecds"	0.7	0.56	0.52	0.6	0.77	0.56	0.58	0.55	0.51	0.53	0.4	0.55	0.25	0.07	0.54	0.13	-0.8	-0.63
"zincfingerproteinmRNA,completecds"	-0.23	-0.34	-0.08	-0.16	-0.08	-0.14	-0.34	-0.32	-0.27	-0.3	-0.54	-0.32	-0.36	0.06	-0.07	-0.32	-0.26	-0.99
Insulinreceptor	-1.24	-1.54	-1.41	-1.41	-1.41	-1.45	-1.42	-1.28	-1.43	-1.24	-1.31	-1.38	-1.46	-0.84	-1.48	-1.47	-0.83	-0.71
JNKACTIVATINGKINASE1	-0.41	-0.68	-0.58	-0.41	-0.63	-0.42	-0.5	-0.42	-0.67	-0.55	-0.5	-0.24	-0.65	0.02	-0.52	-0.45	0.21	-0.17
M-PHASEINDUCERPHOSPHATASE2	-1.24	-1.66	-1.41	-1.41	-1.56	-1.42	-1.65	-1.31	-1.47	-1.37	-1.47	-1.27	-1.49	-0.52	-1.58	-1.2	-0.58	-0.9
Myotubularmyopathy1	-0.88	-1.06	-1.08	-1.02	-1.02	-0.9	-1.37	-0.97	-1.09	-0.96	-1.17	-0.95	-1.17	-0.63	-1.07	-0.94	-0.6	-0.65
"Inositol1,4,5-triphosphatereceptor,type3"	-1.54	-1.58	-1.66	-1.66	-1.61	-1.68	-1.72	-1.42	-1.38	-1.43	-1.49	-1.04	-1.57	-1.14	-1.83	-1.48	-0.86	-1.07
"Majorhistocompatibilitycomplex,classI,C"	-0.48	-0.63	-0.64	-0.41	-0.58	-0.43	-0.52	-0.42	-0.53	-0.52	-0.61	-0.45	-0.51	-0.21	-0.47	-0.4	-0.15	-0.52
Muscledeterminationfactor	0.85	0.79	0.68	0.73	0.59	0.68	0.71	0.86	0.63	0.66	0.74	0.93	0.49	1.21	0.67	0.89	1.54	1.36
"Non-metastaticcells2,protein(NM23B)expressedin"	3.76	3.91	3.3	3.45	3.43	3.56	3.38	3.66	3.41	3.54	3.82	3.86	3.57	3.6	3.38	3.82	4.51	4.85
"Nucleophosmin(nucleolarphosphoproteinB23,numatrin)"	0.97	0.57	0.49	0.94	0.2	0.71	0.06	0.15	0.52	0.45	0.59	1.56	0.24	0.16	0.3	0.53	1.16	0.87
POSSIBLEGTP-BINDINGPROTEINHSR1	-0.23	-0.42	-0.27	-0.31	-0.45	-0.35	-0.32	-0.37	-0.46	-0.43	-0.56	-0.43	-0.57	0.08	-0.46	-0.42	-0.2	-0.45
Hexokinase1	-0.83	-0.99	-0.79	-0.87	-0.78	-1.17	-0.91	-0.85	-0.92	-0.86	-1.04	-0.94	-1.01	-0.53	-0.99	-0.96	-0.86	-0.85
"breastepithelialantigenBA46mRNA,completecds"	-0.16	-0.29	-0.15	-0.07	-0.02	-0.26	-0.32	-0.21	-0.26	-0.15	-0.34	-0.19	0.01	-0.2	-0.28	-0.42	-0.35	-0.81
"nuclearchlorideionchannelprotein(NCC27)mRNA,completecds"	-0.31	-0.59	-0.46	-0.56	-0.49	-0.51	-0.28	-0.28	-0.69	-0.62	-0.73	-0.57	-0.51	-0.24	-0.58	-0.5	-0.51	-0.43
PROTO-ONCOGENETYROSINE-PROTEINKINASELCK	0.68	0.43	0.17	0.13	0.16	-0.04	0.56	0.64	-0.07	-0.1	-0.27	-0.07	0.42	-0.35	-0.05	-0.48	-0.86	-0.83
"RAB6,memberRASoncogenefamily"	-0.56	-1.04	-0.81	-0.71	-0.89	-0.67	-0.74	-0.63	-0.81	-0.8	-0.74	-0.57	-0.69	0.05	-0.87	-0.77	-0.21	-0.33
Sp2transcriptionfactor	-0.58	-0.97	-0.71	-0.67	-0.82	-0.73	-0.89	-0.55	-0.79	-0.73	-0.72	-0.55	-0.96	-0.18	-0.82	-0.72	-0.18	-0.25
"lambda/iota-proteinkinaseC-interactingproteinmRNA,completecds"	-0.9	-1.12	-1.25	-1.03	-1.07	-1.23	-1.25	-1.05	-1.09	-1.02	-1.04	-0.83	-1.01	-0.65	-1.15	-0.74	-0.46	-0.41
"KIAA0075gene,partialcds"	1.62	1.51	1.44	1.64	1.56	1.48	1.43	1.61	1.59	1.47	1.39	1.67	2.01	1.39	1.62	1.66	1.35	1.27
"MNK1,completecds"	0.36	0.11	0.06	0.24	0.04	0.11	0.15	0.16	0.12	0.16	0.01	0.23	0.03	0.46	0.1	0.29	0.5	0.16
"uKATP-1,completecds"	0.08	-0.03	-0.12	0.05	-0.23	0.06	-0.17	0.19	0.57	0.87	-0.05	0.71	0.91	0.42	0.01	0.08	0.85	0.5
"proteinkinase(MLK-3)mRNA,completecds"	0.64	0.5	0.44	0.61	0.65	0.67	0.61	0.77	0.66	0.5	0.36	0.59	0.55	0.74	0.5	0.62	0.74	0.5
"proteintyrosinephosphatase1E(PTP1E)mRNA,completecds"	2.22	2.21	2.05	2.05	2.13	2.13	2.28	2.38	2.23	2.2	2.21	2.27	2.29	2.14	1.95	2.02	2.36	2.27
"ESTs, Highly  similar to PUTATIVE GTP-BINDING PROTEIN MOV10 [Mus musculus]"	1.01	0.88	1.04	1.08	1.14	1.18	0.36	0.62	0.87	1.02	0.44	0.45	1.43	0.89	1.47	1.25	0.07	-0.26
"ESTs,HighlysimilartoRIBOSOMALPROTEINS6KINASEIIALPHA2[Musmusculus]"	0.25	0.05	0.12	0.21	0.15	0.27	0.2	0.19	0.07	0.12	-0.05	-0.02	0.14	0.47	0.22	0.26	-0.11	-0.39
"ESTs,HighlysimilartoFB19protein[]"	0.53	0.23	0.46	0.4	0.43	0.25	0.07	0.23	0.22	0.43	0.2	0.24	0.89	0.32	0.24	0.23	0.21	-0.05
"ESTs,HighlysimilartocyclicAMPresponseelement-bindingprotein[]"	0.48	0.32	0.23	0.26	0.16	0.24	0.16	0.39	0.16	0.2	0.25	0.35	0.51	0.73	0.15	0.25	0.43	0.07
"ESTs, Highly similar to ras GTPase-activating protein [H.sapiens]"	-0.22	-0.49	-0.51	-0.36	-0.45	-0.31	-0.42	-0.2	-0.41	-0.49	-0.4	-0.07	-0.33	0.23	-0.25	-0.14	0.2	-0.1
"ESTs,ModeratelysimilartoPUTATIVESERINE/THREONINE-PROTEINKINASEP78[]"	0.96	0.8	0.83	0.82	0.68	0.9	0.79	1.02	0.75	0.71	0.87	1.08	0.77	1.45	0.77	0.93	1.42	1.5
"DNA-dependentproteinkinasecatalyticsubunit(DNA-PKcs)mRNA,completecds"	1.16	1.06	1.23	1.29	1.21	1.14	0.97	1.12	1.13	1.16	0.75	1.06	1.37	0.69	1.2	1.3	0.45	0.22
"Human G protein coupled inward rectifier potassium channel 2 (hiGIRK2) mRNA, complete cds"	1.09	0.91	0.86	0.99	1.02	0.89	0.72	0.86	1	0.89	0.73	1.06	1.12	0.75	0.81	0.96	0.94	0.9
"Human GTP cyclohydrolase I feedback regulatory protein gene, complete cds"	0.31	0.12	0.3	0.17	0.2	0.11	-0.05	0.23	0.19	0.1	-0.14	0.14	-0.01	0.31	0.17	0.24	0.33	0.05
"MAPkinasephosphatase(MKP-2)mRNA,completecds"	-0.45	-0.58	-0.74	-0.68	-0.76	-0.78	-0.85	-0.56	-0.7	-0.72	-0.81	-0.42	-0.72	-0.26	-0.84	-0.7	-0.19	-0.33
"Rho-associated,coiled-coilcontainingproteinkinasep160ROCKmRNA,completecds"	-0.1	-0.29	-0.18	-0.13	-0.21	-0.18	-0.35	-0.15	-0.17	-0.31	-0.5	-0.21	-0.47	-0.03	-0.27	-0.25	-0.02	-0.27
"Human SH3 domain-containing protein SH3P18 mRNA, complete cds"	0.99	0.88	1.15	1.08	1.09	1.13	0.86	1	1.03	0.98	0.5	0.79	0.88	0.74	1.07	1.09	0.35	0.23
"ESTs, Weakly similar to GTP-binding regulatory protein Gs alpha-XL chain [R.norvegicus]"	-0.09	-0.3	-0.27	-0.17	-0.15	-0.3	-0.41	-0.2	-0.26	-0.25	-0.41	-0.28	-0.41	0.14	-0.14	-0.04	-0.08	-0.48
"ESTs, Weakly similar to REGULATOR OF G-PROTEIN SIGNALLING 2 [Homo sapiens]"	-0.36	-0.71	-0.55	-0.35	-0.31	-0.45	-0.74	-0.55	-0.42	-0.43	-0.73	-0.53	-0.68	-0.51	-0.44	-0.47	-0.62	-0.57
"ESTs,Weaklysimilartocytokine-inducibleproteinCIS[M.musculus]"	-0.19	-0.66	-0.49	-0.48	-0.53	-0.6	-0.82	-0.47	-0.54	-0.55	-0.5	-0.36	-0.42	-0.1	-0.59	-0.29	-0.28	-0.51
"ESTs,Weaklysimilartoepidermalgrowthfactorreceptorkinasesubstrate[]"	0.73	0.47	0.49	0.38	0.32	0.57	0.21	0.45	0.49	0.48	0.54	0.63	0.77	0.89	0.48	0.59	0.57	0.43
"ESTs,WeaklysimilartoproteinkinaseC-bindingproteinBeta15[R.norvegicus]"	3.44	3.51	3.07	3.21	3.11	3.43	3.12	3.31	3.22	3.33	3.43	3.52	3.27	3.29	3.31	3.56	3.97	4.3
ESTs	1.22	0.72	0.75	0.55	0.23	0.39	0.65	0.67	0.52	0.42	0.45	0.87	0.87	0.67	0.16	0.18	1.02	0.79
"RGS5,completecds"	-0.27	-0.38	-0.31	-0.28	-0.23	-0.26	-0.54	-0.34	-0.27	-0.25	-0.54	-0.28	-0.33	0.08	-0.38	-0.14	0.34	-0.05
"fructose-1,6-bisphosphatase"	3.43	3.56	2.96	3.22	3.14	3.31	3.15	3.39	3.22	3.33	3.57	3.61	3.22	3.34	3.17	3.51	4.1	4.48
"microsomalglutathioneS-transferase2(MGST2)mRNA,completecds"	1.03	1.08	1.18	1.15	1.06	1.02	1.01	1	1.08	1.03	0.69	0.93	1.12	0.92	1.1	1.24	0.71	0.95
"orphanGprotein-coupledreceptor(GPR39)mRNA,completecds"	0.38	0.2	0.19	0.14	0.14	-0.33	0.11	0.26	0.32	0.18	0.32	0.39	0.43	0.65	0.09	0.23	0.7	0.54
"potassiumchannelKv2.1mRNA,completecds"	0.52	0.33	0.52	0.52	0.45	0.48	0.4	0.47	0.58	0.39	0.27	0.38	0.37	0.62	0.47	0.52	0.3	0.04
"proteinkinasemRNA,completecds"	-0.72	-0.87	-0.78	-0.74	-0.68	-1	-0.79	-0.63	-0.71	-0.81	-0.72	-0.55	-0.74	-0.77	-0.94	-0.68	-0.78	-1.05
"Proteintyrosinephosphatase,non-receptortype3"	-0.93	-1.15	-1.13	-1.13	-1.13	-1.23	-1.01	-0.9	-1.07	-1	-0.95	-0.97	-1.11	-0.43	-1.19	-0.79	-0.63	-0.56
"RAP1,GTPaseactivatingprotein1"	-1.29	-1.78	-1.47	-1.79	-1.8	-1.74	-1.53	-1.19	-1.37	-1.24	-1.21	-1.23	-1.67	-0.91	-1.83	-1.38	-0.88	-0.74
RegulatorofG-proteinsignalling1	-1.21	-1.62	-1.53	-1.48	-1.48	-1.4	-1.39	-1	-1.29	-1.22	-0.93	-1.07	-1.32	-0.78	-1.63	-1.09	-0.35	-0.64
ESTs	0.78	0.59	0.88	0.88	0.77	0.75	0.41	0.54	0.64	0.68	0.38	0.48	1.05	1.01	0.94	0.97	0.62	0.3
ESTs	1.71	1.48	1.58	1.6	1.48	1.72	1.47	1.6	1.5	1.52	1.5	1.59	1.54	1.92	1.65	1.78	2.02	2.05
"ESTs,HighlysimilartoCYCLIN-DEPENDENTKINASESREGULATORYSUBUNIT2[]"	3.81	4.04	3.72	3.76	3.75	3.98	3.61	3.81	3.81	3.95	3.89	3.9	4	3.66	3.68	3.88	4.24	4.61
"Clk-associatedRScyclophilinCARS-CypmRNA,completecds"	1.31	1.23	1.6	1.49	1.41	1.35	1.33	1.29	1.46	1.3	1.1	1.18	0.67	0.37	1.47	1.35	-0.72	-0.58
"Gprotein-coupledreceptor(STRL22)mRNA,completecds"	-0.06	-0.26	0.04	-0.03	0.07	-0.08	-0.07	-0.03	0.04	-0.24	-0.34	-0.19	-0.25	0.65	0	-0.1	-0.43	-0.64
"Cdc6-relatedprotein(HsCDC6)mRNA,completecds"	0.1	-0.14	0.41	0.25	0.14	0.15	-0.11	-0.13	0.21	0.07	-0.12	-0.09	0.11	0.24	0.15	0.19	-0.85	-0.73
"Grb2-associatedbinder-1mRNA,completecds"	-0.92	-1.04	-0.8	-0.87	-1.11	-0.86	-1.18	-1.21	-1.13	-1.16	-1.33	-1.13	-0.98	-0.33	-0.99	-1.07	-0.85	-0.9
"K-rasoncogeneproteinmRNA,completecds"	-0.97	-1.26	-0.78	-0.96	-1	-0.79	-1.36	-1.13	-1.16	-1.31	-1.47	-1.15	-1.21	-0.81	-0.96	-1.04	-1.35	-1
"MAPkinasemRNA,completecds"	-0.67	-1.02	-0.48	-0.63	-0.75	-0.6	-0.85	-0.8	-0.91	-0.88	-1.26	-0.88	-0.75	-0.63	-0.96	-0.71	-1.2	-0.87
Protein-tyrosinekinase7	0.91	0.86	1.35	1.15	1.1	1.03	0.77	0.82	0.85	0.83	0.66	0.79	0.69	1.42	1.24	1.27	0.53	0.11
Proto-oncogenec-cot(protein-serine/threoninekinase)	1.84	1.71	2.03	1.95	1.89	1.83	1.24	1.34	1.55	1.63	1.57	1.57	1.75	0.88	1.75	1.76	0.53	-0.11
RANbindingprotein1	0.49	0.37	0.41	0.31	0.34	0.38	0.31	0.23	0.4	0.39	0.49	0.58	0.57	0.71	0.26	0.41	0.23	0.04
"Rashomologgenefamily,memberG(rhoG)"	0.65	0.47	0.56	0.52	0.52	0.45	0.43	0.24	0.5	0.52	0.34	0.55	0.74	0.55	0.51	0.48	0.12	-0.49
SERINE/THREONINE-PROTEINKINASERECEPTORR3	1	0.84	1.06	1	1.04	1.07	0.68	0.67	0.78	0.81	0.51	0.49	1.06	0.34	0.96	0.9	-0.12	-0.49
"TRANSCRIPTIONINITIATIONFACTORIIF,BETASUBUNIT"	-0.26	-0.33	-0.18	-0.21	-0.28	-0.21	-0.43	-0.38	-0.49	-0.51	-0.5	-0.39	-0.41	-0.26	-0.42	-0.44	-0.44	-0.53
Cdc42-interactingprotein4(CIP4)	-0.57	-0.8	-0.53	-0.82	-0.82	-0.36	-0.6	-0.41	-0.65	-0.63	-0.72	-0.55	-0.62	0.08	-0.7	-0.71	-0.2	-0.63
L-3-phosphoserine-phosphatasehomologue	0.19	0.01	0.4	0.28	0.36	0.34	0.27	0.38	0.38	0.27	-0.04	0.12	0.22	0.9	0.27	0.24	-0.27	-0.4
"aurora/IPL1-relatedkinase,completecds"	0.95	0.77	1.15	1.04	1.09	0.88	0.82	0.89	0.9	0.92	0.4	0.53	0.94	1.14	0.94	0.87	-0.56	-0.56
"phosphatase2AB56-alpha(PP2A)mRNA,completecds"	0.04	-0.22	0.34	0.14	0.13	0.13	-0.23	-0.19	-0.04	-0.19	-0.56	-0.32	0.06	0	0.07	0.05	-1.09	-0.64
"pyruvatedehydrogenasekinaseisoenzyme2(PDK2)mRNA,completecds"	0.01	-0.27	0.25	0.12	0.15	0.01	-0.23	-0.17	-0.12	-0.25	-0.57	-0.44	-0.39	-0.04	0.16	0.2	0.05	-0.01
"(cloneN5-4)proteinp84mRNA,completecds"	0.3	-0.01	0.68	0.56	0.45	0.47	-0.08	0.06	0.33	0.21	-0.3	-0.15	0.03	-0.05	0.73	0.82	-0.06	0.15
PUTATIVESERINE/THREONINE-PROTEINKINASEP78	-0.49	-0.65	-0.4	-0.5	-0.58	-0.59	-0.81	-0.92	-0.63	-0.5	-0.73	-0.62	-0.21	-0.45	-0.34	-0.33	-0.55	-0.66
Phosphoenolpyruvatecarboxykinase1(soluble)	0.19	-0.04	0.68	0.55	0.5	0.24	-0.26	-0.11	0.19	0.17	-0.23	-0.12	0.14	0.18	0.78	0.82	-0.48	-0.37
"PhospholipaseC,gamma2(phosphatidylinositol-specific)"	-0.54	-0.87	-0.55	-0.65	-0.57	-0.46	-0.87	-0.9	-0.62	-0.7	-0.84	-0.67	-0.57	-0.56	-0.63	-0.57	-0.66	-0.65
"Plasminogenactivator,urokinasereceptor"	0.79	0.63	0.75	0.7	0.87	0.79	0.48	0.51	0.66	0.57	0.43	0.5	0.67	0.56	0.64	0.7	-0.06	-0.31
"ProteinkinaseC,alpha"	-1.3	-1.41	-1.3	-1.55	-1.46	-1.41	-1.73	-1.32	-1.28	-1.34	-1.51	-1.33	-1.1	-0.87	-1.63	-1.25	-1.07	-1.08
"ProteinkinaseC,gamma"	-0.76	-1.04	-0.87	-0.94	-0.9	-0.68	-0.98	-1.01	-0.97	-1.22	-1.07	-0.94	-0.84	-0.72	-1.18	-0.79	-0.79	-0.46
(cloneC-2k)serine/threonineproteinkinase	-0.07	-0.25	-0.08	-0.1	-0.13	-0.1	-0.27	-0.52	-0.22	-0.36	-0.79	-0.52	-0.34	0.29	-0.16	-0.44	-0.57	-0.62
GTP-bindingprotein	-0.53	-0.8	-0.47	-0.57	-0.56	-0.59	-0.67	-0.59	-0.61	-0.67	-1.08	-0.84	-0.64	0.14	-0.59	-0.71	-1.09	-0.82
MAPkinaseactivatedproteinkinase	0.55	0.36	0.58	0.5	0.58	0.39	0.17	0.33	0.33	0.36	-0.17	0.15	0.55	0.05	0.33	0.23	-0.99	-0.96
H.sapiens mRNA for RanGTPase activating protein 1	0.25	0.16	0.31	0.26	0.32	0.15	-0.02	0	0.12	-0.14	-0.42	-0.09	0.2	-0.23	-0.03	0	-1.25	-1.07
activintypeIIreceptor	0.9	0.63	1.16	1.05	1.05	1.02	0.48	0.6	0.63	0.57	0.2	0.29	0.7	0.47	1.07	1.02	0.76	0.59
phosphatidylinositol3-kinase	0.51	0.18	0.69	0.72	0.58	0.47	0.03	0.24	0.28	0.24	-0.19	-0.02	0.05	0.36	0.63	0.63	-0.21	-0.2
"scaffoldproteinPbp1mRNA,completecds"	1.01	0.9	1.26	1.2	1.22	1.08	0.7	0.61	0.87	0.81	0.33	0.56	0.61	0.62	1.17	1.23	0.43	0.34
"smallGTPbindingproteinRab9mRNA,completecds"	-1.18	-1.34	-1.17	-1.29	-1.01	-1.07	-1.42	-1.3	-1.3	-1.37	-1.39	-1.18	-1.28	-0.83	-1.2	-1.01	-0.99	-0.96
"tatinteractiveproteinmRNA,completecds"	-0.24	-0.5	-0.53	-0.4	-0.44	-0.33	-0.9	-0.63	-0.55	-0.67	-0.82	-0.56	-0.64	-0.74	-0.45	-0.32	-0.77	-0.4
"twoP-domainK+channelTWIK-1mRNA,completecds"	-0.09	-0.42	-0.21	-0.28	-0.24	-0.15	-0.47	-0.51	-0.38	-0.42	-0.51	-0.35	-0.04	-0.53	-0.3	-0.24	-0.68	-0.78
Inositolpolyphosphate-1-phosphatase	-0.07	-0.45	-0.2	-0.23	-0.07	-0.09	-0.48	-0.39	-0.26	-0.43	-0.55	-0.32	-0.27	0.01	-0.3	-0.16	-0.73	-0.63
Kinaseinsertdomainreceptor(atypeIIIreceptortyrosinekinase)	0.26	0.15	0.28	0.26	0.31	0.24	0	0.01	0.21	-0.03	-0.02	0.05	0.3	0.32	0.17	0.34	-0.01	-0.2
EXTRACELLULARSIGNAL-REGULATEDKINASE3	-1.63	-1.59	-1.52	-1.8	-1.91	-1.61	-1.88	-1.75	-1.72	-1.63	-1.86	-1.42	-1.64	-0.96	-1.82	-1.52	-0.9	-0.87
Epidermalgrowthfactorreceptor	-0.22	-0.34	-0.09	-0.2	-0.15	-0.31	-0.38	-0.31	-0.48	-0.4	-0.71	-0.42	-0.48	0.09	-0.38	-0.22	-0.86	-0.92
Eukaryotictranslationinitiationfactor4E	-0.1	-0.42	-0.06	-0.18	-0.19	-0.25	-0.45	-0.26	-0.31	-0.38	-0.91	-0.54	-0.27	-0.28	-0.25	-0.32	-1.02	-1.14
Formylpeptidereceptor-like1	-0.69	-0.7	-0.51	-0.67	-0.59	-0.84	-0.8	-0.62	-0.8	-0.86	-1.06	-0.88	-0.66	-0.49	-0.82	-0.84	-1.15	-0.69
"Fucosidase,alpha-L-1,tissue"	-0.1	-0.28	0.05	-0.15	-0.21	-0.22	-0.47	-0.48	-0.39	-0.37	-0.63	-0.42	-0.04	0	-0.12	-0.02	-0.47	-0.46
"GA-bindingproteintranscriptionfactor,betasubunit2(47kD)"	-0.44	-0.68	-0.36	-0.46	-0.4	-0.51	-0.72	-0.75	-0.69	-0.69	-1.03	-0.66	-0.81	-0.41	-0.42	-0.29	-0.67	-0.41
"KIAA0380gene,completecds"	2.03	1.97	1.97	2.03	2.09	2	1.6	1.65	1.77	1.73	1.19	1.3	1.34	1.04	2.05	2.18	1	0.89
"clathrin-likeprotein,completecds"	-0.02	-0.43	-0.18	-0.4	-0.27	-0.41	-0.64	-0.6	-0.5	-0.36	-0.66	-0.4	-0.25	-0.54	-0.61	-0.37	-0.9	-0.74
proteinphosphatase2A(beta-type)	-0.75	-0.81	-0.85	-1.06	-1.06	-1.07	-0.87	-0.92	-0.86	-0.96	-0.91	-0.79	-0.7	-0.5	-0.96	-0.75	-0.77	-0.27
"unc-18homologue,completecds"	-1.29	-1.57	-1.37	-1.35	-1.46	-1.3	-1.43	-1.65	-1.29	-1.45	-1.48	-1.27	-1.26	-0.86	-1.39	-1.17	-1.18	-0.83
"monocytechemoattractantprotein-4(MCP-4)mRNA,completecds"	-0.81	-1.05	-1	-1.03	-0.99	-1.05	-0.98	-1.05	-0.95	-1	-0.94	-0.82	-0.81	-0.4	-1.28	-0.94	-0.68	-0.5
"nuclearorphanreceptorLXR-alphamRNA,completecds"	0.37	0.28	0.42	0.28	0.34	0.27	0.06	0.09	0.18	0.14	0.23	0.29	0.31	0.41	0.14	0.36	-0.03	-0.37
"RasGAP-relatedprotein(IQGAP2)mRNA,completecds"	-1.88	-1.99	-1.95	-2.08	-1.96	-1.96	-2.2	-1.69	-1.8	-1.86	-1.92	-1.85	-1.84	-1.17	-2.03	-1.83	-1.31	-0.88
"Snkinteractingprotein2-28mRNA,completecds"	-0.46	-0.71	-0.31	-0.45	-0.44	-0.57	-0.75	-0.63	-0.51	-0.73	-0.99	-0.74	-0.56	0.05	-0.59	-0.47	-0.88	-0.75
"celladhesionkinasebeta(CAKbeta)mRNA,completecds"	-0.22	-0.3	-0.06	-0.22	-0.21	-0.14	-0.4	-0.21	-0.2	-0.34	-0.93	-0.45	-0.2	-0.08	-0.29	-0.23	-1.07	-0.66
"cyclin-dependentproteinkinasemRNA,completecds"	-1.37	-1.7	-1.23	-1.4	-1.47	-1.38	-1.71	-1.37	-1.47	-1.55	-1.45	-1.37	-1.25	-0.59	-1.61	-1.41	-1.23	-0.84
"focaladhesionkinase(FAK)mRNA,completecds"	-0.12	-0.44	0.25	0.15	0.2	-0.05	-0.52	-0.49	-0.19	-0.22	-0.9	-0.44	0.41	0.1	-0.17	-0.1	-1.18	-0.82
"hematopoieticprogenitorkinase(HPK1)mRNA,completecds"	-0.83	-1.13	-0.88	-0.83	-0.88	-0.99	-1.05	-0.97	-0.92	-1.03	-1.13	-0.98	-1.02	-0.77	-1.1	-0.73	-0.59	-1.08
YY1transcriptionfactor	1.5	1.28	1.51	1.37	1.45	1.54	1.05	1.14	1.2	1.36	0.82	1.06	0.86	-0.27	1.22	1.16	-0.34	-0.45
Activatedleucocytecelladhesionmolecule	1.63	1.4	1.66	1.58	1.7	1.59	1.22	1.25	1.36	1.38	0.89	1.07	0.64	0.58	1.31	1.46	-0.51	-0.19
ActiveBCR-relatedgene	-0.25	-0.28	-0.34	-0.53	-0.47	-0.59	-0.39	-0.37	-0.25	-0.32	-0.34	-0.17	-0.06	-0.13	-0.64	-0.4	-0.36	-0.39
"Adrenergic,beta,receptorkinase1"	0.23	0.1	0.32	0.17	0.33	0.17	0.04	-0.13	0.04	0.08	-0.18	0.02	0.19	0.22	0.17	0.29	-0.25	-0.47
AnnexinI(lipocortinI)	-0.95	-1	-0.99	-1.11	-1.13	-0.95	-1.16	-1.21	-1.01	-1.1	-1.06	-1.04	-0.99	-0.82	-1.3	-0.98	-0.86	-0.84
BASICTRANSCRIPTIONFACTOR62KDSUBUNIT	0.76	0.68	0.59	0.44	0.47	0.47	0.58	0.5	0.83	0.79	0.94	0.95	1.2	1.08	0.43	0.73	0.64	0.49
tyrosinephosphatase	-1.13	-1.41	-1.26	-1.44	-1.42	-1.48	-1.44	-1.1	-1.38	-1.42	-1.2	-1.35	-1.32	-0.6	-1.25	-1.38	-1.03	-0.8
sds22-likemRNA	-0.63	-0.76	-0.45	-0.47	-0.69	-0.62	-0.61	-0.55	-0.51	-0.58	-0.83	-0.61	-0.61	-0.03	-0.62	-0.51	-0.83	-0.87
Hepatomatransmembranekinase	-1.58	-1.51	-1.61	-1.82	-1.69	-1.73	-1.58	-1.35	-1.55	-1.57	-1.64	-1.58	-1.45	-0.74	-1.73	-1.35	-0.88	-1.21
"brainandreproductiveorgan-expressedprotein(BRE)gene,completecds"	-0.42	-0.54	-0.55	-0.69	-0.78	-0.65	-0.75	-0.51	-0.64	-0.64	-0.64	-0.48	-0.32	0.01	-0.75	-0.59	-0.32	-0.72
"clk2mRNA,completecds"	0.58	0.5	0.46	0.33	0.39	0.38	0.15	0.09	0.13	0.11	0	0.24	0.08	0.44	0.26	0.42	0.14	-0.08
"immunophilinhomologARA9mRNA,completecds"	0.45	0.34	0.13	0.41	0.44	0.41	0.05	0.1	0.22	0.24	-0.14	0.07	0.03	0.12	0.23	0.39	-0.69	-0.42
RAS GTPASE-ACTIVATING-LIKE PROTEIN IQGAP1	-0.17	-0.27	-0.46	-0.31	-0.23	-0.25	-0.62	-0.36	-0.36	-0.4	-0.82	-0.56	-0.61	-0.46	-0.36	-0.27	-0.93	-0.92
RYKreceptor-liketyrosinekinase	0.94	0.84	1.38	1.36	1.28	1.35	0.56	0.77	1.07	1.19	-0.41	-0.12	1.51	0.77	1.46	1.61	-0.64	-0.74
Receptorprotein-tyrosinekinaseEDDR1	-0.68	-0.99	-0.62	-0.57	-0.84	-0.72	-0.91	-0.85	-0.78	-0.87	-1.12	-0.73	-0.77	-0.24	-0.75	-0.48	-0.67	-0.5
RhoE	-1.2	-1.33	-1.28	-1.29	-1.31	-1.33	-1.25	-1.21	-1.34	-1.45	-1.35	-1.15	-1.21	-0.72	-1.42	-1.13	-0.97	-1.07
"SERINE/THREONINEPROTEINPHOSPHATASE2BCATALYTICSUBUNIT,BETAISOFORM"	0.16	0.02	0.25	0.25	0.29	0.25	0.05	0.02	0.09	0.06	0	0.03	0.17	0.34	0.18	0.22	-0.24	-0.54
SERINE/THREONINE-PROTEINKINASERECEPTORR1	0.4	0.19	0.76	0.73	0.69	0.6	0.3	0.36	0.48	0.54	0.08	0.21	0.87	0.12	0.66	0.63	-0.41	-0.3
"Fibroblastgrowthfactorreceptor2(bacteria-expressedkinase,keratinocytegrowthfactorreceptor,craniofacialdysostosis1,Crouzonsyndrome,Pfeiffersyndrome,Jackson-Weisssyndrome)"	0.16	0.01	0.18	0.09	0.18	0.1	-0.18	-0.09	-0.15	-0.13	-0.17	-0.01	-0.24	0.64	0.11	0.12	-0.29	-0.56
GTPase-activatingproteinrasp21(RASA)	0.61	0.34	0.58	0.51	0.49	0.51	0.46	0.53	0.39	0.32	0.38	0.52	0.28	1.19	0.46	0.6	0.82	0.64
GlutathioneS-transferaseM1	0.93	0.74	1.01	0.91	1.02	0.93	0.73	0.77	0.7	0.71	0.54	0.71	0.64	1.6	0.95	1	0.64	0.36
"Guaninenucleotidebindingprotein(Gprotein),alpha11(Gqclass)"	0.63	0.55	0.49	0.53	0.4	0.53	0.62	0.59	0.45	0.39	0.4	0.62	0.41	1.07	0.43	0.62	0.8	0.92
HEK2proteintyrosinekinasereceptor	3.6	3.59	3.34	3.35	3.24	3.44	3.35	3.46	3.22	3.25	3.27	3.54	3.28	3.84	3.38	3.87	4.41	4.76
CAAT-boxDNAbindingproteinsubunitB(NF-YB)	1.68	1.65	1.84	1.71	1.82	1.75	1.5	1.53	1.58	1.56	1.3	1.39	1.58	1.71	1.83	1.94	0.95	0.93
NeuroblastomaRASviral(v-ras)oncogenehomolog	1.14	1.07	1.31	1.22	1.29	1.2	0.91	0.97	1.07	1	0.67	0.9	0.89	1.3	1.32	1.41	0.45	0.11
PCTAIREproteinkinase3	1.27	1.11	1.31	1.28	1.28	1.17	0.9	0.9	1.04	0.97	0.68	0.92	1.23	0.6	1.08	1.28	-0.07	-0.3
PROBABLE G PROTEIN-COUPLED RECEPTOR HM74	-0.88	-0.96	-0.94	-0.96	-0.99	-1.02	-1.03	-0.97	-0.95	-0.95	-1.2	-0.89	-1.03	-0.49	-0.98	-0.71	-0.64	-0.49
"Phosphodiesterase4B,cAMP-specific(dunce(Drosophila)-homologphosphodiesteraseE4)"	-1.03	-1.18	-1.03	-1.3	-1.06	-1.33	-1.26	-1.08	-1.12	-1.21	-1.25	-0.99	-1.18	-0.5	-1.18	-0.87	-0.71	-0.27
"PhospholipaseA2,groupIIA(platelets,synovialfluid)"	-0.16	-0.42	-0.37	-0.4	-0.47	-0.51	-0.56	-0.53	-0.53	-0.5	-0.46	-0.35	-0.3	-0.1	-0.73	-0.38	-0.21	-0.22
ProteinkinaseCsubstrate80K-H	0.16	0.01	0.01	0.11	0.12	0.05	-0.07	0.06	-0.05	-0.02	0.08	0.25	-0.02	0.23	-0.05	0.26	0.59	0.39
V-raf-1murineleukemiaviraloncogenehomolog1	-1.27	-1.35	-1.35	-1.28	-1.5	-1.35	-1.54	-1.08	-1.24	-1.26	-1.22	-1.09	-1.46	-0.73	-1.34	-0.97	-0.88	-0.8
V-yes-1Yamaguchisarcomaviralrelatedoncogenehomolog	0.19	0.05	0.11	0.09	0.09	0.22	0.02	0.03	0.04	-0.01	0.11	0.1	-0.1	0.55	0.14	0.28	0.48	0.37
CD69antigen(earlyTcellactivationantigen)	0.43	0.09	0.35	0.33	0.37	0.37	0.19	0.34	0.22	0.24	0.19	0.4	0.16	0.98	0.27	0.43	0.69	0.64
CELLDIVISIONPROTEINKINASE8	-0.16	-0.47	-0.43	-0.38	-0.52	-0.36	-0.4	-0.12	-0.43	-0.47	-0.19	-0.2	-0.4	0.16	-0.54	-0.16	0.38	0.12
CNCG	0.9	0.98	1.22	1.09	1.04	1.07	0.68	0.92	1.04	0.97	0.46	0.65	0.91	1.04	1.66	1.73	1.14	1.15
"Catenin(cadherin-associatedprotein),beta1(88kD)"	0.17	0.07	0.19	0.22	0.09	0.14	0.01	0.09	0.15	-0.02	-0.17	-0.14	-0.04	0.36	0.13	0.32	0.06	-0.15
"proteintyrosinekinaset-Ror1(Ror1)mRNA,completecds"	1.44	1.38	1.44	1.29	1.22	1.21	1.16	1.26	1.21	1.11	1.01	1.28	0.97	-0.06	1.2	1.24	-0.45	-0.7
"Human putative G-protein (GP-1) mRNA, complete cds"	2.48	2.31	2.62	2.39	2.36	2	1.98	2.04	2.09	1.99	1.92	2.02	2.57	1.29	2.19	2.29	0.8	0.26
"putativeserine/threonineproteinkinasePRK(prk)mRNA,completecds"	0.09	-0.13	-0.07	-0.09	-0.18	-0.2	-0.16	-0.06	-0.09	-0.34	-0.38	-0.15	-0.08	0.04	-0.19	0.01	0.08	-0.07
"Human putative transmembrane GTPase mRNA, partial cds"	0.8	0.64	0.51	0.58	0.45	0.64	0.69	0.69	0.7	0.68	0.76	1.02	0.85	1.25	0.51	0.76	1.29	1.32
"retinoicacid-andinterferon-inducible58KproteinRI58mRNA,completecds"	0.95	0.91	0.61	0.71	0.58	0.92	0.88	1.08	1.02	0.98	1.18	1.39	1.2	1.4	0.67	0.9	1.52	1.43
"smallacidicproteinmRNA,completecds"	-0.42	-0.43	-0.43	-0.48	-0.54	-0.41	-0.35	-0.2	-0.42	-0.43	-0.38	-0.11	-0.41	0.13	-0.49	-0.29	0.33	0.05
"putativeATP/GTP-bindingprotein(HEAB)mRNA,completecds"	-0.15	-0.4	-0.2	0.18	0.11	-0.23	-0.26	0.04	-0.06	0.12	-0.31	-0.32	-0.24	-0.37	0.55	-0.06	-0.24	-0.55
"rasinhibitormRNA,3'end"	0.06	-0.23	-0.23	-0.09	-0.27	-0.16	-0.12	-0.08	-0.27	-0.28	-0.09	0.06	-0.25	0.43	-0.17	-0.09	0.54	0.38
"retinoidXreceptor-gammamRNA,completecds"	0.43	0.08	0.17	0.24	0.12	0.13	0.24	0.29	0.18	0.13	0.13	0.47	0.05	0.79	0.18	0.38	0.97	1.02
"serinekinaseSRPK2mRNA,completecds"	3.04	3.1	2.74	2.8	2.72	3.03	2.79	2.97	2.75	2.84	3.08	3.14	2.95	3.27	2.81	3.16	3.84	4.15
"serineproteinaseinhibitor(P19)mRNA,completecds"	0.73	0.52	0.6	0.85	0.5	0.52	0.56	0.59	0.81	0.51	0.43	0.92	0.6	0.77	0.88	1.06	1.01	0.61
"serine/threoninekinasemRNA,partialcds"	-0.59	-0.77	-1.04	-0.89	-0.95	-0.87	-0.88	-0.66	-0.82	-0.89	-0.83	-0.71	-0.89	-0.55	-1	-0.58	-0.5	-0.49
"ESTs, Moderately similar to FceRI gamma-chain interacting protein SH2-B [R.norvegicus]"	-0.58	-0.7	-0.76	-0.7	-0.83	-0.81	-0.9	-0.86	-0.77	-0.85	-0.99	-0.7	-0.84	-0.5	-0.88	-0.64	-0.43	-0.6
"ESTs,Moderatelysimilartohypotheticalserine-threonineproteinkinaseR31240_1[]"	0.13	-0.11	-0.12	-0.11	-0.18	-0.13	0.1	0.02	-0.08	-0.2	-0.02	0.03	0	0.32	-0.3	-0.02	0.21	0.33
"ESTs,WeaklysimilartoBruton'styrosinekinase-associatedprotein-135[]"	-0.28	-0.51	-0.29	-0.32	-0.38	-0.43	-0.44	-0.38	-0.41	-0.57	-0.51	-0.28	-0.3	-0.02	-0.51	-0.31	-0.11	-0.21
"ESTs,WeaklysimilartoCASEINKINASEIHOMOLOGHRR25[Saccharomycescerevisiae]"	-1.04	-1.17	-1.25	-1.26	-1.38	-1.27	-1.14	-1.05	-1.08	-1.14	-0.92	-0.81	-0.98	-0.53	-1.42	-0.99	-0.4	-0.42
"ESTs,Weaklysimilartosimilartoadenylatecyclase[C.elegans]"	-0.39	-0.58	-0.68	-0.52	-0.64	-0.46	-0.53	-0.43	-0.41	-0.33	-0.49	-0.38	-0.38	-0.15	-0.74	-0.27	-0.13	-0.45
Glucokinaseregulator	0.01	-0.06	-0.1	0	-0.12	0.05	0.03	0.09	0.01	0.05	-0.05	0.18	0.03	0.52	-0.04	0.06	0.64	0.49
"TAK1bindingprotein1(TAB1)mRNA,completecds"	0.09	-0.03	0.34	0.21	0.11	0.13	-0.04	0.23	0.12	0.1	-0.14	0.02	0.44	0.08	0.42	0.27	-0.1	-0.03
"adenylatekinase2(adk2)mRNA,completecds"	1.2	1.04	1.31	1.22	1.15	1.3	1.05	1.23	1.17	1.13	0.99	1.18	1.36	1.35	1.34	1.32	1.19	1.16
"caseinkinaseIgamma2mRNA,completecds"	0.25	0.02	0.1	0.09	-0.07	0.21	0.03	0.1	0.04	0.03	-0.07	0.35	0.06	0.61	-0.01	0.21	0.7	0.8
"cyclin-dependentkinaseinhibitorp27kip1mRNA,completecds"	1.59	1.62	1.5	1.49	1.41	1.6	1.41	1.59	1.39	1.42	1.5	1.58	1.44	1.92	1.45	1.71	2.18	2.4
"epidermalgrowthfactorreceptorkinasesubstrate(Eps8)mRNA,completecds"	3.47	3.62	3.15	2.98	3.18	3.55	3.41	3.57	3.38	3.47	3.66	3.71	3.5	3.44	3.31	3.64	4.11	4.48
"kinaseMyt1(Myt1)mRNA,completecds"	0.59	0.61	0.75	0.62	0.5	0.69	0.17	0.47	0.49	0.43	0	1.06	0.39	0.84	0.79	0.91	0.72	0.96
ESTs	0.11	-0.25	-0.61	-0.08	-0.5	-0.66	-0.37	-0.49	-0.43	-0.75	-0.89	-0.4	-0.74	-0.36	-0.52	-0.06	-0.02	-0.21
"ESTs,Highlysimilarto5'-AMP-ACTIVATEDPROTEINKINASE,GAMMA-1SUBUNIT[Rattusnorvegicus]"	-0.32	-0.71	-0.51	-0.58	-0.67	-0.62	-0.79	-0.69	-0.66	-0.71	-0.86	-0.63	-0.27	-0.33	-0.52	-0.26	-0.27	-0.43
"ESTs,HighlysimilartoCALCIUM/CALMODULIN-DEPENDENTPROTEINKINASETYPEIIDELTACHAIN[Rattusnorvegicus]"	0.25	0.16	0.43	0.35	0.37	0.22	0	0.11	0.22	0.09	-0.05	0.01	0.53	0.39	0.3	0.54	-0.16	-0.15
"ESTs,HighlysimilartoEXTRACELLULARSIGNAL-REGULATEDKINASE1[Dictyosteliumdiscoideum]"	-0.08	-0.2	-0.37	-0.21	-0.31	-0.34	-0.37	-0.16	-0.23	-0.3	-0.61	-0.18	0.13	0.29	-0.2	0.01	0.34	0.07
"ESTs, Highly  similar to GTP-BINDING PROTEIN SARA [Mus musculus]"	-0.92	-1.1	-1.38	-1.12	-1.42	-1.13	-1.07	-0.85	-1.02	-1.01	-0.9	-0.85	-0.74	-0.71	-1.41	-1.05	-0.53	-0.52
"ESTs,HighlysimilartoINORGANICPYROPHOSPHATASE[Bostaurus]"	2.35	2.43	2.08	2.02	2.01	2.23	2.47	2.56	2.45	2.43	2.71	2.78	2.66	2.53	2.15	2.36	2.87	3
"proteinphosphataseWip1mRNA,completecds"	1.1	0.91	1.26	1.06	1.11	1.03	0.83	1.09	1.02	0.96	0.67	0.87	1.11	0.74	1.06	1.02	0.64	0.44
"putativemitoticcheckpointproteinkinase(HsBUB1)mRNA,partialcds"	-0.27	-0.58	-0.48	-0.54	-0.65	-0.54	-0.78	-0.36	-0.4	-0.5	-0.59	-0.34	-0.35	-0.12	-0.55	-0.38	-0.19	-0.37
"regulatorofGproteinsignaling(RGS13)mRNA,completecds"	-0.02	-0.38	-0.23	-0.21	-0.23	-0.19	-0.42	-0.05	-0.15	-0.21	-0.17	-0.12	-0.29	0.18	-0.4	-0.09	0.1	0.22
"(ard-1)mRNA,completecds"	1.48	1.35	1.09	1.11	1.2	1.62	1.12	1.37	1.38	1.36	1.47	1.6	1.63	1.66	1.25	1.37	1.57	1.67
"68kDatypeIphosphatidylinositol-4-phosphate5-kinasealphamRNA,clonePIP5KIa1,completecds"	0.63	0.94	0.4	0.44	0.49	0.63	0.24	0.68	0.52	0.4	0.25	0.44	0.25	0.54	0.46	0.65	0.49	0.42
"proteinkinase(HSTPK13)mRNA,completecds"	0.1	-0.19	-0.24	-0.2	-0.28	-0.16	-0.47	-0.04	-0.23	-0.17	-0.12	0	-0.3	0.09	-0.14	0.25	0.47	0.35
"ESTs, Moderately similar to ras-GTPase-activating protein SH3-domain binding protein [M.musculus]"	3.42	3.63	3.11	3.2	3.06	3.25	3.06	3.25	3.01	3.08	2.89	3.34	3.05	3.42	3.17	3.62	4.21	4.47
"ESTs, Highly  similar to PUTATIVE GTP-BINDING PROTEIN MOV10 [Mus musculus]"	0.72	0.68	0.95	0.85	0.74	0.84	0.49	0.67	0.55	0.59	0.42	0.66	0.7	1.01	0.77	0.97	0.72	0.83
"ESTs,Highlysimilartometabotropicglutamatereceptortype3[]"	0.07	-0.11	0.09	0.03	0.04	0.02	-0.2	-0.24	0.04	0.21	0.05	0.05	0.32	0.2	0.1	0.31	0.16	-0.23
"ESTs, Moderately similar to GTP-binding protein rah [M.musculus]"	2.76	2.91	2.35	2.41	2.39	2.62	2.58	2.55	2.77	2.8	2.98	3.12	2.95	2.71	2.57	2.73	3.28	3.52
"ESTs,ModeratelysimilartoproteinkinaseC[]"	1.23	1.23	1.09	1.14	1.06	1.17	0.96	1.12	1.16	1.14	1.12	1.33	1.15	1.4	1.3	1.43	1.71	1.55
"ESTs,WeaklysimilartoCELLDIVISIONPROTEINKINASE5[Bostaurus]"	1.04	1.09	1.03	0.96	0.72	0.93	0.95	1.15	0.99	0.96	1.06	1.14	1.07	1.43	1.02	1.16	1.55	1.41
tyrosinephosphatase	-0.29	-0.43	-0.41	-0.39	-0.29	-0.42	-0.66	-0.28	-0.29	-0.57	-0.54	-0.29	-0.42	-0.32	-0.55	-0.29	-0.21	-0.23
"(cloneFBKIII16)proteintyrosinekinase(NETPTK)mRNA,completecds"	-0.92	-1.2	-1.05	-1.17	-1.13	-1.11	-1.31	-0.85	-0.83	-1.08	-1.02	-0.98	-0.92	-0.71	-1.27	-0.98	-0.83	-0.54
"STE20-likekinase3(mst-3)mRNA,completecds"	0.8	0.68	0.54	0.49	0.44	0.76	0.65	0.87	0.81	0.68	0.88	1.05	1.13	1.01	0.57	0.59	0.93	1.05
"chloridechannelprotein(ClC-2)mRNA,completecds"	0.01	-0.22	-0.25	-0.17	-0.08	0.03	-0.11	-0.07	-0.02	-0.17	-0.27	0.11	-0.1	0.28	-0.14	-0.12	0.22	0.31
"clk3mRNA,completecds"	-0.24	-0.5	-0.4	-0.38	-0.37	-0.42	-0.8	-0.39	-0.52	-0.61	-0.66	-0.61	-0.84	-0.75	-0.29	-0.23	-0.51	-0.35
"interleukin-1receptor-associatedkinase(IRAK)mRNA,completecds"	-0.12	-0.2	-0.14	-0.14	-0.27	-0.14	-0.3	-0.05	-0.19	-0.31	-0.54	-0.36	-0.34	0.08	-0.24	0.05	-0.12	-0.3
"PROTEINKINASEC,DELTATYPE"	-0.26	-0.07	-0.47	-0.61	-0.64	-0.21	-0.59	-0.41	-0.87	-0.12	-0.56	-0.06	-0.15	-0.1	-0.5	0.16	0.75	0.08
Phosphataseandtensinhomolog(mutatedinmultipleadvancedcancers1)	-0.15	-0.46	-0.49	-0.43	-0.47	-0.48	-0.56	-0.34	-0.47	-0.59	-0.47	-0.57	-0.47	-0.11	-0.36	-0.08	-0.07	-0.36
"Phosphorylasekinase,alpha2(liver),glycogenstoragediseaseIX"	0.86	0.74	1.26	1.15	1.13	1.23	0.55	0.62	0.95	0.94	0.23	0.31	1.56	0.98	1.67	1.66	0.2	0.41
Platelet-derivedgrowthfactorPDGF-A	-0.05	-0.08	0.05	0.17	0.07	0.17	-0.12	0.01	0.23	-0.01	-0.11	0.05	0.36	-0.05	0.15	0.17	0.32	0.14
"ProteinkinaseC,mu"	1.47	1.43	1.65	1.64	1.53	1.57	1.41	1.48	1.53	1.46	1.34	1.48	1.54	1.91	1.57	1.78	1.82	1.79
"Proteinphosphatase3(formerly2B),catalyticsubunit,alphaisoform(calcineurinAalpha){alternativeproducts}"	-0.37	-0.26	-0.37	-0.37	-0.34	-0.33	-0.51	-0.06	-0.43	-0.37	-0.38	-0.35	-0.42	-0.02	-0.42	-0.09	0.11	0.05
"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"	-0.09	-0.38	0.12	0.08	0.18	0.08	-0.2	-0.28	-0.1	-0.2	-0.37	-0.36	-0.08	0.4	-0.12	0.05	-0.55	-0.67
"ESTs,HighlysimilartoADENYLYLSULFATEKINASE[Saccharomycescerevisiae]"	-0.95	-0.96	-0.73	-1.2	-0.92	-0.71	-0.94	-1.19	-0.81	-0.97	-1.29	-1.13	-0.54	-0.78	-0.98	-0.77	-1.05	-1.1
"ESTs,HighlysimilartoCLATHRINCOATASSEMBLYPROTEINAP19[Musmusculus]"	1.91	1.97	2.19	2.01	2.15	2.2	1.98	1.8	2.04	2.06	1.68	1.86	1.68	1.33	2.02	1.91	0.57	0.57
"ESTs,HighlysimilartoHEXOKINASE,TYPEI[]"	-0.28	-0.83	-0.39	-0.38	-0.46	-0.35	-0.82	-0.67	-0.65	-0.33	-0.98	-0.41	-0.59	-0.32	-0.52	-0.2	-0.67	-0.4
"ESTs,HighlysimilartoINORGANICPYROPHOSPHATASE[Bostaurus]"	0.06	0.02	0.34	0.36	0.27	0.34	-0.07	-0.13	0.11	-0.16	-0.5	-0.18	0	0.26	0.07	0.1	-0.27	-0.48
"ESTs,HighlysimilartoPOSSIBLEGLOBALTRANSCRIPTIONACTIVATORSNF2L1[]"	0.78	0.74	1.1	1.06	1.09	1.03	0.65	0.42	0.71	0.6	0.17	0.28	0.38	0.53	1.01	0.85	-0.22	-0.32
"Guaninenucleotidebindingprotein(Gprotein),alpha15(Gqclass)"	0.2	0.23	0.52	0.35	0.49	0.34	0.02	-0.07	0.24	0.18	-0.44	-0.28	-0.37	-0.35	0.45	0.04	-0.44	-0.52
"Guaninenucleotidebindingprotein(Gprotein),alphatransducingactivitypolypeptide1"	0.89	0.95	0.84	1	1.1	1.01	0.92	0.91	1.03	1	0.85	0.92	0.95	0.76	0.97	0.88	0.74	0.59
IL13receptor	-0.31	-0.28	-0.45	-0.31	-0.32	-0.3	-0.49	-0.56	-0.29	-0.27	-0.43	-0.48	-0.43	-0.15	-0.28	-0.46	-0.21	-0.31
nucleoside-diphosphatekinase	-0.69	-0.56	-0.95	-0.9	-0.83	-0.75	-0.7	-0.85	-0.8	-0.78	-0.61	-0.64	-0.9	-0.44	-0.65	-0.66	-0.11	-0.3
proteintyrosinephosphatase	-0.49	-0.35	-0.61	-0.46	-0.56	-0.46	-0.58	-0.7	-0.49	-0.56	-0.32	-0.39	-0.57	-0.32	-0.38	-0.46	0.12	-0.52
protein-tyrosine-phosphataseD1	-1.4	-1.03	-1.49	-1.76	-1.84	-1.75	-1.48	-1.48	-1.42	-1.33	-1.06	-1.03	-1.4	-0.93	-1.43	-1.23	-0.65	-0.3
"ESTs,ModeratelysimilartoproteinkinaseC[]"	2.04	1.95	2.37	2.12	2.25	2.27	1.96	1.88	1.96	2.06	1.42	1.58	2.23	0.8	2.22	2.24	0.69	-0.43
"ESTs,WeaklysimilartoSimilartonitrophenylphosphatase[C.elegans]"	-0.82	-1.28	-0.5	-0.88	-0.9	-0.69	-1.32	-1.1	-1.14	-0.55	-1.08	-0.99	-0.53	-0.91	-0.96	-0.93	-0.88	-1
"ESTs,Weaklysimilartomyosinlightchainkinase[]"	0.89	0.79	1.22	1.1	1.24	1.05	0.75	0.66	1.01	0.91	0.59	0.87	1.18	-0.01	0.92	0.71	-0.01	-0.13
p40	-0.11	-0.17	0.37	0.3	0.33	0.04	-0.26	-0.32	-0.02	-0.08	-0.45	-0.25	0.25	-0.23	0.35	-0.04	-0.91	-0.52
"cGMPphosphodiesterasedeltasubunitmRNA,completecds"	0.83	0.84	1.05	1.06	1.13	0.88	0.83	0.76	0.99	0.91	0.63	0.73	1.13	1.02	1.04	0.95	0.58	0.69
"mitoticcheckpointkinaseMad3L(MAD3L)mRNA,completecds"	0.41	0.39	0.42	0.43	0.43	0.44	0.54	0.47	0.52	0.39	0.47	0.59	0.4	0.79	0.44	0.42	0.64	0.54
CAMP-dependentproteinkinaseregulatorysubunittypeI	-0.69	-0.7	-0.56	-0.79	-0.67	-0.65	-0.9	-0.89	-0.78	-0.66	-0.83	-0.76	-0.61	-0.75	-0.64	-0.85	-0.35	-0.39
"CGMP-DEPENDENTPROTEINKINASE,BETAISOZYME"	1.09	0.92	1.36	1.31	1.33	0.99	0.76	0.73	1.09	1.02	0.56	0.71	1.38	-0.12	1.1	0.57	-0.15	-0.41
"Caseinkinase1,epsilon"	1.65	1.8	1.01	1.3	1.19	1.32	1.8	1.94	2.02	1.96	2.12	2.28	2.17	1.7	1.48	1.63	2.28	2.32
"Caseinkinase2,alphaprimepolypeptide"	-0.49	-0.19	-0.49	-0.61	-0.59	-0.55	-0.39	-0.49	-0.3	-0.31	-0.26	-0.44	-0.51	-0.16	-0.3	-0.4	0.06	-0.26
"Cell division cycle 42 (GTP-binding protein, 25kD)"	-0.64	-0.76	-0.74	-1.03	-0.91	-0.9	-0.66	-0.91	-0.6	-0.63	-0.47	-0.74	-0.78	-0.44	-0.79	-0.83	-0.33	-0.35
"Clathrin,lightpolypeptide(Lcb)"	0.26	0.45	0.24	0.25	0.17	0	0.12	0.11	0.12	0.14	0.14	0.27	-0.48	-0.67	-0.25	-0.71	-0.31	-0.37
"""""""Caspase 3, apoptosis-related cysteine protease"""""""	-0.4	-0.67	-0.16	-0.45	-0.55	-0.4	-0.81	-0.82	-0.5	-0.6	-0.72	-0.73	-0.18	-0.42	-0.49	-0.45	-0.57	-0.74
v-jun avian sarcoma virus 17 oncogene homolog	-0.78	-1.02	-0.69	-0.73	-1.11	-0.66	-0.99	-1.17	-0.84	-1	-0.96	-0.96	-0.8	-0.41	-0.82	-0.76	-1.07	-0.64
B-cell CLL/lymphoma 2	0.56	0.42	0.94	0.78	0.88	0.75	0.16	0.07	0.48	0.32	-0.03	0.21	0.59	0.12	0.45	0.5	-0.16	-0.27
Early growth response 1	0.19	-0.07	0.46	0.29	0.31	-0.05	-0.2	-0.28	0.18	-0.04	-0.18	-0.06	0.46	-0.73	0.14	0.01	-0.83	-0.99
Monokine induced by gamma interferon	1.23	1.19	1.44	1.56	1.57	1.44	1.12	1.09	1.31	1.2	0.97	1.11	1.15	1.17	1.31	1.34	0.63	0.58
JAK binding protein	1.6	1.62	1.21	1.33	1.28	1.42	1.68	1.79	1.84	1.85	1.93	2.12	1.99	2.06	1.42	1.68	2.18	2.17
ESTs	0.39	0.42	0.4	0.47	0.47	0.39	0.45	0.5	0.5	0.39	0.43	0.67	0.52	0.35	0.3	0.41	0.7	0.45
ESTs	-0.95	-0.98	-0.77	-0.97	-0.87	-0.97	-1.09	-1.17	-0.99	-0.93	-0.74	-0.75	-0.8	-1.23	-1.02	-1	-0.74	-0.57
"ESTs,HighlysimilartoINORGANICPYROPHOSPHATASE[Bostaurus]"	0.41	0.29	0.33	0.38	0.45	0.27	0.5	0.44	0.53	0.46	0.52	0.6	0.64	0.75	0.41	0.39	0.66	0.67
"ESTs, Highly  similar to RB INTRON ENCODED PUTATIVE G-PROTEIN COUPLED RECEPTOR [Homo sapiens]"	0.48	0.44	0.4	0.5	0.62	0.55	0.55	0.4	0.68	0.54	0.36	0.44	0.57	0.84	0.53	0.31	0.55	0.53
"ESTs,ModeratelysimilartofingerproteinHZF5,Krueppel-related[]"	0.65	0.69	0.91	0.92	0.84	0.68	0.69	0.58	0.97	0.85	0.72	0.57	1.02	1.02	0.93	0.64	0.69	0.37
"ESTs,WeaklysimilartoGLYCINERECEPTORALPHA-1CHAIN[]"	2.95	3.12	2.17	2.43	2.44	2.61	3.04	3.13	3.14	3.12	3.3	3.42	3.15	3.03	2.73	2.98	3.45	3.67
ribosomal protein L7a; SURF3	-0.53	-0.71	-0.35	-0.41	-0.45	-0.51	-0.82	-0.86	-0.67	-0.67	-0.79	-0.86	-0.53	-0.31	-0.52	-0.44	-0.69	-0.82
small inducible cytokine A4 (homologous to mouse Mip-1b)	-0.35	-0.5	-0.16	-0.18	-0.22	-0.16	-0.66	-0.64	-0.39	-0.62	-0.66	-0.51	-0.35	-0.09	-0.46	-0.22	-0.65	-0.75
angiotensin receptor 1	0.66	0.54	0.86	0.6	0.78	0.73	0.49	0.49	0.82	0.66	0.44	0.7	0.93	0.77	0.69	0.87	0.47	0.45
"""transforming growth factor, beta receptor III (betaglycan, 300kD)"""	-0.47	-0.56	-0.22	-0.21	-0.26	-0.32	-0.55	-0.63	-0.23	-0.29	-0.65	-0.36	-0.53	-0.49	-0.08	-0.09	-0.52	-0.47
villin2; ezrin	1.17	1.15	1.03	1.05	1.08	1.09	1.28	1.33	1.38	1.19	1.29	1.47	1.4	1.68	1.06	1.21	1.58	1.54
Serine/threonine protein-kinase	-0.16	-0.15	-0.27	-0.34	-0.42	-0.31	-0.38	-0.36	-0.22	-0.2	-0.11	0.13	-0.04	0.09	-0.33	-0.28	0.08	0.16
"ESTs,WeaklysimilartoSERINE/THREONINE-PROTEINKINASENRK2[]"	0.47	0.32	0.75	0.69	0.61	0.36	0.3	0.13	0.54	0.46	0.31	0.47	0.49	-0.16	0.59	0.18	-0.3	-0.52
"ESTs,Weaklysimilartoepidermalgrowthfactorreceptorkinasesubstrate[]"	-1.01	-1.26	-1.03	-1.32	-1.24	-1.25	-1.21	-1.43	-1.16	-1.26	-0.91	-1.01	-1.25	-1.41	-1.13	-1.24	-0.48	-0.89
"ESTs,Weaklysimilartoprotein-tyrosinephosphatase[]"	-0.25	-0.3	-0.15	-0.22	-0.09	-0.42	-0.3	-0.37	-0.2	-0.42	-0.49	-0.28	-0.23	-0.35	-0.13	-0.41	-0.64	-0.56
"ESTs,WeaklysimilartotyrosinekinaseA6[]"	0.16	0.09	0.32	0.24	0.27	0.04	-0.03	0.04	0.32	0.18	0.17	0.07	0.3	0.49	0.24	-0.07	0	-0.19
"Homo sapiens mRNA for GTPase-activating protein, complete cds"	-0.8	-0.86	-0.83	-1.03	-0.87	-0.94	-0.88	-0.83	-0.82	-0.64	-0.54	-0.64	-0.67	-0.57	-0.84	-0.86	-0.32	-0.3
"regulatorofGproteinsignalingRGS12(RGS)mRNA,completecds"	1.04	1.06	0.74	0.84	0.72	0.86	1.13	1.15	1.17	1.17	1.28	1.31	1.22	1.48	1.08	1.13	1.46	1.37
chemokine (C-C motif) receptor 1	-0.78	-1.01	-0.72	-0.91	-0.83	-0.83	-0.98	-1.05	-1.01	-1.05	-0.93	-1.03	-0.97	-0.73	-0.97	-0.9	-0.64	-0.51
endothelin 1	-0.85	-0.9	-0.55	-0.64	-0.57	-0.49	-0.85	-0.95	-0.69	-0.8	-0.83	-0.82	-0.94	-0.44	-0.93	-0.57	-0.49	-0.68
"""nuclear receptor subfamily 3, group C, member 1"""	-0.44	-0.54	-0.34	-0.75	-0.29	-0.34	-0.7	-0.69	-0.6	-0.67	-0.69	-0.54	-0.41	-0.56	-0.57	-0.35	-0.66	-0.98
"""glutamate receptor, metabotropic 3"""	-1.32	-1.56	-1.47	-1.49	-1.51	-1.54	-1.55	-1.5	-1.35	-1.4	-1.29	-1.31	-1.34	-1.15	-1.7	-1.23	-0.9	-0.72
"""glutamate receptor, ionotropic, N-methyl D-aspartate 2C"""	-1.05	-1.1	-1.2	-1.36	-1.14	-1.28	-1.13	-1.08	-1.05	-1.01	-1.14	-1	-0.95	-0.45	-1.25	-0.9	-0.66	-0.53
"""CCAAT/enhancer binding protein (C/EBP), delta"""	-0.98	-1.04	-0.86	-0.99	-1.01	-1.01	-1.28	-1.28	-1.08	-1.08	-1.09	-1.16	-1.1	-0.65	-0.8	-0.8	-0.66	-0.77
human insulin-like growth factor binding protein 5	-1.18	-1.23	-1.11	-1.12	-1.15	-1.23	-1.29	-1.15	-1.2	-1.06	-1.1	-1.03	-1.23	-0.77	-1.06	-1.14	-1.05	-1.27
"""ESTs, highly similar to transcription factor 8 (represses interleukin 2 expression); AREB6; NIL-2-A, BZP"""	-0.82	-0.98	-0.72	-0.58	-0.68	-0.95	-0.91	-0.97	-0.8	-0.87	-0.69	-0.78	-1.05	-1.13	-0.78	-0.96	-0.8	-0.96
insulin-like growth factor binding protein 1	-1.18	-1.16	-1.22	-1.33	-1.36	-1.37	-1.16	-1.22	-1.2	-1.31	-1.1	-1.28	-1.26	-1.18	-1.33	-1.3	-0.92	-0.94
"""interleukin 1 receptor, type I"""	-0.31	-0.35	-0.26	-0.34	-0.23	-0.31	-0.2	-0.32	-0.3	-0.35	-0.34	-0.32	-0.58	-0.35	-0.25	-0.19	-0.25	-0.6
"""interleukin 1 receptor, type II"""	-0.99	-0.91	-1.28	-1.07	-1.2	-1.08	-0.9	-1.03	-0.86	-1.01	-0.68	-0.91	-1.03	-1.22	-0.82	-1.13	-0.56	-0.34
"""integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)"""	-0.46	-0.57	-0.55	-0.8	-0.61	-0.71	-0.41	-0.57	-0.55	-0.58	-0.24	-0.35	-0.28	-0.8	-0.51	-0.78	-0.21	-0.51
"""tumor necrosis factor (ligand) superfamily, member 12"""	-0.17	-0.27	0.31	0	0.1	0.03	-0.39	-0.36	-0.06	-0.19	-0.64	-0.54	0.03	-0.61	-0.13	0.16	-0.51	-0.7
ribosomal protein L7	-0.43	-0.55	-0.51	-0.67	-0.58	-0.71	-0.68	-0.76	-0.63	-0.55	-0.64	-0.63	-0.23	-0.23	-0.74	-0.47	-0.43	-0.4
RAD51 (S. cerevisiae) homolog C	-1.21	-1.2	-1.27	-1.24	-1.41	-1.37	-1.47	-1.36	-1.41	-1.34	-1.19	-1.18	-1.28	-1.2	-1.5	-1.29	-0.83	-0.92
"""mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1)"""	-1.44	-1.4	-1.55	-1.47	-1.39	-1.44	-1.36	-1.35	-1.45	-1.48	-1.34	-1.3	-1.36	-1.08	-1.46	-1.16	-0.73	-1.16
ESTs	-0.48	-0.6	-0.46	-0.44	-0.43	-0.55	-0.68	-0.62	-0.54	-0.72	-0.87	-0.86	-1.05	-0.92	-0.48	-0.4	-0.82	-0.96
ESTs	-0.79	-0.88	-0.74	-0.74	-0.87	-0.83	-0.91	-0.97	-0.8	-0.81	-1.19	-1	-1.32	-1.23	-0.53	-0.49	-0.88	-0.99
"""tumor necrosis factor receptor superfamily, member 5"""	-0.52	-0.7	-0.27	-0.38	-0.39	-0.52	-0.73	-0.85	-0.67	-0.65	-0.79	-0.69	-0.47	-0.8	-0.6	-0.61	-0.63	-0.83
"""CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344)"""	-0.58	-0.65	-0.55	-0.37	-0.48	-0.45	-0.61	-0.63	-0.59	-0.59	-0.62	-0.56	-0.73	-1.13	-0.63	-0.81	-0.82	-1.15
corticotropin releasing hormone receptor 1	-0.15	-0.16	-0.28	-0.23	-0.11	-0.23	-0.32	-0.38	-0.16	-0.27	-0.44	-0.33	-0.51	-0.48	-0.3	-0.6	-0.45	-0.67
"""cholinergic receptor, nicotinic, epsilon polypeptide"""	-0.38	-0.53	-0.44	-0.47	-0.41	-0.48	-0.47	-0.62	-0.53	-0.57	-0.62	-0.66	-0.66	-0.87	-0.65	-0.88	-0.71	-0.89
coagulation factor II (thrombin) receptor	0.67	0.47	1.37	1.19	0.88	1.02	0.59	0.38	0.93	1.02	0.36	0.29	0.97	-0.09	0.95	0.06	-0.09	-0.38
cyclin D2	-0.49	-0.72	-0.33	-0.28	-0.49	-0.57	-0.49	-0.62	-0.48	-0.45	-0.64	-0.66	-0.51	0.2	-0.26	-0.54	-0.45	-0.47
insulin-like growth factor-binding protein 4	1.65	1.75	1.72	1.71	1.73	1.75	1.47	1.49	1.45	1.44	1.4	1.56	1.4	1.72	1.53	1.84	2.09	2.17
RAR-related orphan receptor A	-0.22	-0.47	-0.5	-0.63	-0.6	-0.55	-0.56	-0.56	-0.57	-0.61	-0.78	-0.52	-0.47	-0.33	-0.69	-0.47	-0.27	-0.34
GDNF family receptor alpha 1	-0.52	-0.51	-0.49	-0.41	-0.47	-0.58	-0.44	-0.6	-0.71	-0.83	-0.68	-0.64	-0.61	-0.49	-0.82	-0.49	-0.47	-0.38
"""interleukin 10 receptor, beta"""	-0.86	-0.96	-1.01	-0.92	-0.97	-1.01	-0.99	-0.96	-0.96	-1.05	-0.92	-1.03	-0.99	-0.54	-0.92	-0.72	-0.51	-0.48
Bruton agammaglobulinemia tyrosine kinase	0.75	0.5	0.76	0.74	0.86	0.82	0.85	0.75	0.94	0.82	0.66	0.7	0.82	0.67	0.76	0.76	0.48	0.38
thyroid stimulating hormone receptor	-0.77	-0.91	-0.65	-0.72	-0.65	-0.74	-0.69	-0.59	-0.54	-0.68	-0.69	-0.59	-0.7	-0.58	-0.65	-0.52	-0.54	-0.82
Bcl-2-related protein A1	0.47	0.48	0.43	0.27	0.46	0.34	0.47	0.5	0.57	0.54	0.47	0.58	0.72	0.57	0.37	0.47	0.47	0.08
forkhead (Drosophila)-like 13; forkhead transcription factor HFH-4 (HFH-4) mRNA	0.95	0.86	0.79	0.77	0.8	0.9	1.27	1.09	1.19	1.25	1.23	1.39	1.3	1.1	0.88	0.84	1.18	1.02
neuronal apoptosis inhibitory protein	-0.75	-0.74	-1.06	-0.79	-0.96	-0.88	-0.58	-0.62	-0.67	-0.84	-0.57	-0.58	-0.86	-0.4	-0.89	-0.9	-0.43	-0.58
proline-serine-threonine phosphatase interacting protein 1	-0.86	-0.9	-0.96	-0.79	-0.89	-0.88	-0.75	-0.89	-0.89	-0.87	-0.76	-0.8	-0.75	-0.58	-0.93	-0.93	-0.58	-0.87
interleukin 4 receptor	1.2	1.15	0.83	0.94	0.9	0.98	1.36	1.38	1.38	1.33	1.27	1.48	1.44	1.2	0.99	0.84	1.31	1.29
"""major histocompatibility complex, class II, DM beta 1"""	0.24	-0.09	0.5	0.5	0.29	0.38	0.01	0	0.1	0.09	-0.01	0.12	0.4	-0.37	0.57	-0.54	-0.38	-0.43
"""prostaglandin E receptor 2 (subtype EP2), 53kD"""	1.86	2.03	1.94	1.99	1.88	1.95	1.88	1.95	1.72	1.72	1.81	2.02	1.7	2.27	1.79	2.18	2.82	2.89
fms-related tyrosine kinase 3	-0.33	-0.79	-0.85	-0.72	-0.76	-0.53	-0.76	-0.65	-0.9	-1.05	-0.65	-0.52	-0.69	0.05	-0.66	-0.55	0.03	-0.22
lymphoid blast crisis oncogene; breast cancer nuclear receptor-binding auxiliary protein (BRX) mRNA	0	-0.14	0.19	0.21	0.09	0.07	-0.15	-0.1	-0.03	-0.01	-0.32	-0.28	-0.09	-0.2	0.1	0.25	-0.28	-0.36
leukemia inhibitory factor receptor	-0.16	-0.66	-0.36	-0.27	-0.17	-0.2	-0.11	-0.21	-0.25	-0.21	-0.22	-0.19	-0.29	-0.08	-0.37	-0.07	-0.06	-0.2
corticotropin releasing hormone receptor 1	0.13	-0.11	0.1	0.21	0.28	0.21	0.05	0.08	0.08	0.05	-0.15	-0.26	-0.01	0.03	0.06	0.25	-0.31	-0.47
GRO3 oncogene	0.55	0.54	0.65	0.71	0.72	0.69	0.49	0.53	0.51	0.49	0.05	0.22	0.4	0.2	0.57	0.57	0	-0.1
"""nerve growth factor receptor (TNFR superfamily, member 16)"""	-1.1	-1.36	-1.12	-1.14	-1	-1.06	-1.12	-1.02	-1.24	-1	-1.05	-1	-0.96	-0.74	-1.03	-0.97	-0.73	-0.52
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase); COX-2	-1.27	-1.1	-1.47	-1.48	-1.5	-1.3	-1.31	-1.07	-1.22	-1.04	-0.94	-1.04	-1.11	-1.02	-1.33	-1.08	-0.34	-0.83
CD4	1.58	1.63	1.68	1.75	1.78	1.72	1.75	1.62	1.48	1.55	1.49	1.57	1.4	1.7	1.56	1.44	1.31	1.06
	1.11	1.07	1.26	1.21	1.45	1.23	1.23	1.08	1.13	1.05	1.07	1.25	1.13	0.65	1.16	0.7	0.4	0.16
ESTs	0.22	0.14	0.37	0.32	0.46	0.35	0.05	0.13	0.22	0.3	0.18	0.34	0.23	0.37	0.29	0.02	0.02	-0.25
"""phospholipase C, beta 2"""	-0.57	-0.63	-0.22	-0.32	-0.34	-0.56	-0.67	-0.6	-0.51	-0.55	-0.45	-0.58	-0.36	-0.37	-0.15	-0.57	-0.52	-0.72
Histone (H2A.Z)	1.94	2.02	1.99	2.01	1.95	1.97	1.93	1.97	1.82	1.75	1.85	2.01	1.63	2.12	1.83	2.1	2.52	2.6
Cytochrome c oxidase subunit VIIa (COX7A) muscle isoform	-0.32	-0.45	-0.26	-0.24	-0.11	-0.28	-0.39	-0.3	-0.31	-0.37	-0.49	-0.46	-0.31	-0.32	-0.34	-0.13	-0.17	-0.2
Centromere protein-A (CENP-A)	-0.73	-0.72	-0.95	-0.96	-0.89	-0.93	-0.74	-0.61	-0.75	-0.66	-0.61	-0.8	-0.64	-0.48	-0.86	-0.55	-0.45	-0.34
activator of apoptosis harakiri (HRK); neuronal death protein 5 (DP5); BID3	1.92	1.95	1.39	1.5	1.65	1.76	2.08	2.15	2.13	2.15	2.41	2.51	2.37	2.14	1.71	1.92	2.31	2.36
cytochrome P450 IIF1 (CYP2F1)	0.39	0.26	0.52	0.45	0.42	0.36	0.25	0.13	0.17	0.15	0.12	0.06	0.66	0.32	0.4	0.46	-0.29	-0.21
Tyrosine kinase receptor	-0.25	-0.16	-0.13	-0.13	-0.03	-0.17	-0.31	-0.33	-0.44	-0.43	-0.49	-0.5	-0.4	-0.2	-0.22	-0.17	-0.71	-0.87
"""prostaglandin E receptor 1 (subtype EP1), 42kD"""	0.92	0.85	1.03	1.11	1.05	1.07	0.6	0.61	0.82	0.84	0.09	0.19	0.94	-0.03	0.96	0.79	-0.53	-1.05
"""adrenergic, alpha-1A-, receptor"""	-1.1	-1.19	-1.32	-1.51	-1.37	-1.24	-1.36	-1.21	-1.32	-1.36	-0.83	-1.14	-1.07	-0.73	-0.96	-1.27	-0.8	-0.95
angiotensin receptor-like 2	0.28	0.16	0.4	0.24	0.52	0.58	0.28	0.34	0.21	0.22	-0.01	0.08	0.55	0.69	0.41	0.35	0.28	0.2
"""interleukin 5 receptor, alpha"""	1.02	1.13	1.18	1.13	1.26	1.06	0.91	0.8	0.88	0.85	0.91	1.1	1.03	0.48	0.96	0.57	0.14	-0.19
"""Janus kinase 3 (a protein tyrosine kinase, leukocyte)"""	0.49	0.23	0.83	0.83	0.76	0.65	0.5	0.42	0.47	0.56	0.47	0.46	0.22	0.42	0.79	0.38	0.27	0.13
"""anti-Mullerian hormone receptor, type II"""	-1.19	-1.21	-1.14	-1.25	-1.14	-1.3	-1.18	-1.17	-1.25	-1.07	-0.87	-1.05	-1.05	-0.48	-0.84	-1.06	-0.65	-0.62
60S Ribosomal Protein L23 (RPL23:  ribosomal protein L23)	0.31	0.25	0.2	0.32	0.35	0.35	0.23	0.48	0.2	0.14	0.05	0.46	0.08	0.47	0.37	0.5	0.63	0.54
transcriptional enhancer factor (TEF1); protein GT-IIC; transcription factor 13 (TCF13)	-0.5	-0.36	-0.19	-0.02	0.03	-0.04	-0.41	-0.15	-0.23	-0.26	-0.55	-0.53	-0.44	-0.02	-0.06	0.05	-0.31	-0.29
heat shock protein beta 3 (HSPB3); heat shock 17-kDa protein; HSPL27	-0.66	-0.57	-0.64	-0.73	-0.61	-0.62	-0.69	-0.6	-0.78	-0.7	-0.61	-0.65	-0.54	-0.22	-0.41	-0.35	-0.33	-0.78
cyclin-dependent kinase inhibitor 1C (CDKN1C); p57-KIP2	-0.45	-0.33	-0.86	-0.82	-0.58	-0.81	-0.46	-0.21	-0.44	-0.48	-0.23	0.07	0.12	-0.04	-0.74	-0.62	0.12	-0.05
Aldehyde Dehydrogenase-3 	-0.18	-0.14	-0.19	-0.11	-0.04	-0.07	-0.17	-0.21	-0.35	-0.18	-0.34	-0.41	-0.03	0.18	-0.13	-0.04	-0.52	-0.6
HAS2 (hyaluronan synthase)	-0.01	-0.23	0.4	0.05	0.23	0.12	-0.28	-0.25	-0.26	-0.29	-0.6	-0.47	0.36	-0.27	0.06	-0.12	-1.08	-0.95
prodynorphin	-0.81	-0.89	-0.94	-0.91	-0.74	-0.94	-0.9	-0.71	-0.85	-0.79	-0.56	-0.55	-0.89	-0.46	-0.74	-0.73	-0.81	-0.82
catalase	-1.51	-1.32	-1.47	-1.72	-1.61	-1.53	-1.21	-1.27	-1.48	-1.38	-1.14	-1.45	-1.43	-0.64	-1.33	-1.42	-0.99	-0.71
Down syndrome candidate region 1	-0.41	-0.53	-0.55	-0.5	-0.48	-0.49	-0.51	-0.36	-0.57	-0.7	-0.5	-0.47	-0.69	0.18	-0.24	-0.45	-0.13	-0.07
Down syndrome candidate region 1-like 1	-0.09	-0.04	0.07	0.06	0	-0.05	-0.07	-0.03	-0.18	-0.08	-0.16	-0.19	-0.27	0.54	0.14	0.1	0.3	0.02
"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"	-1.13	-1.02	-1.18	-1.15	-1.21	-1.14	-1.1	-0.9	-1.13	-0.92	-0.76	-1.16	-1.17	-0.49	-0.89	-1.05	-0.58	-0.55
TCR adaptor molecule cbl-b	0.35	0.34	0.64	0.65	0.56	0.49	0.34	0.33	0.31	0.34	0.15	0.13	-0.02	-0.18	0.66	0	-0.28	-0.44
WSL protein + TRAMP + Apo-3 + death domain receptor 3 (DDR3)	2.13	2.23	1.99	2.02	1.95	2.11	2.03	2.14	1.93	1.87	2.13	2.18	1.87	2.45	1.95	2.34	2.99	3.11
dual-specificity protein phosphatase 9; mitogen-activated protein kinase phosphatase 4 (MAP kinase phosphatase 4 (MKP4)	-0.22	-0.47	-0.67	-0.74	-0.6	-0.44	-0.68	-0.57	-0.54	-0.76	-0.64	-0.46	-0.6	-0.15	-0.51	-0.52	0.15	0.44
G1/S-specific cyclin D3 (CCND3)	1.78	1.84	1.93	1.87	1.81	1.85	1.88	1.84	1.7	1.66	1.66	1.76	1.48	2.27	1.89	2.13	2.41	2.5
heat shock factor protein 2 (HSF2); heat shock transcription factor 2 (HSTF2)	0.05	-0.15	-0.07	-0.22	-0.06	-0.09	-0.01	0.11	-0.06	-0.21	-0.11	-0.11	-0.12	0.36	0.1	0.13	0.18	0.05
ionizing radiation resistance-conferring protein + death-associated protein 3 (DAP3)	-1.14	-1.16	-1.48	-1.17	-1.36	-1.39	-1.4	-1.09	-1.21	-1.18	-0.93	-1.26	-1.13	-0.5	-1.31	-1.05	-0.68	-0.68
protein serine/threonine kinase STK1; cell division protein kinase 7 (CDK7); CDK-activating kinase (CAK); 39-kDa protein kinase	0.27	0.19	0.67	0.49	0.61	0.49	0.18	0.15	0.39	0.4	-0.08	0.07	0.65	-0.22	0.65	0.54	-0.58	-0.82
"""SKI-like; sno oncogene, SnoN2 mRNA"""	-1.25	-1.7	-1.29	-1.59	-1.49	-1.7	-1.58	-1.17	-1.51	-1.44	-1.09	-1.62	-1.11	-0.5	-1.3	-1.21	-0.84	-0.97
interferon regulatory factor 7C mRNA	-1.75	-1.62	-1.79	-1.85	-1.87	-1.8	-1.83	-1.33	-1.89	-1.58	-1.34	-1.73	-1.58	-0.71	-1.85	-1.49	-0.84	-1.13
"""T-cell receptor, alpha (V,D,J,C)"""	-0.84	-0.73	-0.7	-0.61	-0.74	-0.79	-0.69	-0.61	-1.01	-0.83	-0.58	-0.93	-0.84	-0.03	-0.56	-0.52	-0.13	-0.52
complement component (3d/Epstein Barr virus) receptor 2	-1.12	-1	-1.14	-1.09	-1.17	-1.18	-1.08	-0.99	-1.19	-0.92	-0.83	-1.14	-1.1	-0.6	-1.05	-1.17	-0.39	-0.75
activation-induced down-regulation of retinoid receptor RXR alpha	-1.27	-1.15	-1.33	-1.27	-1.35	-1.48	-1.33	-0.96	-1.35	-1.29	-0.81	-1.54	-1.23	-0.56	-1.21	-1.13	-0.37	-0.48
Tec protein tyrosine kinase	0.06	0	0.53	0.46	0.36	0.28	-0.03	0.11	0.38	0.39	-0.17	-0.44	0.74	0.06	0.48	-0.21	-0.14	-0.4
Inducible SH2-Containing Protein (CISH:  cytokine inducible SH2-containing protein)	2.8	2.62	2.75	2.78	2.78	2.84	2.73	2.85	2.65	2.67	2.78	2.83	2.54	3.02	2.79	3.1	3.62	3.86
CCAAT/enhancer binding protein alpha (C/EBP alpha)	1.2	1.2	1.2	1.1	1.15	1.17	1.14	1.25	0.95	1	1.06	1.34	1.02	1.74	1.12	1.34	2.11	2.23
"26S Proteasome Component TBP1(PSMC3: proteasome (prosome, macropain) 26S subunit, ATPase, 3)(similar to RAM206, but PSMA2)"	0.2	0.14	0.23	0.23	0.28	0.29	0.24	0.38	0.24	0.2	-0.06	-0.03	0.11	0.27	0.35	0.53	0.28	0.2
nervous-system specific octamer-binding transcription factor N-oct3; N-oct5A & N-oct5B; brain-specific homeobox/POU domain protein 2 (POU3F2); brn2; oct7	-1.3	-1.31	-1.58	-1.24	-1.43	-1.39	-1.48	-0.95	-1.48	-1.44	-1.13	-1.26	-1.35	-0.61	-1.48	-1.16	-0.67	-0.89
endonuclease III homolog 1; HNTH1; OCTS3	-0.06	-0.1	0.01	0.01	0.11	-0.02	0.05	0.11	-0.1	-0.15	-0.17	-0.18	-0.18	0.46	-0.09	0.08	-0.15	-0.23
ubiquitin (UBB:  ubiquitin B)	-0.78	-1.02	-0.98	-0.81	-0.72	-1.05	-0.92	-0.61	-0.91	-0.9	-0.77	-1.1	-1.1	0.04	-0.82	-0.86	-0.64	-0.53
Peroxisomal Protein PAS8	-0.89	-0.93	-0.77	-0.72	-0.68	-0.97	-0.97	-0.43	-0.77	-0.67	-0.64	-1.07	-0.88	-0.15	-0.72	-0.76	-0.42	-0.43
caspase-2 precursor (CASP2); ICH-1L protease + ICH-1S protease	-1.41	-1.68	-1.66	-1.52	-1.73	-1.83	-1.47	-1.05	-1.68	-1.51	-1.07	-1.44	-1.45	-0.51	-1.7	-1.33	-0.68	-0.83
"DAXX ( death-associated protein 6) DAP6, BING2   "	-0.06	-0.18	0.19	0.02	0.25	0.08	0	0.13	0.1	0.15	0.07	-0.26	0.51	0.42	0.21	0.15	-0.21	-0.28
methyl CpG-binding protein 2 (MECP2)	0.15	-0.22	0.5	0.31	0.56	0.36	0.19	0.33	0.2	0.25	0.16	0.01	0.3	0.85	0.42	0.37	0.19	-0.13
interferon-inducible RNA-dependent protein kinase (P68 kinase)	-0.46	-0.6	-0.26	-0.29	-0.21	-0.41	-0.3	-0.11	-0.43	-0.36	-0.19	-0.53	-0.45	0.35	-0.3	-0.15	-0.13	-0.35
cytochrome P450 IID6 (CYP2D6); P450-DB1; debrisoquine 4-hydroxylase	-1.08	-1.09	-1.17	-1.03	-1.14	-1.25	-0.97	-0.67	-0.95	-0.75	-0.57	-1.15	-0.76	0.1	-1.04	-0.9	-0.32	-0.42
"Human SH3-containing protein EEN mRNA, complete cds"	-0.8	-0.53	-0.73	-0.91	-0.79	-0.75	-1.05	-0.79	-0.74	-0.76	-0.41	-0.76	-0.62	-0.99	-0.39	-0.51	-0.27	-0.23
"proteinkinaseATRmRNA,completecds"	0.3	0.47	0.39	0.51	0.53	0.4	0.17	0.27	0.33	0.31	0.31	0.2	0.19	-1.15	0.58	0.48	0.18	-0.01
RETINOBLASTOMABINDINGPROTEIN3	-1.01	-0.75	-1.1	-1.1	-1.07	-1.22	-1.13	-0.97	-1.22	-1.01	-0.55	-1.03	-1.12	-2.26	-0.85	-0.91	-0.37	-0.31
"EST,ModeratelysimilartoSERINE/THREONINEPROTEINPHOSPHATASEPP1-ALPHA2CATALYTICSUBUNIT[Oryctolaguscuniculus]"	-0.86	-0.69	-0.97	-0.65	-0.87	-0.8	-0.91	-0.89	-1.04	-0.82	-0.47	-0.8	-1.01	-2.49	-0.71	-0.55	-0.32	-0.48
ESTs	-0.66	-0.61	-0.53	-0.42	-0.81	-0.72	-0.88	-0.77	-0.88	-0.8	-0.22	-0.57	-0.78	-2.81	-0.65	-0.59	-0.46	-0.22
ESTs	0.08	0.33	0.12	0.42	0.34	0.2	-0.18	-0.04	0	0.01	0.21	-0.11	-0.23	-2.9	0.26	0.01	-0.24	0.06
Cyclin-dependentkinase7(homologofXenopusMO15cdk-activatingkinase)	0.97	1.09	0.91	1.13	1.1	0.91	0.89	0.9	0.96	0.99	1.07	0.98	0.83	-1.39	1.12	0.9	0.79	0.84
"Down-regulatoroftranscription1,TBP-binding(negativecofactor2)"	-0.73	-0.27	-0.78	-0.52	-0.58	-0.72	-0.59	-0.58	-0.75	-0.51	0.15	-0.37	-0.67	-2.11	-0.62	-0.44	-0.1	0.09
"E2Ftranscriptionfactor5,p130-binding"	-1.21	-0.6	-1.59	-1.07	-1.25	-1.23	-0.75	-0.88	-1.33	-0.81	0	-0.61	-1.22	-3.25	-1.12	-0.64	-0.21	0
Fibrillarin	-0.5	-0.08	-0.56	-0.31	-0.39	-0.45	-0.2	-0.2	-0.53	-0.13	0.48	-0.01	-0.54	-2.94	-0.3	-0.02	0.41	0.6
GPROTEIN-COUPLEDRECEPTORKINASEGRK4	-0.33	-0.01	-0.58	-0.41	-0.33	-0.46	-0.35	-0.22	-0.37	-0.08	0.53	0.17	-0.15	-3.38	-0.34	-0.21	0.45	0.27
"GeneraltranscriptionfactorTFIIEbetasubunit,34kD"	-0.72	-0.02	-0.94	-0.85	-0.79	-0.68	-0.24	-0.12	-0.68	-0.06	0.65	-0.12	-0.48	-3.43	-0.62	-0.29	-0.04	0.53
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)	1.67	1.82	1.89	1.86	1.94	1.64	1.47	1.6	1.76	1.68	1.25	1.28	1.84	-0.84	2	0.94	0.64	0
"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"	0.81	0.86	1.08	1.13	1.02	0.68	0.5	0.63	0.7	0.78	0.62	0.77	0.9	-1.99	0.96	0.02	-0.07	-0.18
vascular cell adhesion molecule 1	-0.89	-0.75	-0.94	-0.74	-0.94	-1.1	-1	-1.04	-0.97	-0.85	-0.34	-0.71	-0.81	-2.59	-0.9	-0.69	-0.17	-0.18
"""""""Caspase 3, apoptosis-related cysteine protease"""""""	0.3	0.42	0.41	0.49	0.45	0.17	0.15	0.23	0.36	0.43	0.48	0.45	0.22	-2.66	0.63	-0.25	-0.17	-0.32
"""""""Small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je)"""""""	0.1	0.12	0.3	0.42	0.35	0.29	0.05	0.06	-0.03	0.21	0.31	0.13	0.04	-2.5	0.33	0.33	0.04	0.08
vascular cell adhesion molecule 1	-0.02	0.06	-0.01	0.16	0.1	0.02	-0.07	0.06	0.05	0.07	0.38	0.19	-0.05	-1.97	0.16	0.16	0.15	0
"ESTs,Weaklysimilartoprotein-tyrosine-phosphatase[]"	0.88	0.87	0.99	1.11	1.12	0.94	0.51	0.59	0.79	0.82	0.77	0.69	0.96	-1.57	0.91	0.61	0.38	0.2
AQUAPORIN-CHIP	-0.28	-0.29	-0.09	0.08	-0.12	-0.19	-0.37	-0.28	-0.32	-0.14	0.07	-0.32	-0.24	-1.64	-0.26	-0.02	-0.17	-0.09
"Acidphosphatase1,soluble"	-0.63	-0.61	-1	-0.62	-1.03	-0.86	-0.57	-0.41	-0.72	-0.59	0.17	-0.34	-0.78	-2.71	-0.62	-0.55	0.04	0.13
AdenosineA2breceptor	-0.93	-0.49	-1.08	-0.8	-0.95	-0.96	-0.54	-0.58	-0.87	-0.65	0.2	-0.44	-1.06	-2.93	-0.79	-0.53	-0.23	0.28
AnnexinV(endonexinII)	-1.26	-0.48	-1.35	-0.84	-1.02	-0.94	-0.79	-0.58	-1.12	-0.62	0.25	-0.41	-1.07	-3.73	-0.99	-0.39	-0.16	0.2
Basicfibroblastgrowthfactor(bFGF)receptor(shorterform)	-0.33	0.16	-0.01	0.11	0.05	-0.11	-0.01	0.2	-0.33	0.26	0.68	0.16	-0.27	-2.78	-0.14	0.02	0.28	0.66
"""""""Tumor necrosis factor receptor superfamily, member 6"""""""	-0.48	-0.26	-0.55	-0.79	-0.46	-0.42	-0.7	-0.56	-0.54	-0.51	-0.29	-0.55	-0.41	-0.71	-0.11	-0.23	-0.17	-0.28
Down syndrome candidate region 1	0.57	0.7	0.84	0.79	0.81	0.61	0.29	0.47	0.51	0.59	0.53	0.5	0.75	-0.11	0.68	0.26	0.09	-0.21
"""""""Intercellular adhesion molecule 1 (CD54), human rhinovirus receptor"""""""	0.39	0.38	0.71	0.45	0.64	0.26	0.28	0.24	0.43	0.45	0.4	0.28	0.58	-1.3	0.49	-0.06	-0.01	-0.07
"""""""Interleukin 6 (interferon, beta 2)"""""""	0.4	0.59	0.62	0.64	0.5	0.28	0.23	0.34	0.37	0.43	0.37	0.22	0.24	-2.18	0.24	-0.28	-0.12	-0.16
Signal transducer and activator of transcription 4	1.13	1.27	1.19	1.15	1.28	1.26	1.04	1.06	1.13	1.17	1.23	1.17	1.09	-1.26	1.25	1.27	1.04	0.91
"""""""cytochrome P450, subfamily XIX (aromatization of androgens)"""""""	1.91	1.97	1.33	1.49	1.43	1.44	2	2.08	1.97	2.08	2.2	2.37	2.18	1.52	1.69	1.94	2.35	2.29
"Myosin,lightpolypeptide2,regulatory,cardiac,slow"	-0.21	0.08	-0.08	0.08	0.03	-0.01	-0.17	-0.09	-0.13	-0.08	0.38	0.01	-0.17	-1.48	-0.07	-0.07	0.33	0.16
NUCLEOSIDEDIPHOSPHATEKINASEA	0.06	0.21	0.17	0.45	0.36	0.24	-0.15	0.01	-0.01	0.15	0.24	-0.15	-0.31	-1.1	0.32	0.32	-0.21	-0.04
Phosphoglyceratekinase1	2.56	2.72	2.02	2.2	2.14	2.15	2.64	2.76	2.6	2.74	2.94	2.99	2.81	-0.13	2.42	2.24	2.99	3.07
ESTs	1.65	1.78	1.53	1.59	1.53	1.47	2	1.9	1.74	1.81	2	1.88	1.77	-0.6	1.59	1.77	2.13	2.08
ESTs	-0.71	-0.15	-0.53	-0.59	-0.55	-0.58	-0.25	-0.22	-0.35	-0.19	0.43	-0.03	-0.7	-2.42	-0.56	-0.11	0.3	0.5
ESTs	0.83	1.02	0.64	0.85	0.67	0.71	1.13	1.19	0.94	1.22	1.46	1.21	0.88	-1.76	0.89	1.22	1.63	1.77
"""integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)"""	-0.98	-0.84	-1.11	-0.93	-1.13	-1.07	-1.05	-0.92	-1.14	-1.04	-0.59	-0.94	-1.06	-1.12	-0.72	-0.77	-0.22	-0.26
"""interferon (alpha, beta and omega) receptor 2"""	0.22	0.15	0.41	0.22	0.43	0.19	0.13	0.09	0.17	0.26	0.29	0.17	0.27	-0.53	0.42	0.33	0.33	-0.12
interferon-induced protein 56	-0.13	-0.11	-0.03	-0.06	-0.04	-0.2	-0.08	-0.09	-0.1	-0.09	0.18	-0.05	-0.14	-0.98	-0.09	-0.11	0.43	0.19
v-myb avian myeloblastosis viral oncogene homolog	-0.46	-0.4	-0.37	-0.4	-0.52	-0.69	-0.5	-0.75	-0.49	-0.35	-0.05	-0.42	-0.2	-1.72	-0.34	-0.59	-0.06	-0.17
"""v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived; N-myc"""	1.69	1.79	1.26	1.25	1.25	1.24	1.88	1.9	1.87	1.87	2.08	2.16	2.1	0.09	1.62	1.85	2.16	2.21
retinoblastoma-like 2 (p130)	2.65	3.01	2.24	2.25	2.19	2.34	2.41	2.55	2.4	2.54	2.76	2.83	2.56	2.33	2.45	2.86	3.55	3.68
"ESTs,HighlysimilartoPROTEIN-TYROSINEPHOSPHATASEYVH1[Saccharomycescerevisiae]"	1.06	1.29	1.13	1.12	1.1	0.89	0.69	0.89	0.98	0.93	1.38	1.06	0.82	-0.35	0.97	0.29	0.49	0.26
"ESTs,HighlysimilartoRIBOKINASE[Bacillussubtilis]"	-1.16	-0.81	-1.38	-1.16	-1.08	-1.1	-1.13	-0.82	-1.07	-0.81	-0.25	-0.59	-1.07	-1.54	-1.22	-0.89	-0.34	-0.23
"ESTs,HighlysimilartoCAMP-DEPENDENTPROTEINKINASETYPEII-ALPHAREGULATORYCHAIN[]"	1.11	1.25	0.89	0.93	0.98	0.99	1.26	1.21	1.22	1.36	1.55	1.48	1.37	-0.9	1.02	1.15	1.54	1.42
"ESTs,HighlysimilartoPROTEIN-TYROSINEPHOSPHATASEDELTA[]"	0.84	1.04	0.73	0.7	0.72	0.75	1	0.9	0.86	1.01	1.29	1.09	1.19	-0.88	0.75	0.88	1.06	1
"ESTs,Highlysimilartothymidinekinase2[]"	1.81	1.99	1.54	1.55	1.55	1.62	1.72	1.8	1.66	1.77	2.03	1.96	1.7	-0.7	1.62	2	2.51	2.46
"ESTs,WeaklysimilartoNdrproteinkinase[]"	0.51	0.63	0.09	0.07	0.1	0.3	0.62	0.66	0.43	0.82	1.16	0.84	0.91	-1.83	0.51	0.61	0.92	1.02
"""superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"""	-0.7	-0.66	-0.46	-0.45	-0.55	-0.57	-0.83	-0.77	-0.67	-0.64	-0.35	-0.71	-0.98	-0.41	-0.47	-0.59	-0.09	-0.86
X-ray repair complementing defective repair in Chinese hamster cells 4	0.34	0.34	0.53	0.5	0.46	0.26	0.04	0.1	0.25	0.35	0.27	0.01	-0.05	-0.71	0.48	-0.29	0.12	-0.15
"""mitogen induced nuclear orphan receptor (MINOR) mRNA; chondrosarcoma, extraskeletal myxoid, fused to EWS in"""	-1.15	-0.83	-0.98	-0.81	-1.03	-1.11	-1.06	-1.05	-1	-0.83	-0.5	-0.93	-1.2	-1.11	-0.99	-1.06	-0.43	-0.75
"""Burkitt lymphoma receptor 1, GTP-binding protein; CXCR5"""	-0.93	-0.61	-0.89	-0.83	-0.9	-0.89	-0.84	-0.94	-0.88	-0.68	-0.25	-0.77	-1.02	-0.92	-0.73	-0.73	-0.18	-0.17
macrophage receptor with collagenous structure	0.37	0.5	0.84	0.72	0.59	0.49	0.25	0.38	0.65	0.66	0.37	0.04	1.27	0.07	0.86	-0.04	0.26	-0.2
"""adrenergic, beta-2-, receptor, surface"""	-0.4	-0.11	-0.58	-0.51	-0.73	-0.47	-0.73	-0.46	-0.58	-0.34	-0.12	-0.05	-0.18	-0.75	-0.77	-0.42	0.77	0.36
endothelin 3	-0.81	-0.6	-0.87	-1.08	-0.8	-0.96	-0.82	-0.77	-0.77	-0.79	-0.05	-0.64	-0.83	-1.58	-0.82	-0.84	-0.37	-0.37
"""glutamate receptor, ionotropic, AMPA 1"""	-1.09	-0.66	-0.97	-0.8	-0.85	-0.84	-0.82	-0.63	-0.74	-0.65	-0.17	-0.58	-0.82	-1.58	-0.86	-0.69	-0.38	-0.34
catalase	-0.02	0.26	-0.05	0.1	0.02	0.1	-0.11	0.05	-0.07	0.14	0.35	-0.03	0.41	-1.96	0	-0.32	-0.04	0.08
GDNF family receptor alpha 2	0.38	0.69	0.69	0.67	0.64	0.68	0.42	0.54	0.56	0.65	0.6	0.39	0.74	-1.33	0.68	0.34	0.16	0.19
Down syndrome candidate region 1-like 1	-0.64	-0.38	-0.66	-0.56	-0.51	-0.18	-0.4	-0.15	-0.53	-0.17	0.29	-0.07	-0.48	-1.94	-0.38	-0.11	0.45	0.7
CASP2 and RIPK1 domain containing adaptor with death domain	-0.14	0.06	-0.12	-0.01	0.1	0	-0.06	0.64	-0.1	0.15	0.64	0.13	-0.14	-1.92	0.06	0.26	0.43	0.63
interferon regulatory factor 6	-1.61	-1.46	-1.8	-1.82	-1.71	-2.01	-1.71	-1.51	-1.61	-1.57	-0.96	-1.47	-1.68	-1.24	-1.45	-1.42	-0.69	-0.79
ephrin-A5	-0.86	-0.75	-0.72	-0.67	-0.93	-1.02	-0.92	-0.91	-0.82	-0.66	-0.46	-0.85	-0.5	-0.9	-0.58	-0.95	-0.12	-0.36
interleukin 9 receptor	-1.6	-1.38	-1.57	-1.45	-1.47	-1.57	-1.52	-1.32	-1.26	-1.16	-0.72	-1.28	-0.73	-1.19	-1.16	-1.35	-0.3	-0.91
muscarinic acetylcholine receptor M1 (human)	-1.6	-1.45	-1.76	-1.57	-1.65	-1.76	-1.59	-1.36	-1.61	-1.18	-0.7	-1.51	-1.62	-1.16	-1.4	-1.28	-0.37	-0.72
complement component 3a receptor 1	-0.4	-0.14	-0.47	-0.51	-0.44	-0.34	-0.41	-0.31	-0.56	-0.42	-0.23	-0.53	-0.66	-1.09	-0.15	-0.96	-0.31	-0.65
"""collagen, type XI, alpha 2"""	-1.33	-0.95	-1.35	-1.32	-1.5	-1.44	-1.23	-1.09	-1.29	-1.15	-0.59	-1	-1.48	-1.55	-1.12	-1.13	-0.48	-0.64
"""pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)"""	-0.91	-0.58	-1.01	-0.69	-0.54	-0.59	-0.73	-0.47	-0.68	-0.69	-0.04	-0.68	-0.99	-1.46	-0.75	-0.67	-0.31	-0.6
"""proteasome (prosome, macropain) subunit, alpha type, 2"""	-0.71	-0.34	-0.52	-0.53	-0.42	-0.35	-0.58	-0.25	-0.5	-0.33	0.04	-0.47	-0.86	-1.27	-0.64	-0.19	-0.16	-0.26
"""RAB6, member RAS oncogene family"""	0.19	0.54	0.48	0.5	0.56	0.52	0.41	0.4	0.43	0.48	0.74	0.45	0.09	-0.62	0.43	0.33	0.42	0.28
SHC (Src homology 2 domain-containing) transforming protein 1	-0.19	0.16	0.12	0.15	0.13	0.24	0.04	0.22	0.03	0.09	0.5	0.01	-0.24	-0.86	0.15	0.32	0.47	0.23
breakpoint cluster region	-0.88	-0.45	-1.01	-0.84	-0.65	-0.61	-0.71	-0.38	-0.74	-0.42	0.1	-0.57	-1.1	-1.71	-0.67	-0.28	0.07	0.24
nuclear factor I/C (CCAAT-binding transcription factor)	-0.99	-0.62	-1.17	-0.88	-0.71	-0.57	-0.73	-0.23	-0.77	-0.47	0.19	-0.69	-1	-2.26	-0.7	-0.44	-0.01	0.22
"""cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle)"""	-0.7	-1.02	-0.59	-0.64	-0.57	-0.73	-0.52	-0.53	-0.45	-0.64	-0.16	-0.64	-0.49	-0.06	-0.42	-0.48	0.06	-0.41
apoptosis-associated tyrosine kinase	0.72	0.6	0.95	0.53	0.82	0.75	0.98	0.88	0.9	0.73	0.83	0.78	0.94	1.2	0.77	0.71	0.94	0.53
"""glutamate receptor, ionotropic, N-methyl D-aspartate 2B"""	-1.24	-1.15	-1.28	-1.21	-0.93	-1.17	-0.86	-0.99	-1.08	-0.9	-0.49	-1.06	-1.01	-0.53	-0.97	-0.86	-0.32	-0.49
estrogen receptor 2 (ER beta)	-0.15	0.01	-0.08	-0.1	-0.02	-0.21	-0.22	-0.08	-0.12	0.05	0.33	-0.17	-0.18	0.23	-0.1	-0.04	0.35	-0.06
src kinase-associated phosphoprotein of 55 kDa	0.26	0.33	0.21	0.15	0.3	0.3	0.55	0.53	0.46	0.46	0.72	0.53	0.48	0.49	0.39	0.31	0.72	0.39
"""tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain"""	0.65	0.84	0.71	0.63	0.74	0.71	0.76	0.83	0.77	0.79	0.91	0.7	0.71	0.53	0.78	0.59	0.7	0.48
ESTs	-0.62	-0.25	-0.57	-0.51	-0.37	-0.62	-0.45	-0.26	-0.42	-0.31	0.09	-0.4	-0.39	-0.57	-0.44	-0.32	-0.04	-0.3
endothelin receptor type A	-1.23	-0.78	-1.28	-1.15	-1.08	-0.94	-0.89	-0.72	-1.02	-0.8	-0.22	-0.94	-1.43	-1.14	-1	-0.57	-0.37	-0.16
"""MHC class II DQ-alpha associated with DRw6, DQw1 protein, complete cds, clone b"""	0.32	0.55	0.46	0.43	0.53	0.42	0.24	0.32	0.19	0.33	0.53	0.24	0.26	-0.22	0.3	0.37	0.36	0.14
v-ski avian sarcoma viral oncogene homolog	-0.08	0.21	0.04	0.04	0.21	0.13	-0.03	0.17	-0.11	0	0.47	0.16	-0.03	-0.29	-0.01	0.25	0.23	0.01
fibroblast growth factor 2 (basic)	-0.96	-0.46	-0.98	-0.73	-0.59	-0.48	-0.44	-0.27	-1.02	-0.54	0.08	-0.58	-1.02	-1.01	-0.54	-0.36	0.03	0.19
integrin cytoplasmic domain-associated protein 1	-0.36	0.01	-0.13	-0.1	0.06	0.14	-0.21	0.29	-0.15	0.01	0.48	-0.19	-0.14	-1.52	0.08	-0.02	0.31	0.36
dopamine receptor D2	1.48	1.29	1.63	1.57	1.51	1.43	1.66	1.63	1.66	1.48	1.57	1.55	1.54	1.98	1.6	1.71	2.04	2.02
platelet-activating factor receptor	0.04	-0.3	0.24	0.24	0.38	0.3	-0.08	0.01	0.23	0.23	0.13	-0.21	0.28	-0.18	0.51	-0.27	-0.02	-0.22
"""T-cell receptor, delta (V,D,J,C)"""	-0.96	-0.97	-1.17	-0.94	-1.08	-1.22	-0.87	-0.84	-0.97	-0.78	-0.45	-0.97	-0.9	-0.61	-0.95	-0.95	-0.11	-0.61
"""tumor necrosis factor receptor superfamily, member 8 """	-1	-0.88	-1.11	-1.07	-1.1	-1.24	-0.95	-0.89	-1.1	-0.64	-0.44	-0.92	-1.02	-0.68	-0.97	-0.85	-0.07	-0.26
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog	-1.47	-1.23	-1.56	-1.7	-1.48	-1.62	-1.41	-1.17	-1.43	-0.99	-0.72	-1.36	-1.29	-1.34	-1.45	-1.32	-0.56	-0.77
cocaine- and amphetamine-regulated transcript	0.12	0.22	0.19	0.17	0.21	0.23	-0.02	0.12	0.14	0.11	0.19	-0.08	-0.07	0.06	0.25	0.13	0.1	-0.31
regulator of G-protein signalling 4	-0.51	-0.26	-0.95	-0.87	-0.65	-0.59	-0.47	-0.41	-0.72	-0.31	0.02	-0.58	-0.44	-0.54	-0.6	-0.43	0.17	-0.12
"""interferon (alpha, beta and omega) receptor 1"""	-0.35	-0.2	-0.25	-0.38	-0.26	-0.3	-0.37	-0.14	-0.27	-0.11	0.1	-0.32	-0.31	-0.71	-0.21	-0.36	0.22	0.01
interferon regulatory factor 5	2.09	2.38	2.08	2.23	2.27	2.27	1.99	1.93	2.07	2.02	2.17	2.21	2.28	0.41	2.02	1.09	1.05	0.46
interleukin 7 receptor	0.99	1.18	1.06	1.08	1.26	1.15	1.07	1.05	0.97	1	1.19	1.15	1.07	0.22	0.91	0.74	0.73	0.35
"""major histocompatibility complex, class II, DR beta 1"""	-1.17	-0.55	-1.17	-0.95	-0.6	-0.61	-0.59	-0.2	-1.04	-0.38	0.06	-0.72	-1.19	-1.51	-0.71	-0.68	0.09	-0.06
"""major histocompatibility complex, class II, DQ beta 1"""	0.76	0.9	0.82	0.89	0.78	0.91	0.87	1.06	0.65	0.87	1.15	0.81	0.56	-0.18	0.96	1	1.45	1.27
cadherin1 (CDH1); epithelial cadherin precursor (E-cadherin; CDHE); uvomorulin (UVO); CAM 120/80	-0.17	-0.54	-0.3	-0.12	-0.26	-0.3	-0.24	-0.22	-0.33	-0.25	-0.06	-0.15	-0.18	0.02	-0.22	-0.22	0.18	-0.29
"Phosphoprotein Phosphatase (PPP1R1B:  protein phosphatase 1, regulatory (inhibitor) subunit 1B (dopamine and cAMP regulated phosphoprotein, DARPP-32)"	-0.45	-0.45	-0.56	-0.53	-0.62	-0.68	-0.77	-0.43	-0.42	-0.25	-0.22	-0.49	-0.3	-0.2	-0.44	-0.44	0	-0.36
D-amino acid oxidase (DAMOX; DAO; DAAO)	-0.15	-0.09	-0.45	-0.57	-0.49	-0.56	-0.17	-0.07	-0.18	-0.01	0.19	-0.04	0.18	0.19	-0.39	-0.15	0.62	0.17
PEA3 (Pea3:  polyomavirus enhancer activator 3)	0.85	0.72	0.4	0.48	0.56	0.51	0.98	1	0.95	1.07	1.14	1.13	1.15	1.04	0.72	0.74	1.38	1.09
mitochondrial brown fat uncoupling protein 1 (UCP1)	0.24	0.33	0.43	0.4	0.39	0.38	0.02	0.19	0.19	0.27	0.11	-0.09	0.37	-0.14	0.39	0.12	0.14	-0.28
"JAK3 (JAK3:  Janus kinase 3 (a protein tyrosine kinase, leukocyte)"	0.5	0.44	0.95	0.82	0.76	0.6	0.2	0.34	0.53	0.6	0.46	0.32	0.28	-0.1	1.02	0.32	0.24	-0.39
"""MAD (mothers against decapentaplegic, Drosophila) homolog 9; Smad9"""	-0.54	-0.41	-0.44	-0.21	-0.32	-0.33	-0.65	-0.42	-0.44	-0.1	-0.27	-0.59	-0.61	-0.86	-0.16	-0.34	-0.16	-0.49
Smad anchor for receptor activation	-0.78	-0.24	-0.89	-0.56	-0.56	-0.65	-0.62	-0.23	-0.72	-0.25	-0.11	-0.75	-0.78	-0.86	-0.63	-0.54	-0.21	-0.34
CD28; (Tp44)	0.03	0.32	-0.11	0.11	0.29	0.38	-0.09	0.21	-0.01	0.18	0.19	0.16	0.56	-0.39	0.05	-0.05	-0.12	-0.29
"anti-oxidant protein 2 (non-selenium glutathione peroxidase, acidic calcium-independent phospholipase A2)"	1.34	1.61	1.53	1.54	1.69	1.55	1.28	1.38	1.35	1.35	1.51	1.37	1.38	0.68	1.4	1.16	0.86	0.46
glutathione peroxidase 4 (phospholipid hydroperoxidase)	-0.53	-0.09	-0.49	-0.31	-0.13	-0.13	-0.4	0.01	-0.34	0	0.16	-0.16	-0.65	-0.96	-0.06	-0.27	0.27	0.15
"""activin A receptor, type IB"""	-0.1	0.34	0.04	0.2	0.42	0.36	0.11	0.4	0.09	0.32	0.51	-0.03	-0.2	-0.92	0.31	0.18	0.51	0.23
down-regulated in adenoma protein (DRA)	-0.45	-0.42	-0.56	-0.27	-0.36	-0.4	-0.24	-0.27	-0.42	-0.35	-0.2	-0.48	-0.08	-0.13	-0.31	-0.21	-0.16	-0.66
heat shock 70-kDa protein 6 (heat shock 70-kDa protein B)	-0.38	-0.37	-0.25	-0.06	-0.21	-0.29	-0.2	-0.22	-0.19	-0.1	-0.15	-0.44	-0.12	-0.08	-0.13	-0.02	0.33	-0.06
Insulin-Activated Amino Acid Transporter	-0.76	-0.66	-0.96	-0.8	-0.82	-0.9	-0.75	-0.58	-0.76	-0.51	-0.35	-0.6	-0.41	-0.45	-0.82	-0.76	-0.1	-0.53
Histone(H2A.2)	0.55	0.57	0.34	0.35	0.4	0.33	0.7	0.71	0.64	0.82	0.85	0.85	0.83	1.16	0.55	0.59	0.99	0.63
20S Proteasome Subunit	-0.81	-0.48	-0.71	-0.97	-0.76	-0.84	-0.73	-0.43	-0.85	-0.45	-0.55	-0.83	-0.79	-0.15	-0.68	-0.72	0.05	-0.41
cell division protein kinase 3 (CDK3:  cyclin-dependent kinase 3)	-0.57	-0.02	-0.55	-0.55	-0.42	-0.45	-0.4	-0.18	-0.48	0.13	0.2	-0.55	-0.5	-0.06	-0.26	-0.06	0.68	0.01
corticotropin releasing hormone-binding protein	-0.65	-0.2	-0.57	-0.48	-0.37	-0.42	-0.48	-0.24	-0.48	-0.05	0.01	-0.42	-0.85	-0.86	-0.32	-0.19	0.12	-0.33
growth hormone receptor	-0.94	-0.41	-1.11	-0.86	-0.78	-0.74	-0.79	-0.36	-0.71	-0.41	-0.21	-0.65	-0.89	-1.02	-0.68	-0.47	0.08	-0.2
"""ESTs, highly similar to cholinergic receptor, nicotinic, alpha polypeptide 7"""	-0.01	0.21	0.02	0.08	0.19	0.25	0.14	0.45	0.06	0.29	0.38	0.03	-0.04	0.11	0.2	0.49	0.67	0.33
v-maf musculoaponeurotic fibrosarcoma (avian) oncogene homolog	-0.24	0.23	-0.27	-0.13	-0.06	-0.05	-0.19	0.14	-0.2	0.14	0.3	-0.07	-0.27	-0.29	-0.07	0.05	0.4	0.25
"""MAD (mothers against decapentaplegic, Drosophila) homolog 1; Smad1; bsp-1"""	-0.21	0.29	-0.09	-0.01	0.19	0.19	-0.18	0.19	-0.01	0.17	0.24	-0.3	-0.21	-0.81	0.17	0.02	0.39	0.06
diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor)	-0.85	-0.05	-0.83	-0.51	-0.23	-0.12	-0.44	0.02	-0.53	-0.02	-0.06	-0.7	-0.88	-1.15	-0.09	-0.07	0.44	0.17
"ATP Synthase Coupling Factor B (ATP-BL: ATP synthase, subunit b-like)"	0.79	0.5	0.44	0.58	0.52	0.47	0.74	0.68	0.73	0.47	0.88	0.77	0.73	0.58	0.32	0.56	1.63	0.8
"MDR (ABCB7:  ATP-binding cassette, sub-family B (MDR/TAP), member 7)"	2.74	2.8	2.68	2.67	2.59	2.71	2.72	2.76	2.64	2.7	2.84	2.88	2.57	3.04	2.73	3.15	3.63	3.8
proteasome subunit HC3	-0.04	0.06	-0.36	0.1	-0.29	-0.07	0.79	0.34	-0.17	-0.07	-0.02	-0.38	0.16	0.18	-0.26	0.39	0.57	0.56
"x-ray repair cross-complementing protein 2 (XRCC2), RAD51-like protein"	-0.51	-0.47	-0.61	-0.7	-0.58	-0.66	-0.72	-0.33	-0.63	-0.32	-0.37	-0.55	-0.29	0.06	-0.55	-0.58	0.11	-0.36
protein-tyrosine phosphatase MEG2 (PTPASE-MEG2)	-0.59	-0.39	-0.68	-0.6	-0.56	-0.7	-0.63	-0.45	-0.71	-0.35	-0.36	-0.62	-0.93	-0.27	-0.59	-0.77	0.19	-0.52
"heat shock transcription factor 4 (HHSF4, HSF4)"	-1.22	-0.4	-1.22	-1.21	-1.13	-1.1	-1.07	-0.65	-1.1	-0.61	-0.48	-0.89	-1.13	-0.73	-1.07	-1.07	0.19	-0.44
921-L Presynaptic Protein (BSN:  bassoon (presynaptic cytomatrix protein)(ZNF231)	0.38	0.55	0.54	0.49	0.54	0.5	0.3	0.23	0.42	0.55	0.63	0.56	-0.16	-1.04	0.51	-0.41	0.1	-0.4
cytochrome P450 IA2 (P450-P3) (P450-4)	0.28	0.56	0.52	0.47	0.62	0.45	0.34	0.4	0.46	0.58	0.39	0.26	0.53	-0.29	0.41	-0.04	0.19	0.02
endothelial transcription factor GATA2	2.67	2.74	2.04	2.16	2.15	2.22	2.68	2.75	2.67	2.84	2.98	3.09	2.97	2.5	2.47	2.82	3.33	3.41
novel centrosomal protein RanBPM	-0.06	0.34	-0.39	-0.5	-0.26	-0.01	-0.09	0.5	0.12	0.07	0.15	0.08	-0.14	-0.63	0.18	-0.06	0.32	0.41
eukaryotic translation initiation factor 4B	-0.19	0.4	0	0.01	0.14	0.15	0.03	0.3	0.03	0.3	0.33	-0.24	0.29	-0.49	0.19	0.09	0.54	0.17
"""calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism)"""	0.01	0.4	0.43	0.46	0.61	0.7	0.16	0.54	0.49	0.73	0.38	-0.03	0.43	-0.48	0.61	0.4	0.75	0.19
CCAAT/enhancer-binding protein epsilon (C/EBP epsilon; CEBPE)	4.25	4.51	4.01	4.06	3.94	4.06	4.07	4.2	4.16	4.19	4.38	4.46	4.24	4.09	4.11	4.55	5.16	5.71
rhoB 	1.12	1.93	1.4	1.32	1	0.79	0.89	1.19	1.57	0.62	0.74	1.03	0.86	1.39	0.85	1.01	1.42	1.29
cytoplasmic beta-actin (ACTB)/Actin 1(beta cytoskeletal actin)	1.82	1.94	1.88	1.85	1.82	1.75	1.65	1.93	1.78	1.81	1.85	1.94	1.73	2.39	1.85	2.14	2.61	2.67
galactosyltransferase-associated protein kinase p58 (GTA); cell division cycle 2-like 1 (CDC2L1; CLK1)/p130PITSL Cyclin-kinase	-0.74	-0.29	-0.87	-0.46	-0.45	-0.82	-0.88	-0.38	-0.5	-0.71	-0.37	-0.86	-0.76	-0.16	-0.97	-0.37	0.18	-0.19
apoptosis regulator bax	-0.89	-0.61	-1.14	-1.11	-0.87	-1	-0.89	-0.53	-1.06	-0.69	-0.5	-0.88	-0.83	0.16	-1	-0.7	0.42	-0.28
inhibitor of apoptosis protein1 (HIAP1; API1) +  IAP homolog C; TNFR2-TRAF signaling complex protein 1; MIHC	-0.81	-0.72	-0.93	-0.72	-0.72	-0.82	-0.82	-0.45	-0.76	-0.58	-0.36	-0.89	-0.96	-0.33	-0.69	-0.69	0.21	-0.17
"Ovalbumin Transcription Factor I (NR2F1:  nuclear receptor subfamily 2, group F, member 1)"	-0.7	-0.54	-0.38	-0.35	-0.36	-0.49	-0.39	-0.2	-0.48	-0.29	-0.33	-0.6	-0.41	-0.77	-0.51	-0.66	0.22	-0.29
"Oncogene Tls/Chop, fusion activated"	-0.24	0	-0.05	0.07	0.14	-0.03	-0.04	0.21	0.05	0.24	0.18	-0.19	0.06	-0.22	0.22	0.14	0.29	0.11
Cardiac Muscle Myosin Beta-Actin	-0.35	0.1	-0.37	-0.08	-0.12	0.05	-0.21	0.4	-0.03	0.42	0.25	-0.17	-0.27	-0.39	-0.03	0.11	0.86	0.22
peroxisome assembly factor-2 (PAF-2); peroxisomal-type ATPase 1; peroxin-6; PEX6; PXAAA1	-0.1	0.14	-0.16	-0.1	0.01	0.07	-0.08	0.22	-0.02	0.27	0.29	-0.16	0.54	-0.58	0.03	-0.05	0.45	0.14
RabB 	-0.8	-0.29	-1.1	-0.79	-0.54	-0.42	-0.57	0.02	-0.51	-0.08	-0.19	-0.72	-0.72	-0.99	-0.3	-0.01	0.39	0.21
ETFR-1 (TEA domain family member 5)	-0.26	0.1	-0.26	-0.18	0.04	0.1	0.04	0.28	-0.15	0.3	0.21	-0.17	-0.09	-1.11	0.11	-0.18	0.46	-0.01